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ABSTRACT 
 
 Gold nanoparticles (Au NPs) are being research extensively for various biomedical 
applications; their applicability arises from a unique set of optical and physical properties 
brought on by their nanoscale dimensions.1 Furthermore, facile and scalable synthetic and 
surface functionalization strategies for Au NPs make these properties highly tunable.1 These 
areas of research are still relatively new and the number of publications per year referring to 
gold nanomaterials has skyrocketed from 11 in 1990, to 673 in 2000, to more than 31,400 
in 2015 (Web of Science database, topic search = “gold nano*”, accessed March 2, 2016). 
The potential application of Au NPs for disease detection, diagnosis and therapy has 
motivated numerous analyses of their interactions with biomolecules, cells, animals, 
humans and the environment.1,2 A vast majority of studies aimed at gaining a better 
understanding of how cells interact with and are influenced by Au NPs have focused mainly 
on measuring cytotoxicity and simple cell processes like proliferation or NP uptake. While Au 
NPs larger than 4-5 nm in diameter (with appropriate, non-toxic surface coatings) have been 
shown to be largely non-cytotoxic, there can be subtle non-toxic effects induced by Au NPs.3 
The adsorption of soluble proteins onto NP surfaces (the protein corona) is highly studied, 
but little attention has been paid to how those interactions perturb gene expression of cells 
or to understanding NP interactions with other types of biomolecules. This thesis aims to 
look deeper into how molecular level effects of NPs in cells and cellular environments can 
lead to down-stream changes to cell gene expression and behavior. 
 Firstly, the impact of Au nanorods (Au NRs) on 3D cancer cell migration via 
interactions between Au NRs and extracellular matrix (ECM) structural proteins was 
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examined.4 While experiments on the influence of NPs on cell behaviors exist, nearly all of 
these studies neglect the impact of the ECM. In vivo cells exist in complex, fibrous 3D 
environments and series of intricate biochemical, cell-cell and cell-ECM interactions govern 
behaviors such as migration. Cancer cell migration allows tumor cells to spread and 
metastasize to new areas of the body, but little is known about how Au NR interaction with 
the ECM after injection and targeting to tumors may affect this process. The inevitable 
contact of in vivo Au NRs with the ECM presents a possible source of unintended side 
effects. In order to study how gold nanoparticles can influence ECM properties and cell-ECM 
interactions, we have created a nested-gel type I collagen matrix for measuring whether Au 
NRs alter the migration of MDA-MB-231 human breast cancer cells in 3D collagen 
environments. In contrast to the few studies of Au NR-induced migration changes in 2D 
environments, our results show that Au NRs in a model ECM increase the frequency of 
spontaneous cellular migration. The presence of negatively-charged polyelectrolyte-coated 
Au NRs during the collagen self-assembly process was shown to induce mechanical and 
structural changes, to alter molecular diffusion, and to affect cellular adhesion, morphology, 
locomotion strategy and protease expression. The results demonstrate the indirect impact 
nanoparticles can exert on cell behaviors within three-dimensional ECMs.  
 The shape and surface chemistry of Au NPs was also investigated in terms of the role 
of these factors in cellular transcriptomic (gene expression) responses after both short- and 
long-term exposures.5 Respectively, human dermal fibroblasts (HDF) and prostate cancer 
(PC3) cells were exposed to 0.1 nM (24 hours) and 1.0 nM (48 hours) concentrations of Au 
NPs of four different, but related surface chemistries. A combination of microarray gene 
expression analysis techniques and typical cellular characterization was used to learn more 
about how the nature of the Au NP surface coating influences cells on a molecular level. 
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Identity, charge and lability of surface coatings (and cell type and dosing parameters) were 
all implicated as important factors to consider in order to predict gene expression 
responses. In a separate study, HDF cells were exposed to 0.1 nM (low-dose) Au NPs of 
different shapes and surface coatings for 20 weeks. The long-term effects of acute (24 hour) 
and chronic (20 weeks) exposure were measured by viability, proliferation, NP uptake, and 
morphology studies combined with gene expression analysis of genes related to stress and 
toxicity pathways. It is rare to find chronic exposure studies, especially with Au NPs, and 
these experiments showed that acute, sub-cytotoxic doses of NPs may induce long-term 
stress on cells. These cells were found to react very differently to acute versus chronic doses 
of the same NPs after 20 weeks. Additionally, surface coating was shown to have a much 
larger impact on determining NP-cell interactions than shape of Au NPs. In all, we have 
expanded the collective understanding of the molecular interactions Au NPs experience 
inside cells based on surface chemistry, shape, dosage and exposure time and parameters. 
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CHAPTER 1: 
 
An Introduction to Gold Nanoparticles in Biological 
Environments 
 
1.1 Introduction to Gold Nanoparticles 
 Nanotechnology is a relatively new branch of interdisciplinary science that began to 
draw attention in the late 1980s and 1990s.1 Authors such as Richard Feynman helped to 
introduce a new way of thinking about technology and chemistry with a bottom-up 
approach.1,2 With creation of the scanning tunneling microscope and the atomic force 
microscope, the scientific community has been imaging and manipulating materials on the 
nanoscale for 30 years.3. Objects in the general size range of 1-100 nm are considered 
“nano”, including fullerenes, carbon nanotubes, quantum dots, and nanoparticles. The 
nanoscale opens up a whole new toolbox for scientists and engineers, as inorganic 
nanoparticles (NPs) exhibit properties very different from their bulk counterparts. These new 
properties arise because NPs have high surface-to-volume ratio and the surface atoms 
themselves determine the behavior of the particles, often translating into increased 
reactivity.4–6 Additionally, confinement of electrons to a small space (the particle volume) 
can induce interesting optical properties in metals, and quantum effects dominate the 
properties of very small nanoparticles (<2 nm for gold, <10 nm for semiconductors, etc.) to 
induce fluorescence or superparamagnetism.4,7–9 Finally, besides the size-related property 
changes, the size alone opens up new possibilities because biological processes occur 
fundamentally on the nanoscale.4–6,10,11 NPs can travel through plant and animal structures 
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and can even be passively directed to tumors depending on their size via the enhanced 
retention and permeation effect.12,13  
Gold nanoparticles (Au NPs) are one of the most highly studied NPs with a particularly 
long history dating back long before the idea of nanotechnology itself. In modern times, 
Michael Faraday (c. 1857) was among the first to understand the unique optical properties 
of colloidal gold particles and chemically prepare them.14 Since then, scientists (beginning 
with Gustav Mie in 1908) have described the theoretical underpinnings of the plasmonic 
properties of these particles.13,15–18 When the grain size of gold particles approaches the 5-
200 nm size range, the diameter of the particles is on the order of the mean free path of the 
electrons.19,20 When Au NPs are excited by light irradiation (the visible to near-infrared 
region for gold nanoparticles), the electrons begin to oscillate collectively about the particle 
in resonance with the light (Figure 1.1).17,19,20 This is called a localized surface plasmon 
resonance (LSPR) and is the basis for the radiative (scattering) and non-radiative 
(absorption, heat generation) optical properties of metal NPs.16–21 The frequency of light 
that induces the LSPR depends on the nanoparticle size, nanoparticle shape and dielectric 
constant of the material surrounding the nanoparticle, making the optical properties highly 
tunable.16–20 Spherical Au NPs have a plasmon at about 520 nm in water and appear red in 
color.16–20 The plasmon of spherical Au NPs has limited sensitivity to size and dielectric 
constant changes; the most effective way to shift the location of the plasmon in the visible 
to near-infrared (NIR) is to change the NP shape.16–19,22 Separate plasmons emerge when 
Au NPs become anisotropic.16–20 For Au nanorods (Au NRs), the transverse plasmon 
resonance corresponds to light being absorbed and scattered along the short axis and also 
appears at about 520 nm in water.16–20 The longitudinal plasmon resonance corresponds 
light being absorbed and scattered along the long particle axis and depends on the aspect 
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Figure 1.1 Schematic depicting the electron cloud oscillating about gold nanoparticles (Au 
NPs) and gold nanorods (Au NRs) in response to resonant incoming light. Figure adapted 
from Yasun et al.23  
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ratio (length/width) of the nanorod.16–20 This longitudinal plasmon is red-shifted to higher 
wavelengths throughout the visible-NIR-IR region, depending on the aspect ratio.16–20 The 
near-IR region corresponds to the “water window” where water absorbs very little; this 
means that NPs with plasmons in this region are particularly useful for optical applications 
involving biological systems. Various other shapes (nanocubes, nanocages, nanoplates, 
nanostars, etc.) and architectures (nanoshells, etc.) of Au NPs can be made to tune 
properties as well (Figure 1.2).12,13  
Other metal NPs (such as silver and copper) support plasmons in the UV-visible-NIR 
range of light, but gold is particularly suitable for biological applications. Silver has a higher 
extinction coefficient in the visible region than gold,24,25 but also can release Ag+ ions and 
cause cytotoxicity in biological systems.26,27 Gold is relatively chemically inert,28–30 and has 
been shown in many systems to induce low/no direct toxicity in humans and animals at 
sizes above 4-5 nm, unlike silver and copper NPs.26–29,31–34 Despite this inertness, it is still 
easy to change the original surface chemistry of Au NPs by way of electrostatic interactions 
(polyelectrolyte wrapping), by exploiting the strength of gold-thiol bonds (ligand exchange) or 
by ion exchange.12,30,35,36 Many different strategies have been employed to functionalize 
surfaces with specific molecules (hydrophobic entrapment, electrostatic absorption, 
covalent cross-coupling, click chemistry, direct gold-thiol attachment, oligonucleotide 
hybridization), and the choice of method depends of the desired lability of the ligands.12 
The facile and scalable synthesis of Au NPs of various shapes in water-based 
reactions adds to their applicability (synthesis schemes for some Au NP types will be 
discussed in the upcoming section).37,38 It is the unique combination of the ease of 
synthesis and surface manipulation, strong plasmonic properties (especially in the near-IR), 
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Figure 1.2 Electron micrographs of a variety of shapes and sizes of gold nanoparticles: a) 
small and b) large nanospheres, c) nanorods, d) sharp nanorods, e) nanoshells, f) 
nanocages, g) hollow nanospheres, h) tetrahedra/octahedra/cubes/icosahedra, m) rhombic 
dodecahedra, j) octahedra, k) concave nanocubes, l) tetrahexahedra, m) rhombic 
dodecahedra, n) obtuse triangular bipyramids, o) trisoctahedra, p) nanoprisms. Reproduced 
from Ref. 12 with permission from The Royal Society of Chemistry. 
 
 
 6 
 
low cytotoxicity and high stability in biological environments that makes these NPs ideal 
choices for various applications. Au NPs have been incorporated into chemical and 
biological sensors,13,39 as catalysts and electrocatalysts,40,41 in solar cells,42 and even for 
water treatment.43 Sensing is often based on chemical-induced shifts in the LSPR 
position/color (due to refractive index changes or aggregation states), fluorescence 
quenching or enhancement, or surface-enhanced Raman spectroscopy (SERS).13,39 In 
medicine, they have found application as contrast agents, for cell tracking and imaging, for 
drug and gene delivery, for radiotherapy and for photothermal therapy.12,13 Au NPs have 
been used as contrast agents in x-ray contrast tomography imaging,44 optical coherence 
tomography,45 and photoacoustic tomography.46 Cell imaging and tracking can be based on 
SERS, elastic light scattering or photoluminescence. Biomedical applications for Au NPs 
span all areas from diagnosis to treatment of disease and Au NPs allow for the combination 
of multiple functionalities into one NP package.47,48 
 
1.2 Synthesis of Gold Nanoparticles 
 With the variety of possible shapes and sizes, there are numerous procedures for 
making Au NPs. Throughout this thesis, three main types of Au NPs will be examined 
(nanospheres, “short” nanorods and “long” nanorods) and their synthetic schemes are 
briefly described here (Figure 1.3). The most basic Au NPs are nanospheres made by 
modification of the Turkevich method dating back to 1951.49,50 In this method, gold(III) 
chloride trihydrate (HAuCl4•3H2O, often termed HAuCl4) is boiled in water and the gold is 
reduced with sodium citrate. Here, there is quick nucleation step followed by slow growth of 
the NPs.51 The sodium citrate acts as both the reducing agent and the stabilizing agent, and 
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Figure 1.3 Synthesis schemes for 10-40 nm gold nanospheres. 1-2 nm gold seeds (used for 
seeded synthesis of gold nanorods), aspect ratio 1-5 gold nanorods, and aspect ratio 18 
gold nanorods. TEM image of 1-2 nm gold seeds adapted with permission from Ref. 52. 
Copyright © 2005 American Chemical Society.  
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size of the NPs can be increased (from ~10 nm up to ~40 nm) by reducing the amount of 
citrate present at the beginning or by increasing the boiling time.  
More complex shapes often require the use of seed-mediated synthesis procedures, 
and this is the case for gold nanorods (Au NRs). “Short” Au NRs (aspect ratio 1-5) are 
typically synthesized with a silver-assisted, seed-mediated procedure in the presence of 
cetyltrimethylammonium bromide (CTAB) surfactant.52,53 Gold “seeds” are first formed by 
sodium borohydride reduction of HAuCl4 in aqueous CTAB solution. This produces very small 
1-2 nm Au NPs stabilized by CTAB that are then used as seeds for Au NR synthesis; this 
allows for separation of growth and nucleation steps in order to make shapes other than 
spheres.37  For the Au NR growth, the growth solution contains more HAuCl4, high 
concentrations of CTAB, a small amount of silver nitrate (AgNO3) and ascorbic acid. Ascorbic 
acid is a weak reducing agent that partially reduces Au(III) without reducing all the way to 
Au(0); gold is only able to be fully reduced in the presence of nucleation sites (seeds) to grow 
the NRs.37,54 After the seed is added, the Au NRs begin to grow anisotropically. The amount 
of AgNO3 added to the growth solution determines the final aspect ratio of the Au NRs 
produced (Figure 1.4).37,54 The roles of CTAB and AgNO3 as anisotropic-growth-promoting 
agents seem to be very complex and intertwined. There are three best-supported 
mechanisms that are considered relevant in the community. The oldest is the “soft template 
mechanism” in which CTAB micelles (which coincidentally are rod-shaped at the necessary 
concentrations for Au NR growth) direct the shape of the Au NRs like a template.37,54 The 
role of the silver is explained by silver-bromide interactions changing the micellar shape and 
dimensions.55,56 Another proposed mechanism is that silver blocks the deposition of gold on 
certain facets of the growing Au NR by complexing with bromide from CTAB on those 
facets.37,54 The final mechanism also involves silver blocking gold deposition but that an  
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Figure 1.4 Increasing amounts of AgNO3 (Ag+) produces higher aspect ratio gold nanorods 
with plasmon peaks at higher wavelengths. Colored TEM boxes correspond to colored UV-Vis 
spectra. Concentrations on TEM images indicate AgNO3 concentrations. Scale bars are 100 
nm for 2-40 µM AgNO3 and 50 nm for 80-100 µM AgNO3. 
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underpotential deposition process reduces Ag(I) to Ag(0) only on higher-energy facets and 
preferentially blocking those facets.37,54 
“Long” gold nanorods (aspect ratio ~18 within the scope of this thesis) are also made 
by a seed-mediated procedure, but without AgNO3. It is not possible to push the silver-
assisted method to produce aspect ratios higher than about 7, even by tweaking other 
parameters. The previously-described borohydride-reduced CTAB gold seeds from the 
“short” Au NR synthesis procedure are used (different from the original 2001 long Au NR 
procedures using larger, citrate-stabilized seeds), and the growth solution also contains 
CTAB, HAuCl4 and ascorbic acid.57,58 The seeds still act as nucleation sites for deposition of 
partially reduced Au, but aliquots of the seed/growth solution are transferred to new growth 
solution in two sequential steps separated by 15 and 30 seconds. In the first step, the 
seeds grow isotropically and become twinned.59 Moving to fresh growth solution allows part 
of the seeds to become elongated and another step elongates these even more into high-
aspect ratio Au NRs.59 Simply, aspect ratio is dependent on the ratio of Au seed to Au salt in 
the growth solution, but the initial symmetry-breaking step must occur first before changing 
concentrations.60 The timing between sequential growth steps can be altered to change the 
aspect ratio of these Au NRs.57  
  Finally, surface modifications of Au NRs can be done post-synthesis in many ways. 
The two most commonly used strategies in the Murphy lab are layer-by-layer polyelectrolyte 
coating and ligand exchange processes (Figure 1.5). In general, all Au NRs must be modified 
after synthesis before they are used in biological applications. As-made Au NRs are 
stabilized by CTAB, which is highly toxic to cells by membrane disruption, although this 
adsorbed CTAB is less bioavailable than free CTAB.61 The negative charge of citrate or the 
positive charge of CTAB on as-made Au NPs can be exploited by introducing polyelectrolytes 
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Figure 1.5 a) As-made gold nanorods are stabilized by a bilayer of cetyltrimethylammonium 
bromide (CTAB). b) Two main strategies for changing the surface chemistry include 
displacing the CTAB with thiolated molecules or layer-by-layer polyelectrolyte coating. 
Adapted with permission from Ref. 29. Copyright © 2012 American Chemical Society.  
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of opposite charge that electrostatically wrap the NPs in the presence of salt.62,63 Multiple 
alternating steps can be done to obtain the desired coating and thickness from the NP 
surface.64 Another strategy is to displace the loosely bound citrate or CTAB with ligands with 
higher affinity to the gold surface. This is often done by utilizing gold-thiol chemistry. Many 
other surface chemistry strategies, including silica and lipid coatings, are commonly 
employed as well.  
 
1.3 Interactions of Gold Nanoparticles With Biomolecules: What We Know vs. 
What We Need to Know 
Nanoparticles of many compositions are currently present in commercial sectors 
relating to products, including automotive parts, home and garden supplies, sporting goods, 
cosmetics, clothing, sunscreens and even dietary supplements.65 The U.S. National 
Nanotechnology Initiative (NNI) has invested upwards of $22 billion since 2001 into 
nanotechnology research and development, and it is expected that the return on these 
investments will be recovered in the long run.66 For instance, while nano-based cancer 
therapy may cost more than chemotherapy at first glance, a recent study of the cost-
effectiveness found that reduced administrative and hospitalization costs would make nano-
based therapies cheaper overall.66 However, a vast majority (71%) of consumer products 
that claim benefit of nanomaterials to improve their function are entirely unsupported and 
only nine products out of 1259 were classified as “extensively verified claim” by the 
Nanotechnology Consumer Products Inventory (NCPI).65 The need to investigate, regulate 
and understand the potentially unique risks of NPs in real-world products has led to the 
development of non-profit groups like the NCPI (dedicated to tracking NPs in consumer 
 13 
 
products), and to the formation of guidelines for analyzing NP safety by the U.S. Food and 
Drug Administration in conjunction with the National Institute of Health’s Nanotechnology 
Characterization Laboratory.65,66 While there are few regulations in consumer products for 
NPs, few nano-based drug formulations have successfully passed federal regulations for use 
in medicine. This is because NPs have characteristics such as size, shape, surface coating 
and aggregation state that introduce new factors not considered with traditional drug 
evaluation studies, and the need for better characterization of NPs in biological systems 
before going to clinical trials is recognized throughout the scientific community.28,66,67 In 
order to successfully translate more nanomedicines from the research laboratory to the 
clinic, a more thorough understanding of all of the ways in which NPs may exert an effect on 
biological systems is required.  
For the case of Au NPs, there is not a strong presence in consumer products at this 
point, but they have great potential in medicinal applications (as discussed in Section 1.1) 
Studies of Au NPs in biological systems exist on all levels from human clinical trials and 
animal in vivo experiments, to cellular and molecular interactions. Many of these 
experiments are still at the exploratory or proof-of-concept levels, but there are Au NP-based 
drug formulations such as CYT-6091, for delivery of recombinant human tumor necrosis 
factor alpha via PEGylated 27 nm Au NPs, and AuroShells made of silica and gold, for 
photothermal therapy in Phase I and Phase II clinical trials.66,68 At least in vitro, it is 
generally accepted that Au NPs above 4-5 nm in diameter with proper surface coatings are 
non-cytotoxic at realistic doses (for reference, single Au NPs can be tracked in vitro with 
optical microscopy techniques, and CYT-6091 PEGylated Au NP drugs were used at 50-500 
µg/m2, or ~0.04-0.2 nM, in Phase I clinical trials)31–33,68,69 Our understanding of the 
physicochemical properties of NPs on toxic responses, cell uptake, biodistribution and 
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intracellular trafficking has vastly improved in recent years, but still relatively few studies 
examine effects of NPs on living systems beyond the obvious cytotoxicity assays. It is often 
taken for granted that an absence of acute toxicity to systems under Au NP exposure means 
minimal NP-cell interactions, but it is becoming increasingly clear that this is not a realistic 
interpretation. 
Upon entering the biological milieu, whether it be serum-containing media, blood, or 
tissue, NPs encounter countless types of biomolecules. It is now well-known that a protein 
corona forms around NPs in biological media and that the physicochemical properties of the 
NP greatly influence the identity and dynamics of the corona and what the cell “sees”.70–73 
Studies on how NP size, surface coating and aggregation state affect the formation of the 
protein corona, influence protein orientation (and possibly deactivation) and thus alter NP-
bio interactions are shedding light onto how NPs may react with biological systems in a 
variety of ways.71,74–76 For instance, at increasing blood plasma concentrations (in a range 
meant to mimic concentrations relevant in vitro to in vivo), the same NPs can have distinct 
protein corona compositions (by gel electrophoresis and electrospray liquid 
chromatography/mass spectrometry), and the identity of proteins adsorbed depends highly 
on the NP change and surface properties.71 The protein corona composition of Au NPs of 
three sizes with 67 different types of surface ligands was used to build a model showing that 
the protein corona “fingerprint” is a more accurate predictor of cell association than just the 
combination of size, aggregation and surface charge factors.74 Time does not seem to 
influence the protein corona in terms of composition, but switching from one biological 
medium to another can induce compositional changes.77,78 These are just a few examples of 
information available to try to piece together the puzzle to develop a more complete 
understanding of NP-protein interactions; the ultimate goal is to be able to predict cellular 
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impact of NPs based on their properties and to counteract the influence of the corona on 
targeting and uptake.74,79,80 From there, hopefully the field can then start to understand if 
and how these interactions might induce effects up to the organismal and environment 
levels.81  
NP adsorption of proteins can influence NP-cell interactions in more ways than simply 
determining cell association and uptake. As proteins inside cells exist in complex signaling 
networks and feedback loops for gene expression, NP-protein interactions can directly 
influence the gene expression of cells and possibly induce down-stream physiological 
changes. Many studies explore how NPs may influence gene expression as a way to 
measure cytotoxicity, but few recognize that non-toxic doses of NPs may induce differential 
transcription. Biomolecular interactions with NPs are thought to be especially sensitive to NP 
surface chemistry as opposed to other physicochemical NP characteristics, as evidenced by 
the formation of protein coronas. Decreased bioavailability of proteins after adhering to 
charged NP surfaces can trigger pathway changes that initiate cells to alter transcription 
rates. In this sense, there is more information to be gained about how NP-protein 
interactions can induce subsequent gene expression changes, especially in terms of NP 
surface chemistry at relevant, non-toxic dosages. 
Much as NPs can interact with soluble proteins by forming coronas and altering gene 
expression, they can also interact with structural proteins in the body. There are now 
hundreds of papers on NP protein coronas, but little attention has been paid to NP 
interactions with extracellular matrix (ECM) components, especially the structural proteins 
like collagens, elastin, fibronectin, laminin and proteoglycans.82 Any effects that NPs may 
have in this space have the potential to perturb the ECM structure and properties, and 
consequently cell morphology, adhesion, gene expression, migration, tumorigenesis and 
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differentiation.82 Many cell fate determinants, such as gene expression and cell migration, 
are highly dependent on cell-ECM interactions, so it is necessary to understand what, if any, 
role NP-ECM interactions play to impact cell-ECM interfaces.82 From a toxicological 
standpoint, this could be a way in which NPs could exert unexpected influence in vivo; when 
using NPs as therapeutic or diagnostic agents, it is imperative to understand how NP-ECM 
associations may enhance or diminish the desired outcome. From another point of view, if 
NP-ECM interactions can alter cell-ECM interactions and thus cell behaviors, control of these 
factors may give us another dimension of cellular control with NPs in vivo. 
Researchers are beginning to conduct nanotoxicology studies (including gene 
expression analysis) in 3D cultures to make more in vivo-like conditions for in vitro 
screening, as the lack of the ECM in 2D experiments often ends in results that are not 
applicable in real human bodies.83 It is well known that in vivo experiments in animals often 
do not accurately predict reactions in humans, and 3D cultures with human cells are seen 
as a way to bridge the gap.83 Other experiments to measure NP-cell interactions beyond 
nanotoxicology have moved to 3D as well. Lee et al. measured the toxicity of Au NPs to cells 
in 3D spheroid culture and found the toxic effects of 5.5 nm CTAB-coated Au NPs at 98.5 µg 
Au/mL (~92 nM NPs) to decrease in 3D relative to 2D (citrate Au NPs were non-toxic in both 
settings).84 TiO2 NPs were found to be non-toxic to A549 cells in 2D cultures over a range of 
concentrations but influenced cell-cell interactions in 3D spheroids.85 It seems that most of 
the 3D studies of NP-cell interactions occur in spheroid models, which incorporates a third 
dimension, but still does not accurately mimic the fibrous matrix structure cells encounter in 
vivo. This fibrous structure is especially important for cell migration, as cells migrate in 3D by 
adhering to, deforming and breaking down the fibrous ECM component.86–89 The current 
need is to extend NP-cell interactions into 3D fibrous matrices to identify ways in which NPs 
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can interact with structural proteins and to deduce whether these NP-ECM interactions are 
important on a cellular and organismal level. 
 
1.4 Thesis Overview 
To further examine the ways in which NPs influence cells on a molecular level, 
experiments on both gene expression changes and phenotypic changes via NP-ECM 
component interactions were conducted. In Chapter 2, the novel measurements of gold 
nanorod-collagen interactions and the influence of gold nanorods on cell behavior in three 
dimensions are discussed. This work stems from an earlier set of work in the Murphy group 
describing the ability of high aspect ratio Au NRs in type I collagen gel to inhibit the ability of 
cardiac fibroblasts to convert to contractile, tissue-remodeling myofibroblasts.90,91 
Additionally, different shapes of Au NPs with various surface coatings were found to 
enhance or inhibit migration in 2D depending on cell type.92 These two studies indicated 
that Au NRs in model ECM may exert an effect in such a way as to change the ability of cells 
to migrate through 3D models. In order to test this, we created a nested-gel type I collagen 
matrix for measuring whether Au NRs alter the migration of MDA-MB-231 human breast 
cancer cells in 3D collagen environments. We found that the ability of these metastatic 
cancer cells to migrate was enhanced, as more cells were prompted to move to the nanorod-
containing outer gel.93 Subsequent studies attempt to untangle the mechanism of the 
observed migratory phenotype changes induced by the presence of Au NRs by thorough 
characterization of the migrating cells and the collagen hydrogel structure and properties.93 
Microstructural and mechanical property changes, as well as possible alterations in 
biochemical diffusion, could all play roles in the observed phenomenon.  
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 While there is a lot of data about how NP surface chemistry alters protein corona 
composition, we currently have only a vague understanding of how NP surface chemistry 
influences gene expression. In Chapter 3, we were able to learn more about how surface 
chemistry alters gene expression by changing the surface coating of 20 nm spherical Au NPs 
and analyzing cells exposed to these NPs by DNA microarray.94 Citrate-, poly(allylamine 
hydrochloride)- (PAH), and lipid-coated Au NPs were made, with the negatively-charged lipids 
being attached by either electrostatic or hydrophobic interactions. Human dermal fibroblast 
(HDF) cells were exposed to NPs at 0.1 nM for 24 hours and prostate cancer (PC3) cells at 
1.0 nM for 48 hours to mimic environmental and therapeutic exposures. By analyzing gene 
expression patterns by pathway analysis and comparing between NP types by weighted gene 
co-expression network analysis, we found that not only the charge, but also the identity and 
lability of the outermost coating layer influences gene expression.94 Surface coating 
influence cell uptake rates as expected, but this was not directly correlated to the gene 
expression patterns.94 Overall, different NP types (citrate Au NPs were found to have 
negligible effect on gene expression) changed gene expression levels of genes associated 
with cell cycle, inflammation, proliferation and others based on cell type and NP dose.94 
In Chapter 4, the long-term effects of chronic and acute exposure of HDF cells to low 
doses (0.1 nM) of Au NPs and Au NRs was measured in one of the first studies of the kind. 
Chronic samples were exposed to 0.1 nM NPs in the media continuously for 20 weeks, while 
“non-chronic” samples were only exposed for 24 hours in the first week and then cultured 
for the full 20 weeks in normal media. Both spherical Au NPs and Au nanorods were studied, 
and a similar surface coating of poly(acrylic acid) (PAA) was used to directly compare the 
effects of shapes. Two popular surface coatings were used for each shape (citrate and PAA 
for spheres, PAA and PEG for nanorods) to compare between different surface coatings on 
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the same shape/size of NP. Alongside viability, proliferation, morphology and NP uptake 
experiments, gene expression analysis of 84 genes associated with stress and toxicity 
pathways was conducted. We found that in terms of stress and toxicity pathways, all these 
NPs appear to be relatively safe. Interestingly, PEG-coated NPs induced the most gene 
expression changes and all non-chronic samples had many more gene expression changes 
than the chronic counterparts. PEG NPs were found to escape endosomes inside of cells 
and this is likely the reason they induced more stress on the cells than other NPs. However, 
the differences between chronic and non-chronic gene expression patterns indicate that the 
ability of cells to regain homeostasis over a long period of time after acute NP exposure may 
be impaired, while a sort of tolerance may be developed under chronic exposure. 
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CHAPTER 2: 
Gold Nanorods Indirectly Promote Migration of Metastatic 
Human Breast Cancer Cells in Three-Dimensional Cultures* 
 
2.1 Introduction 
In the past few decades, nanomaterials have become highly prevalent in the 
biomedical research community for a wide range of applications.1 Gold nanorods (AuNRs) in 
particular are uniquely suited for numerous biological applications due to both their optical 
and physical properties.1-3 These relatively chemically inert, plasmonic nanoparticles (NPs) 
are being investigated for use in biomedical imaging, tracking and sensing, drug and gene 
delivery, and photothermal therapy of cancer.1-10 Moreover, the optical properties of AuNRs 
can be tuned throughout the near-IR “water window” region by facile and scalable synthetic 
strategies, and interactions with biomolecules can be modulated via surface 
functionalization.10-12 
Due to the pervasiveness of nanomaterials in medicine, much research has focused 
on the fundamental understanding of how NPs interact with cells on the molecular and 
organismal levels. There exists substantial data on the cellular uptake and accumulation of 
gold NPs and their effect on simple cell behaviors such as survival and proliferation.13-16 It is 
being increasingly recognized that the “protein corona” plays a large role in the impact of 
 
* This chapter is reprinted (and adapted) with permission from: Grzincic, E.M.; Murphy, C.J. ACS Nano 2015, 9, 
6801-6816. Copyright © 2015 American Chemical Society.  
 26 
 
NPs on cells.17-19 Recently, our group and others have studied the effect of gold NPs on cell 
migration, an essential process in embryogenesis, wound healing and cancer cell 
metastasis.20 We found that gold NPs of various shapes and surface coatings deposited on 
a surface inhibited two-dimensional (2D) cell migration of PC3 cells, while shape and surface 
coating determined the effect on HDF cell migration.21 Positively-charged gold nanospheres 
and AuNRs increased migration rates of HDF cells, while PEGylated gold nanospheres and 
AuNRs inhibited migration.21 Negatively-charged gold nanospheres inhibited migration while 
negatively-charged AuNRs enhanced migration in these cells.21 Others have shown AuNRs to 
inhibit 2D migration of MDA-MB-231, PC3 and B16F10 cells after NP cellular uptake.22 
Other types of NPs were shown to inhibit cell migration as well.23 All of these studies have 
suggested that nanoparticles alter cellular adhesion to the substrate. Furthermore, NPs in 
collagen matrices have been shown to alter cellular phenotypes in cardiac fibroblasts, 
possibly due to the ability of NPs to adsorb soluble factors from the environment.24-25  
Cell migration is a highly matrix-dependent process and 2D studies have not taken 
the extracellular matrix (ECM) into account when observing migrating cells exposed to gold 
NPs.26-28 Typical cell migration through fibrillar matrices (fibrillar type I collagen is the main 
structural component present in ECM of connective tissue) occurs as a cycle.29 Leading 
edge protrusions form and focal adhesions in the front and rear of the cell cause cell 
elongation.29 This is accompanied by proteolytic ECM breakdown, followed by rear-end 
contraction and matrix detachment to move the cell forward.29 Not only is the typical 
process of proteolytic matrix degradation not observed in 2D migration studies on hard 
tissue culture plastic, but the role of substrate adhesions in movement is altered. The 
importance of adhesion contacts in cell migration is actually two-fold: they allow cells both to 
generate traction forces and to sense their mechanical environment.30-31 ECM mechanical 
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properties and microstructure have been shown to be critical factors in the metastatic 
potential of tumor cells (particularly in breast cancer)32 as these factors determine the level 
of steric hindrance cells experience, whether the cells can deform the matrix, and the 
diffusion of soluble biochemical factors.26-34 Furthermore, mechanotransduction pathways 
allow cells to “feel” changes in these properties from a distance and respond directly in a 
myriad of ways.34-37 AuNRs injected into the body for any application would not only come 
into contact with a large assortment of cell types, but also with the three-dimensional (3D) 
ECM containing structural and soluble proteins. NPs themselves are known to adsorb 
soluble biochemical factors in cellular environments, therefore they have the potential to 
alter signaling gradients in 3D matrices that trigger cells to migrate.17-19,25,38 Accordingly, the 
interplay of AuNR-ECM interactions is a largely missing dimension in the study of cell-AuNR 
interactions. 
In order to study the effect of AuNRs in the ECM on cell migration, we have mimicked 
the ECM of MDA-MB-231 human breast cancer cells with 3D type I collagen cell cultures, 
then measured spontaneous cell migration through an outer layer of collagen with and 
without AuNRs. Type I collagen is a ubiquitous component of the ECM and self-assembled 
type I collagen produces a soft mammary gland-like environment ideal for MDA-MB-231 
cells.39 In addition to comparing average frequency of migration in these cell populations, 
we also measured other factors involved in cell migration, including the morphology of the 
migrating cells, locomotion mechanism, β1-integrin expression, overall cell adhesion and 
matrix metalloproteinase expression. The microstructure and mechanical properties of the 
3D collagen gels with and without AuNRs were studied in order to measure changes that 
might alter the ability of cells to move through or deform the matrix. Additionally, we 
measured molecular diffusion rates through gels containing different AuNR concentrations 
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to determine whether the 3D porous collagen/AuNR structure could alter biochemical 
gradients of soluble factors.  
 
2.2 Materials and Methods  
2.2.1 Materials 
Gold (III) chloride trihydrate (HAuCl4•3H2O, ≥99.9%), sodium borohydride (NaBH4), 
hexadecyltrimethylammonium bromide (CTAB, BioUltra), poly(sodium-4-styrenesulfonate) 
(PSS, M.W. 70,000 g/mol), and poly(diallyldimethylammonium chloride) (PDADMAC, very low 
molecular weight) were all purchased from Aldrich and used as received. PureCol type I 
bovine collagen solution (3 mg/mL) was purchased from Advanced BioMatrix. 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) was purchased from Research 
Products International and 10X minimal essential medium (MEM) was purchased from 
Sigma. MDA-MB-231 cells (ATCC® HTB-26™) were obtained frozen from ATCC. Cell culture 
medium contained Dulbecco’s modified eagle medium (DMEM, without phenol red), non-
essential amino acids and penicillin-streptomycin solution from Mediatech, and fetal bovine 
serum (FBS) from Gemini Bio-Products. Medium contained 2.5 μg/mL Fungizone® 
antimycotic (Gibco) when AuNRs were added. All solutions were made with ultrapure 
deionized water (18.2 MΩ, Barnstead NANOpure II) and all glassware was cleaned with aqua 
regia prior to use for AuNR synthesis. All cell culture and experiments were done in a sterile 
environment using typical sterile techniques. Brightfield time-lapse microscopy was done on 
a Zeiss Axio Observer Z1 inverted compound microscope (with incubation chamber, heated 
stage and CO2 sensor) and confocal fluorescence microscopy, confocal reflectance 
microscopy and fluorescence recovery after photobleaching (FRAP) measurements were 
performed on a Zeiss 710 multiphoton confocal microscope. Transmission electron 
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microscopy (TEM) was done on a 2100 JEOL Cryo TEM and scanning electron microscopy 
(SEM) was done on a Hitachi 4700 SEM. Rheological measurements were collected on a TA 
Instruments AR-G2 rheometer. Absorption spectra of RNA were collected with a Nanodrop 
1000 instrument (Thermo Scientific; Wilmington, DE). qPCR was done on the 7900HT Fast 
Real-Time PCR System (Applied Biosystems) with corresponding Sequence Detection 
Systems software (Applied Biosystems). 
 
2.2.2 Synthesis and Preparation of Gold Nanorods 
Aspect ratio 18 AuNRs were synthesized via a scaled-up version of our seed-
mediated three-step approach, as previously described.40-41 ~4 nm diameter gold seeds 
were made first by reduction of 250μm aqueous HAuCl4 in 0.1 M CTAB with 0.01 M NaBH4. 
This solution was stirred (~10 min) and used in a three-step growth procedure after 5 h. For 
the three-step growth procedure, three growth solutions of 0.1 M CTAB, 250 μM HAuCl4, and 
500 μM ascorbic acid were prepared, with the first two solutions containing a final volume of 
about 36 mL and the final solution containing about 360 mL in a glass flask. 4 mL of the 
gold seed solution was transferred to the first growth solution, and after 15 s, 4 mL of this 
first solution was transferred to the second growth solution. After another 30 s, the entire 
second solution was transferred to the final growth solution. This was allowed to sit 
overnight before pouring off the supernatant and rinsing the AuNRs off the bottom of the 
flask with water. These nanorods were washed by centrifugation (3,500 rcf, 10 min) twice 
and autoclaved (for use in cell culture experiments) before being concentrated and coated 
with polyelectrolytes. 
Layer-by-layer deposition of polyelectrolytes onto the CTAB-coated AuNRs was done 
as previously described,42 but under sterile conditions in order to keep AuNRs free of 
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contamination before use with cell studies. All solutions used for LbL coating were made in 
autoclaved 18MΩ/cm water in sterile containers. The success of each wrapping step was 
verified by a ZetaPALS zeta potential analyzer (Brookhaven Instruments Corporation). Briefly, 
the positively-charged as-prepared AuNRs were shaken in 1 mL of 1 mM NaCl and 200 μL of 
10 mg/mL PSS for approximately 1 h. The polymer was removed by centrifugation at 3,500 
rcf for 10 min and the newly negatively-charged AuNRs were again shaken in 1 mL of 1 mM 
NaCl, this time with 200 μL of 10 mg/mL PDADMAC. After centrifugation, again the AuNRs 
were put into the PSS wrapping solution for 1 h and centrifuged. The pellet was finally 
redispersed into sterile water and the concentration was determined by the absorbance at 
the transverse peak by UV-Vis spectroscopy with a Cary 500 Scan UV-Vis-NIR 
spectrophotometer (Varian). 
 
2.2.3 Three-Dimensional (3D) Migration Assay 
MDA-MB-231 cells were grown to confluency in cell culture flasks and used before 
passage 10. Cells were detached with trypsin/EDTA and resuspended in freshly-prepared 
1:1:8 (v/v/v) of 10X MEM:2 M HEPES (pH 9.0):collagen solution to a cell concentration of 
200,000 cells/mL. The light pink cell/collagen solution was then pipetted in 100 μL aliquots 
into the wells of a 96-well plate. These “inner gels” were incubated at 37°C and 5% CO2 to 
polymerize for at least 1 h before adding medium. The medium was added while detaching 
the gels from the wells by injecting the medium under the gels with a syringe. After adding 
the medium, the gels were placed back into the incubator overnight. The next day, AuNRs 
were transferred into microcentrifuge tubes and centrifuged at 3,500 rcf for 10 min. The 
supernatant was removed and the pellet was redispersed in 10X MEM and HEPES solutions, 
followed by collagen solution to make the final 1:1:8 collagen solution. AuNRs were added 
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just prior to polymerization in order to get enough AuNRs into the sample. Samples were 
made with AuNR concentrations varying between zero and 3x1010 rods/mL collagen solution 
(1x109 rods/mL = ~1.7 pM, 5x109 rods/mL = ~8.3 pM, 1x1010 rods/mL = ~17 pM, 2x1010 
rods/mL = ~33 pM, 3x1010 rods/mL = ~50 pM) . This collagen/AuNR solution was used to 
mold into “outer gels” to encapsulate the previously made cell-containing “inner gels”. To do 
this, 150 μL of the collagen/AuNR solution was added to coat the bottom of one well of an 
8-well chamber slide. Then, using a syringe, one “inner gel” was transferred on top of this 
aliquot, followed by a second 150 μL of the collagen/AuNR solution to embed the “inner 
gel”. The “outer gel” was then allowed to polymerize for at least 1 h at 37°C and 5% CO2 
before adding a small volume of complete medium (with 10% FBS) on top of each gel 
construct. The gels were then incubated for four days to allow for cell migration before 
imaging. The medium on top of the gels was changed daily to keep the cells healthy; some 
nanorod loss in the washings was observed. Images were taken all around the perimeter of 
the inner gel, wherever any cells had moved across the interface. “AuNR-treated” control 
samples were made by replacing untreated cells with cells that had been exposed to 3x1010 
rods/mL in 10 mL media in the culture flask for 24 hours before being trypsinized and 
suspended in freshly prepared 1:1:8 (v/v/v) of 10X MEM:2 M HEPES (pH 9.0):collagen 
solution to a cell concentration of 200,000 cells/mL. “Antibody-treated” control samples 
were made with cells that had been pre-treated with 10 μg/mL P5D2 anti-β1-integrin 
blocking antibody for 15 min at 37°C and 5% CO2  prior to encapsulation in collagen 
solution. “PSS control” samples were made with untreated cells encapsulated in 1:1:8 
(v/v/v) of 10X MEM:2 M HEPES (pH 9.0):collagen solution with the addition of 0.1 mg/mL 
PSS. PSS was dissolved in the 10X MEM solution prior to incorporation into the collagen 
solution. 0.1 mg/mL is excess of a rough estimate of the concentration of PSS in the 3x1010 
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rods/mL gels, assuming a 3.0 nM coating,42 and using the powder density of PSS and the 
average dimensions of the AuNRs. 
 
2.2.4 Nanorod Uptake and Toxicity Analysis  
The toxicity of the collagen/AuNR gels was determined using a MarkerGene™ 
Live:Dead/Cytotoxicity Assay Kit. 200,000 cells/mL were cultured in 1:1:8 (v/v/v) 10X 
MEM:2 M HEPES (pH 9.0):collagen solution or collagen solution containing between 1x109 
and 3x1010 rods/mL gel for 24 h with medium in 8-well chamber slides. The gels were 
transferred to a 24-well plate and washed several times for 15 m increments in 1X 
phosphate buffered saline (PBS) before being stained for 1 h with a working solution of 2 
μM carboxyfluorescein diacetate and 4 μM propidium iodide (PBS) from the kit. Gels were 
washed several times with 1X PBS and imaged by fluorescence microscopy. Three separate 
gels were imaged for each sample type in ten random spots per gel (>1,000 cells per AuNR 
concentration).  
 Nanorod uptake was visualized by first culturing 200,000 cells/mL in 3x1010 
rods/mL 1:1:8 (v/v/v) 10X MEM:2 M HEPES (pH 9.0):collagen for 4 days with medium in 8-
well chamber slides. Gels were then scooped into a type I collagenase (Invitrogen) solution 
(1,000 units/mL medium) for 30 min at 37°C. After all collagen was dissolved, cells were 
washed in medium three times to remove non-endocytosed AuNRs, before plating 30,000 
cells into a 35 mm well glass-bottomed culture dish (MatTek Corporation). After allowing 
cells to adhere for 1 h, any additional AuNRs not inside cells were washed away by five 
washes with medium. Samples were then fixed for 15 min with 4% pre-warmed 
paraformaldehyde (in PBS), permeabilized for 10 min with 0.5% Triton X-100 (Sigma, 
BioUltra) and stained with 1:100 fluorescein phalloidin (Molecular Probes, F-actin stain) for 
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1 h and 300 nM 4’,6-diamidino-2-phenylidole dihydrochloride (DAPI, Molecular Probes, 
nuclei stain) for 30 min. Completed samples were imaged by confocal fluorescence 
microscopy and the AuNRs were visualized by their reflectance signal with a 488 nm argon 
laser. Inductively coupled plasma mass spectrometry (ICP-MS) studies were attempted for 
quantification of AuNR uptake, but were unsuccessful with extremely large variation 
between samples as a result of variable separation of cell-bound nanorods and gel-bound 
nanorods. We believe that this is because it is difficult to separate nonendocytosed AuNRs 
of this size and surface coating from the cells by centrifugation; the AuNRs aggregate after 
collagenase treatment and easily sediment on their own so that they cannot be reliably 
separated from the cells. Therefore, as an alternate to AuNR uptake quantification by ICP-
MS, a set of experiments were done in which cells were directly incubated with extremely 
large quantities of AuNRs, and these “AuNR-treated” cells were then subject to the inner 
gel/outer gel migration experiments. 
 
2.2.5 Rheology of Collagen/AuNR Gels  
All components of the collagen solution were kept on ice and the 1:1:8 (v/v/v) 10X 
MEM:2 M HEPES (pH 9.0):collagen solutions were prepared immediately before individual 
rheology measurements. Each sample was loaded into a parallel plate geometry (40 mm top 
plate with solvent trap) with a 500 μm gap with the temperature-controlled bottom plate set 
to room temperature. The edge of the sample was coated with mineral oil and the solvent 
trap filled with water to prevent dehydration. The temperature of the bottom plate was then 
raised to 37°C and the samples were allowed to polymerize between the plates for 30 min 
while monitored under sinusoidal shear strain at 2 rad/s and 1% strain. After 30 min 
polymerization, the sample was subjected to a frequency sweep between 0.1 to 10 Hz at 1% 
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strain (linear viscoelastic region verified with amplitude sweep). Three samples were run for 
each of the six tested AuNR concentrations. 
 
2.2.6 Microscopy of Collagen/AuNR Gels  
Gels were imaged by various methods. For confocal reflectance imaging, 200 μL 
freshly-prepared 1:1:8 (v/v/v) 10X MEM:2 M HEPES (pH 9.0):collagen solution (with various 
AuNR concentrations) was placed on top of a clean glass coverslip and covered by another 
coverslip. These samples were incubated at 37°C for at least 1 h before imaging. Three 
samples were made for each AuNR concentration and Z-stack image sets were collected 
with a 63x oil objective in five random spots per sample from ~50 μm above the bottom 
coverslips for 80 slices of ~0.40 μm thickness (total range of 31.43 μm). The reflectance 
signal of a 488 nm argon laser was collected. 
 Gels for scanning electron microscopy (SEM) were prepared by two separate 
methods. In the first method, 1:1:8 (v/v/v) 10X MEM:2 M HEPES (pH 9.0):collagen solution 
(with or without AuNRs) was pipetted onto clean glass coverslips and allowed to polymerize 
at 37°C for 1 h. The samples were then fixed with 2% aq. glutaraldehyde overnight, followed 
by four 15 min washes with deionized water. Samples were dehydrated by stepwise ethanol 
addition (30%, 50%, 70%, 85%, 100% ethanol) followed by CO2 supercritical drying, SEM 
sample mounting and sputter coating with Au/Pd. SEM samples were also prepared by a 
second method in which they were first fixed with Karnovsky’s fixative in a microcentrifuge 
tube, washed with Sorenson’s buffer, fixed with osmium tetroxide and dehydrated by 
stepwise ethanol addition. The samples were then mixed with 1:1 ethanol and 
hexamethyldisilazane (HMDS), then incubated in pure HMDS and dried, SEM sample 
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mounted and sputter coated with Au/Pd. Samples were gently centrifuged between steps. 
Dried samples were stored under vacuum. 
Samples for transmission electron microscopy (TEM) were prepared much like the 
second type of SEM sample. 1:1:8 (v/v/v) 10X MEM:2 M HEPES (pH 9.0):collagen samples 
(with or without AuNRs) were polymerized in microcentrifuge tubes and fixed with 
Karnovsky’s fixative, followed by washing with Sorenson’s buffer and fixing with osmium 
tetroxide (potassium ferrocyanide added 10 min before end of incubation). The samples 
were then washed, dehydrated by stepwise ethanol addition and transitioned to epoxy using 
acetonitrile. After allowing the sample to harden in pure epoxy at 70°C overnight, the 
microcentrifuge tube was removed and the end was clipped and reset on an epoxy stub. 
Finally, after re-hardening, the sample blocks were cut with a diamond knife and left 
unstained.  
 
2.2.7 Dye Diffusion Experiments  
For the visible dye diffusion experiments, 1:1:8 (v/v/v) 10X MEM:2 M HEPES (pH 
9.0):collagen gels were prepared by molding 3 mL of collagen solution (without AuNRs or 
with 3x1010 rods/mL) into glass vials and incubating at 37°C overnight. Aqueous 1 mM 
Methylene Blue (Sigma) or 1 mM Remazol Brilliant Blue R (Sigma) were carefully pipetted on 
top of the gels at a fixed volume. The dyes were allowed to diffuse through untouched 
overnight. 
 For fluorescein fluorescence recovery after photobleaching (FRAP), 1:1:8 (v/v/v) 10X 
MEM:2 M HEPES (pH 9.0):collagen gels were prepared in 8-well chamber slides and allowed 
to gel overnight at 37°C. The gels were then transferred to a 24-well plate and incubated in 
3 mg/mL aq. sodium fluorescein (Acros Organics) for 8 h. Samples were transferred to 
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glass-bottomed culture dishes immediately before FRAP experiment, covered with remaining 
fluorescein solution and covered with a No. 1 glass coverslip. FRAP was done ~50 μm from 
the bottom of the sample with a 70 nm circular region of interest. Bleaching was started 
after ten 1 s scans (out of a total of 200 1 s scans) with a 488 nm argon laser at 100% 
power (25.0 mW) for 800 iterations. When not bleaching, scans were collected with the 488 
nm laser at 0.09% power. 
 
2.2.8 Confocal Fluorescence Microscopy of Cells 
Live cells cultured in 1:1:8 (v/v/v) 10X MEM:2 M HEPES (pH 9.0):collagen collagen 
gels were stained for F-actin and nuclei for analysis of cell morphology. Cells were first 
cultured at 200,000 cells/mL in collagen without AuNRs or with 3x1010 rods/mL collagen 
for 4 days in 8-well chamber slides. Gels were fixed with 4% pre-warmed paraformaldehyde 
(in PBS) for 1 h at RT and then transferred to a 24-well plate. Long (5-15 min) washing steps 
in PBS were done multiple times between each step. Gels were permeabilized for 10 min 
with 0.5% Triton X-100, blocked with 1% bovine serum albumin (BSA, ChemCruz) and 10% 
FBS for 1 h, and stained with 100 nM rhodamine phalloidin (Cytoskeleton, Inc.) for 90 m 
and 300 nM DAPI for 30 min before being stored in PBS at 4°C. Samples were imaged with 
confocal fluorescence microscopy.  
 Cells were also stained for β1-integrin expression inside the 1:1:8 (v/v/v) 10X MEM:2 
M HEPES (pH 9.0):collagen or collagen/AuNR gels. For this, 4-day old gels were fixed 
overnight with 4% pre-warmed paraformaldehyde (in PBS) at RT, followed by a 
blocking/permeabilization step with 1% BSA, 10% FBS and 0.5% Triton X-100 overnight at 
RT. Gels were washed at least three times with PBS for 5 min between the remaining steps. 
Anti-β1-integrin blocking antibody, clone P5D2 (mouse monoclonal, EMD Millipore) was 
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added to the samples at 2 μg/mL in PBS with 1% BSA and 0.3% Triton X-100 for 24 h. 
1:100 goat anti-mouse Alexa Fluor 488-conjugate secondary antibody (EMD Millipore) was 
then added for 4 h at RT, followed by 300 nM DAPI for 30 min at RT. Samples were then 
imaged with confocal fluorescence microscopy. AuNR-treated cells were also tested as 
controls exactly the same way, but cells were exposed to 3x1010 rods/mL in 10 mL of media 
for 24 hours in a culture flask before being re-cast into collagen gels. 
 
2.2.9 Brightfield and Time-Lapse Microscopy of Cells  
Brightfield micrographs were collected with transmitted light through a 10X objective. 
Live cells in 1:1:8 (v/v/v) 10X MEM:2 M HEPES (pH 9.0):collagen (with or without AuNRs) 
were imaged under incubation conditions (37°C, 5% CO2) with medium. Antibody-treated 
cells pre-treated with 10 μg/mL P5D2 anti-β1-integrin blocking antibody for 15 min at 37°C 
and 5% CO2 and AuNR-treated cells exposed to 3x1010 rods/mL in 10 mL of media for 24 
hours in a culture flask were also imaged in collagen. Only migrated cells (cells that were in 
the outer gel) were counted in morphology studies. For time-lapse studies, images were 
taken every 10 min for 24 h of live cells under incubation conditions. 
 
2.2.10 Cell-Matrix Adhesion Assays  
Cell-matrix adhesion assays were done in 96-well plates, and as described by Kucik 
and Wu.43 The wells were first coated with 100 μL 1:1:8 (v/v/v) 10X MEM:2 M HEPES (pH 
9.0):collagen solution (some without AuNRs, some with 3x1010 rods/mL as designated by 
sample type) overnight at 37°C and 5% CO2. The wells were then blocked with heat-
denatured 10 mg/mL BSA in PBS for 1 h at 37°C and 5% CO2. The wells were then washed 
twice with PBS and 100 μL of 3x1010 rods/mL PBS were added to the collagen/AuNR-
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coated wells (“collagen/rods + rods”, 100 μL PBS was added to all others) for 1 h at 37°C 
and 5% CO2. The wells were washed twice more with PBS and 100 μL of 400,000 cells/mL 
medium was added to each sample well for 2 h at 37°C and 5% CO2 (not including blanks, 
to which 100 μL of medium was added instead). For control samples (“collagen + cells”), 
cells were added to wells coated with MEM/HEPES/collagen solution. For 3x1010 rods/mL 
samples (“collagen/rods + cells”) cells were added to wells coated with 
MEM/HEPES/collagen containing 3x1010 rods/mL. For antibody-treated samples (“collagen 
+ antibody-treated cells”), cells were incubated in medium with 10 μg/mL P5D2 anti-β1-
integrin blocking antibody for 15 min at 37°C and 5% CO2 before adding to wells coated 
with MEM/HEPES/collagen solution (no AuNRs). For nanorod-treated samples (“collagen + 
nanorod-treated cells”), 3x1010 rods/mL medium was added to the cells in the culture flask 
for 24 h before trypsinizing and adding to wells coated with MEM/HEPES/collagen solution 
(no AuNRs). After incubation with cells, wells were washed twice with PBS and 60 μL of 
substrate solution (3.75 mM p-nitro-pheno-N-β-D-glucosaminide, 50 mM citrate, pH 5.0) 
were added to each well and incubated at 37°C and 5% CO2 for 90 min. Finally, 90 μL of 
stop buffer (5 mM EDTA, 50 mM glycine, pH 10.4) was added to each well, and the plate 
was read at 405 nm. Due to the optical absorbance of both AuNRs and collagen solutions, 
proper blanks (no cells) were made with just MEM/HEPES/collagen, AuNRs/collagen and 
AuNRs/collagen with additional rods added on top. 
 
2.2.11 Quantitative Real-Time Polymerase Chain Reaction (qPCR) 
In order to analyze the relative expression of matrix metalloproteinase (MMPs), 
quantitative real-time polymerase chain reaction (qPCR) analysis was performed. For control 
samples and samples with 3x1010 rods/mL collagen, cells were cultured at 200,000 
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cells/mL in MEM/HEPES/collagen with the appropriate amount of AuNRs (control contained 
no AuNRs). For antibody-treated samples, cells were first incubated with 10 μg/mL P5D2 
anti-β1-integrin blocking antibody in 10X MEM for 15 min at 37°C and 5% CO2 before 
adding the HEPES and collagen product solution to 200,000 cells/mL. For nanorod-treated 
samples, cells were first allowed to uptake AuNRs from medium (3x1010 rods/mL medium) 
for 24 h in a cell culture flask before being trypsinized and cultured in the collagen solution 
at 200,000 cells/mL. After 4 days culture, samples were removed from collagen with a 
1,000 unit/mL collagenase solution (in medium) at 37°C and 5% CO2. The cells were 
washed in medium once and then left as a pellet. Total RNA was extracted and purified per 
manufacturer’s protocols using an RNeasy Midi kit (Qiagen). Briefly, Buffer RLT was added to 
the cell pellet and cells were homogenized by rapid mixing and vortexing. 70% ethanol was 
mixed in and the lysate solution was added to the RNeasy spin column and centrifuged at 
4,000 rcf for 5 min. Flow-through was discarded and centrifugation and flow-through steps 
were repeated with Buffer RW1 and twice with Buffer RPE. RNA was finally eluted with 
RNase-free water and tested for concentration and quality by absorbance readings (stored 
at -80°C until ready to dilute and use). For each sample type, RNA was collected and 
processed separately for three separate samples and each of these samples was analyzed 
in duplicates in the final PCR assay. 
 The PCR reaction was done using the AgPath-ID™ one-step RT-PCR kit (Applied 
Biosystems), as previously described.44 Reverse transcription and amplification of 2 μL of 25 
ng/μL purified RNA was done in a 10 μL reaction mixture containing 5 μL of 2X RT-PCR 
buffer, 0.4 μL of 25X RT-PCR enzyme mix,1.25 μL yeast RNA (5 mg/mL, Ambion) and 0.5 μL 
TaqMan® gene-specific primer/probe sets (Applied Biosystems). The primer/probe sets 
(FAM labels) used were as follows: MMP1, Hs00899658_m1; MMP2, Hs01548727_m1; 
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MMP9, Hs00234579_m1; MMP13, Hs00233992_m1 and MMP14, Hs01037009_g1. 
Three reference genes, GADPH (Hs99999905_m1), B2M (Hs_99999907_m1) and HPRT1 
(Hs99999909_m1) were analyzed as well, but only HPRT1 ended up being suitable as a 
reference gene for this cell type. mRNA of the probed genes was quantified by qPCR (10 min 
at 45°C, 10 min at 95°C and then 40 cycles of 15 s at 95°C and 45 s at 65°C). Non-
template controls were used as controls for each primer/probe set. Relative expression 
levels were calculated after normalization against the HPRT1 reference gene. Statistical 
analysis of the qPCR data was performed using the web-based RT2 Profiler™ PCR Array Data 
Analysis software (SABiosciences, www.SABiosciences.com/pcrarraydataanalysis.php). This 
software transforms Ct values to fold changes using the ΔΔCt method with normalization to 
the reference/housekeeping gene via geometric mean. 
 
2.3 Results 
 
2.3.1 Spontaneous Migration of MDA-MB-231 Cells is Enhanced through 3D Collagen 
Matrices Embedded with Gold Nanorods 
MDA-MB-231 cells were chosen due to their high mobility and metastatic potential. 
Type I collagen was used not only because is it a good choice for mimicking a simple fibrous 
matrix for this cell type, but also because its transparency makes it ideal for live cell 
imaging. In order to culture MDA-MB-231 cells in a biomimetic 3D environment while still 
being able to measure migration of whole populations, we used a 3D nested gel matrix 
design (Figure 2.1a).45-46 This allowed us to surround a 3D cell culture (“inner gel”) with a 
secondary collagen gel containing AuNRs (no cells) at various concentrations (“outer gel”). 
This structure created a clear interface between the inner and outer gels that was used as a 
boundary condition for counting how many cells had migrated from the inner gel to the outer 
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Figure 2.1 a) Schematic of 3D nested collagen gels for migration assays. The inner gel 
contains 200,000 cells/mL and the outer gel contains up to 3x1010 rods/mL. b) 
Transmission electron micrograph of aspect ratio 18 AuNRs used in outer gels (scale bar = 
100 nm). c) Example brightfield micrograph of cells migrating from inner gel to outer gel in 
3x1010 rods/mL sample (scale bar = 200 μm).  
 
 
 
gel (Figure 2.1c). The AuNRs used in these experiments are aspect ratio 18 (~280 nm by 
~16 nm) AuNRs triple-coated in polyelectrolytes so that the final layer is a negatively-
charged layer (poly-stryene sulfonate, PSS) (Figure 2.1b). These AuNRs were chosen for this 
study because they are known to induce changes in type I collagen mechanical properties 
and to alter the ability of cardiac fibroblasts to contract collagen gels.24,47 The AuNRs were 
added to the liquid neutralized collagen solution immediately before curing into a gel at 
37°C. Collagen/AuNR environments were non-toxic at all concentrations to the cells (Figure 
2.2). The incubation of preformed collagen gels in AuNR solutions led to little incorporation 
of the nanorods into the gels. However, as cells are continually remodeling their ECM, it is 
not unreasonable to expect that nanoparticles in the ECM could be exposed to cells.39, 48  
The migration experiments were run over a range of five different AuNR 
concentrations from 1x109 rods/mL of collagen solution (~1.7 pM) to 3x1010 rods/mL 
(~50.0 pM) and control samples containing no AuNRs. The experiments lasted four days to 
allow sufficient spontaneous cell migration from the inner to the outer gels and twelve
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Figure 2.2 a) Fluorescence image of cells in control collagen gels and b) in gels containing 
3x1010 rods/mL stained for live (green) and dead (red) cells (scale bars = 100 μm). c) 
Percent alive (%) for each AuNR concentration in collagen tested. n > 1000 cells. 
 
 
 
separate gels were analyzed for each AuNR concentration over four separate experiments. 
The results are shown in Figure 2.3: as the concentration of AuNRs in the outer gel 
increases, the number of cells that spontaneously migrate from the inner gel to the outer gel 
increases. This biological action-at-a-distance effect of NPs on cells is unprecedented. We 
hypothesize that the mechanism(s) by which AuNRs in collagen enhance spontaneous 
migration is by a) changing the mechanical and structural properties of the collagen gel 
networks and/or b) altering biochemical gradients, both in a migration-favored manner. 
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Figure 2.3 3D migration assay results showing the average number of migrating cells 
counted per gel sample (n = 12) as percent of control (control = without AuNRs or any other 
treatment) for each of the AuNR concentrations tested and antibody-treated, AuNR-treated 
and PSS controls. Error bars represent standard deviation. Data is relative to controls 
because data for some sample types comes from different sets of experiments with their 
own controls. The standard deviation of the control for 1x109 rods/mL through 3x1010 
rods/mL samples is 48.6%, for antibody-treated and AuNR-treated samples is 48.7% and for 
PSS control samples is 3.7%. The dashed line indicates 100% (average of control) for 
reference. *p<0.05, **p<0.01 (brackets indicate the p-value between two sample types, no 
bracket = relative to control). 
 
 
 
The cellular uptake of AuNRs alone has been inferred to alter the migration of cells in 
2D experiments.21-23 In 3D, it was not clear to what extent this observation would hold. The 
inner gel/outer gel geometry was chosen to make measurement of cell migration and 
direction relatively easy; in addition, this geometry allows distinct chemical and mechanical 
environments for cells to sample in 3D. Cells were found to uptake some AuNRs after four 
days when well-mixed with AuNRs in collagen gels, indicating that cells migrating from the 
inner to the outer gel can pick up AuNRs as they move (via confocal imaging, Figure 2.4). 
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Figure 2.4 Confocal fluorescence/reflectance images of MDA-MB-231 plated on slides after 
removal (using collagenase) from culture in collagen with 3x1010 rods/mL. Green signal is 
stained F-actin, blue is stained nuclei, and yellow is reflectance from nanorods, which were 
observed to be inside of the cells. Scale bars are 20 μm.  
 
 
 
ICP-MS experiments to rigorously quantify the degree of AuNR uptake failed, due to 
problems in separation of gel-bound rods from cell-bound rods (see Materials and Methods). 
As an alternative approach, migration studies with cells that had previously uptaken large 
numbers of AuNRs (~32,000 AuNRs per cell by ICP-MS) before being cast into the collagen 
gels were performed.. The outer gel for these samples was then pure collagen, with no 
additional AuNRs. The migration of “AuNR-treated” cells was found to have negligible 
difference from controls, as seen in Figure 2.3. Therefore, it appears that in 3D, merely 
bearing a load of nanoparticles does not impact cell migration (in terms of numbers of cells 
that move across a boundary, not rate).  
 Another mechanism by which AuNRs could alter cell migration is if they blocked the 
cellular machinery that makes physical contact to collagen; the principal cell surface protein 
that binds to type I collagen is β1-integrin.49 To test the role of β1-integrin adhesion in the 
observed migration changes, migration of cells that had been pretreated with anti-β1-
integrin blocking antibody was also measured in the inner gel/outer gel setup (“antibody-
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treated”). These samples showed a slight increase in migration compared to controls, but 
these results are statistically insignificant. This data might suggest “integrin fouling” is not 
the primary determinant in the change in cellular behavior, but this assumes that the 
number of integrins per cell is constant. This is not the case; there appear to be fewer 
integrins per cell once the cells have “seen” nanorods (see below). Lastly, to determine if 
observed migration changes could be due simply to the PSS coating of the AuNRs and not 
the AuNRs themselves, controls in which the outer gel contained excess PSS (0.1 mg/mL, 
based on a rough estimate of PSS content on the AuNRs, see Materials and Methods 
section) were analyzed and negligible difference from control was measured in this case as 
well. These three types of samples/controls were first treated by live/dead analysis for 
consistency (Figure 2.5). For all subsequent experiments, both AuNR-treated and antibody-
treated samples were analyzed for both consistency in controls and additional information 
about the possible mechanism of action. 
                               
Figure 2.5 Percent alive relative to control (%) for each AuNR concentration in collagen 
tested and antibody-treated, AuNR-treated and PSS control cells.  
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2.3.2 Cells Become Rounded in the Presence of Collagen Gels Containing Gold Nanorods 
 In order to understand how overall cell migration is increased in collagen/AuNR gels, 
characterization of the entire system (cells and matrix) was done (Figure 2.6). We first 
characterized the migrating cells in ways that are relevant to different parts of the cell 
migration cycle (mode of migration, adhesion, proteolysis). First, we compared the 
morphology of cells that had migrated into an outer gel containing no AuNRs (control) and 
cells that had migrated into a 3x1010 rods/mL outer gel by brightfield microscopy and 
confocal fluorescence microscopy (Figure 2.7). It was observed that more of the migrated 
cells in the AuNR-containing gels were in a rounded morphology and tended to be more 
detached from neighboring cells than in controls. To quantify the difference in morphology, 
we measured the aspect ratio of 600 cells from random brightfield micrographs to get a 
measure of “roundness” (Figure 2.7e).47 It was found that the cells in the AuNR-containing 
gel were significantly more rounded on average (mean aspect ratio/”elongation factor” was
 
        
Figure 2.6 Characterization techniques used for understanding influence of gold nanorods 
on cell-matrix interactions and cell migration.     
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Figure 2.7 a) Representative micrograph of cells that had migrated from the inner gel to the 
outer gel without AuNRs (control) and b) with 3x1010 rods/mL after four days (scale bars = 
200 μm); c) Representative confocal fluorescence micrograph of cells that had migrated 
from the inner gel to the outer gel without AuNRs (control) and d) with 3x1010 rods/mL after 
four days. Cells are stained for F-actin (green) and nuclei (blue). Scale bars = 20 μm); e) Box-
and-whisker plots of elongation factor (aspect ratio) distribution of migrated cells in collagen 
(striped) and 3x1010 rods/mL collagen (white) samples. Center line denotes median, top 
and bottom boxes are 75th and 25th percentiles, whiskers are inner fence limits (1.5 
interquartile range, with cut-off at 1.0 since as a minimum) and plus sign marks the mean 
elongation factor. n = 300, ***p<1.0x10-10. 
 
 
 
4.3 for collagen samples and 2.1 for collagen/AuNR samples). Additionally, AuNR-treated 
cells and antibody-treated cells migrating into collagen outer gels had a mean elongation 
factor of 4.4 and 3.7, respectively (Figure 2.8). The difference in elongation factor from 
controls for AuNR-treated cells was insignificant, but the antibody-treated cells showed slight 
rounding relative to controls (p = 0.012) to land in between the measurement for cells in 
collagen and collagen/AuNR samples. 
Using time-lapse brightfield microscopy, we were able to observe that cells in the 
AuNR-containing gel constructs actually migrated in a rounded fashion. Rather than the 
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cyclic elongation-contraction normally migrating control cells exhibit, cells migrating through 
AuNR-containing collagen seem to propel themselves forward without elongation. 
Chronological images of a representative control cell and rounded cell moving are shown in 
Figure 2.9 (a and b respectively). Mesenchymal or fibroblast-like migration is the term for the 
typical cyclic migration of cells.50-53 These cells first produce leading edge protrusions, which 
are stabilized by binding to the ECM via integrin receptors, inducing integrin clustering and 
focal adhesion formation.27,50-53 These adhesion sites serve as traction sites as the  cells 
moves forward over them, and then they are disassembled at the cell rear, allowing it to 
detach and contract.27,50-53 However, sometimes tumor cells can go through a reversible 
mesenchymal-amoeboid transition where they can quickly switch to an amoeboid mode of 
migration depending on environmental conditions.50-53 The most obvious characteristic 
 
Figure 2.8 Box-and-whisker plots of elongation factor (aspect ratio) distribution of migrated 
cells in collagen (thin diagonal stripes, control) and 3x1010 rods/mL in outer gel (vertical 
stripes), and antibody-treated (thick diagonal stripes) and AuNR-treated (white) cells in 
collagen. Center line denotes median, top and bottom boxes are 75th and 25th percentiles, 
whiskers are inner fence limits (1.5 interquartile range, with cut-off at 1.0 as a minimum) 
and plus sign marks the mean elongation factor. n ≥ 300, ***p<1.0x10-10, *p<0.05 relative 
to control. 
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Figure 2.9 Chronological series of brightfield micrographs from time-lapse experiments 
showing a) normally migrating cell moving through collagen (from Movie S1) and b) round 
migrating cell moving through 3x1010 rods/mL collagen (from Movie S2). Scale bar = 50 μm. 
Bottom right corner of each image denotes time duration in minutes. Red arrow shows cell 
of interest.  
 
 
 
difference between the mesenchymal and amoeboid modes are that amoeboid cells are 
rounded.50-53 Rather than extending protrusions with the force of actin polymerization, 
amoeboid cells use the flexibility of their cytoskeletons to propel and squeeze themselves 
through the ECM with low or nonexistent adhesion to the matrix.50-53 In addition to the 
rounded nature of migration, amoeboid cells are characterized by lack of integrin clustering, 
lack of protease activity (as the cells squeeze through existing space in the ECM and do not 
need to break it down), changes to RhoA-ROCK and Rac signaling pathway activation, and 
locomotion velocity.50-53 On the basis of morphology and time-lapse videos, the movement 
 50 
 
observed in the AuNR-containing gels seems to be an example of amoeboid migration. A 
mesenchymal-amoeboid transition has been documented in the literature to occur many 
times in cancer cells, including this specific cell type, under protease-blocking 
conditions.50,54-55  
 
2.3.3 The Presence of Gold Nanorods is Correlated to Decreased Cellular Adhesion to the 
Matrix 
To further investigate the possibility of a mesenchymal-amoeboid transition occurring 
when cells migrate through AuNR-containing collagen matrices, we then measured the 
ability of cells to adhere to the collagen. Changes to the ECM stiffness and density also 
influence the ligand density, thus the ability of cells to adhere to the network.51-53 Amoeboid 
cells are characterized by reduced cellular adhesion and diffuse, unclustered integrins.51-53 
Figure 2.10 shows representative images of migrating cells in control gels (no AuNRs, Figure 
2.10a-c) and in gels containing 3x1010 rods/mL (Figure 2.10d-f). These cells are 
immunostained for β1-integrins and that signal is shown in green (blue in some images is 
from DAPI staining). β1-integrins were chosen for analysis because the two main type I 
collagen integrin receptors both contain β1 components.49 Images were collected at the 
same parameters. It was found that in control samples, cells had much higher β1-integrin 
expression overall and extensive integrin clustering was observed in most cells. In contrast, 
in cells migrating through AuNR-containing collagen, very low β1-integrin signal was 
observed and the integrins are very diffuse throughout the entire membrane (no clusters 
observed). This is consistent with decreased focal adhesion formation and amoeboid 
migration. AuNR-treated cells appear very similar to control images (Figure 2.11). 
 51 
 
 
Figure 2.10 Confocal fluorescence micrographs of migrating cells in a-c) collagen and d-f) 
3x1010 rods/mL collagen gels, stained with FITC-tagged P5D2 anti-β1-integrin antibody 
(green) and DAPI (blue). Representative images were collected at same imaging parameters 
between samples for ~300 cells. Scale bars are a) 20 μm, b) 20 μm, c) 10 μm, d) 20 μm, e) 
20 μm, and f) 10 μm. 
 
 
 
 
 
Figure 2.11 Confocal fluorescence micrographs of AuNR-treated cells migrating through 
collagen with FITC-tagged P5D2 anti-β1-integrin antibody (green) and DAPI (blue). Scale bars 
are all 20 µm. All microscope and image settings are the same as in Figure 2.10. 
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 To directly measure cellular adhesion, collagen and collagen/AuNR gels were formed 
and cells were allowed to adhere to the tops. By washing away free, unattached cells and 
then staining the still-adhered ones, we acquired a relative measure of cellular adhesion 
proportional to absorbance of the dye (Figure 2.12).43 The dye used was p-nitro-pheno-N-β-
D-glucosaminide, which only turns yellow when metabolized by N-acetyl-β-D-glucosaminidase 
in live cells (absorbance is linearly related to cell number over a wide range).43 We tested 
cellular adhesion to control collagen gels (circle in Figure 2.12) and to collagen/AuNR gels 
(3x1010 rods/mL, square in Figure 2.12). Additionally, to determine if any differences in 
adhesion between collagen and collagen/AuNR gels were solely due to 
stiffness/microstructure changes and not the AuNRs themselves, we also tested 
collagen/AuNR gel samples onto which additional AuNR were allowed to settle on top of the 
already-formed gels before adding the cells (triangle in Figure 2.12). As a positive control, 
cells pre-treated with anti-β1-integrin blocking antibody (antibody-treated) were tested on 
collagen gels (upside-down triangle in Figure 2.12). To determine if adhesion was altered 
simply by the uptake of the AuNRs, AuNR-treated cells were also tested on collagen gels 
(diamond in Figure 2.12). It was found that cell adhesion was decreased on collagen/AuNR 
gels and further decreased on collagen/AuNR with additional rods deposited on top. These 
results confirm that decreased β1-integrin expression and clustering in cells migrating 
through collagen/AuNR gels is correlated with decreased cellular adhesion. Furthermore, 
the AuNRs themselves between the cells and the matrix further decrease the ability of cells 
to adhere and similarly decreased adhesion was measured in antibody-treated cell samples. 
Cells that had previously uptaken Au NRs actually showed stronger adhesion to collagen 
gels.
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Figure 2.12 Averaged normalized absorbance of p-nitro-pheno-N-β-D-glucosaminide, which is 
proportional to number of adhered cells, for each type of sample tested. Circle = cells 
adhered to collagen, square = cells adhered to 3x1010 rods/mL collagen, triangle = cells 
adhered to 3x1010 rods/mL collagen with additional AuNRs deposited on top of gel before 
addition of cells, upside-down triangle = P5D2 β1-integrin blocking antibody-treated cells 
adhered to collagen and diamond = cells that had previously been exposed to 3x1010 
rods/mL medium before adhering to collagen. n = 8, **p<0.001 relative to control. 
 
 
 
It should be noted that cells used for β1-integrin expression analysis were cultured 
well-mixed directly in collagen with 3x1010 rods/mL for the AuNR-containing samples. This 
was done in order to closely study a large population of cells that model cells that have 
already migrated, i.e. have already reached the outer gel. The separation of cells and AuNRs 
into inner and outer gels is a tool for measuring the role of AuNRs in the extracellular 
environment on the migration of large numbers of cells using a clear starting point. However, 
for the integrin expression and matrix metalloproteinase expression measurements, it was 
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necessary to mix cells directly with AuNR-containing collagen in order to measure large 
quantities of only the cells that had ultimately been exposed the outer gel. 
 
2.3.4 Gold Nanorods Up-Regulate Matrix Metalloproteinase Expression but RhoA/ROCK/Rac 
is Unchanged 
In order to measure the effect of the collagen/AuNRs on the proteolytic process, RNA 
expression of multiple matrix metalloproteinases (MMPs) were quantified by qPCR in cells 
that had been cultured in collagen or 3x1010 rods/mL collagen/AuNR gels for four days 
before RNA extraction. Amoeboid-like migration is typically non-proteolytic migration because 
cells can move through existing pathways in the collagen network.50-55 Antibody-treated cells 
and AuNR-treated cells were also tested as controls, after being cultured in collagen for four 
days. The collagenases MMP1 and MMP13, gelatinases MMP2 and MMP9 and MMP14 (a 
membrane-bound MMP, also known as MT1-MMP) were tested. The results from qPCR are 
tabulated in Table 2.1 (and also graphed as fold change and raw Ct in Figure 2.13. All five 
MMPs tested were up-regulated with respect to controls (cells in only collagen) while none 
were altered with antibody-treated cell samples or with cells that had previously uptaken 
AuNRs (MMP13 was actually down-regulated in these samples). The up-regulation of 
proteases by the cells in collagen/AuNR gels is inconsistent with traditional amoeboid-like 
migration, though the amoeboid-like classification is mostly determined by the shape and 
mode of locomotion.50-55 Additionally, RhoA, ROCK1 and Rac1 were tested and found to be 
unaltered relative to control for any of the conditions. Increased Rho/ROCK signaling is 
associated with high contractility characteristic of amoeboid cell lines and is inhibitive of 
Rac-driven processes.50-55 Rac is a regulator of lamellipodia in mesenchymal cells and it’s 
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Table 2.1 qPCR Results 
 
 
Collagen/AuNRsa Antibody-Treatedb AuNR-Treatedc 
Gene FCd p-valuee FC p-value FC p-value 
MMP1 3.65 6.0x10-3 0.88 5.4x10-2 1.05 0.55 
MMP2 2.60 4.0x10-3 1.07 0.44 1.40 5.1x10-3 
MMP9 3.23 1.8x10-3 0.65 2.8x10-3 1.14 0.30 
MMP13 2.09 2.4x10-2 0.50 7.0x10-3 0.37 5.0x10-3 
MMP14 2.10 1.2x10-2 0.81 0.12 0.76 7.2x10-2 
RHOA 1.24 0.26 0.66 7.8x10-3 0.54 4.2x10-3 
RAC1 1.70 0.28 1.68 0.14 1.27 2.9x10-2 
ROCK1 0.82 0.45 0.79 1.9x10-2 0.72 2.9x10-2 
 
 
aSamples of RNA from cells cultured in collagen containing 3x1010 rods/mL. bSamples of 
RNA from cells treated with P5D2 β1-integrin blocking antibody prior to culture in collagen. 
cSamples of RNA from cells treated with 3x1010 rods/mL AuNRs for 24 h prior to culture in 
collagen. dFold change (FC) is the difference in expression relative to control. For example, 
FC of 2 means that the expression is 2-fold higher than in controls, and FC of 0.5 means 
that expression is 2-fold decreased or half the expression than in controls. Up-regulated FCs 
(FC > 2) shown in bold and red and down-regulated (FC < 0.5) in bold and blue. eData 
considered significant if p-value is <0.05. Significant p-values highlighted in bold font.  
 
 
 
deactivation is connected to rounded morphologies.50-55 The absence of changes detected 
in the expression of these proteins is also incongruous with amoeboid migration. 
 
2.3.5 Gold Nanorods Make Collagen Gels Stiffer and More Elastic 
 To explore ways in which the AuNR-collagen interactions could have contributed to 
the altered cell-collagen interactions, thorough characterization of the collagen networks 
themselves was completed. We first performed rheological studies on the collagen/AuNR 
gels in order to elucidate how ECM properties are changed by the addition of AuNRs (Figure 
2.14). For each sample, the still-liquid collagen solution with varying concentrations of 
AuNRs was placed in a parallel plate geometry (sample is between an oscillating top plate 
and a stationary bottom plate) set to 37°C. The sample polymerization was monitored by 
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Figure 2.13  a) Average raw threshold cycle (Ct) values for each set of samples tested by 
qPCR. Error bars denote standard deviations. b) Fold change values between the average Ct 
values for each sample type relative to the average Ct value for controls. Error bars denote 
the 95% confidence interval. **p<0.01, *p<0.05. Dotted lines indicate the upper and lower 
boundaries imposed to determine if the fold change is significant for this study. Above the 
upper limit or below the lower limit is considered interesting. c) Fold regulation values 
change fold change values below 1.0 to negative numbers in order to visualize up- and 
down-regulation more easily. **p<0.01, *p<0.05. Values above the positive dotted line or 
below the negative dotted line are significant.  
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Figure 2.14 a) Storage (solid lines) and loss (dashed lines) moduli (Pa) over time (s) for 
representative control (black lines) and 3x1010 rods/mL collagen samples. Still-liquid 
samples were loaded into rheometer immediately before starting t = 0 and allowed to 
polymerize at 37°C for 30 min while under oscillations at 2 rad/s and 1% strain. b) Average 
storage (white bars) and loss (striped bars) moduli at 1 Hz for each AuNR concentration 
tested. *p<0.05, **p<0.01 (compared to control samples).  
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watching the increase in the storage and loss moduli (storage modulus is the stored energy, 
in-phase, elastic component of the stress/strain relationship in viscoelastic materials, while 
the loss modulus is the measure of energy dissipation and denotes the out-of-phase, viscous  
component) with time under a sinusoidal shear strain at 2 rad/s and 1% strain for 30 min. 
Representative data from one control gel and one gel with 3x1010 rods/mL is shown in 
Figure 2.14a. It was observed that the lag time before significant collagen polymerization 
(fibrillogenesis) occurs is much shortened with the addition of AuNRs, and this effect was 
seen with all concentrations of AuNRs tested. 
Each sample, after it was allowed to fully polymerized (30 min), was subjected to a 
frequency sweep from 0.1 to 10 Hz at 1% strain to obtain measurements of final storage 
and loss moduli across multiple frequencies. The storage and loss moduli for each AuNR 
concentration at 1Hz are shown in Figure 2.14b (full averaged frequency sweep curves are 
shown in Figure 2.15). These results show that the collagen becomes stiffer (higher storage 
modulus) and more elastic (decreased tan(δ), plotted in Figure 2.16), but that the stiffness 
and elasticity is not measurably different for different AuNR concentrations. 
 
2.3.6 Gold Nanorods Alter Collagen Gel Structure 
Imaging of the microstructure was done by multiple techniques. Confocal reflectance 
microscopy allowed us to examine the density of collagen fibrils of a wet gel in the same 
state as during cell culture conditions (Figure 2.17a-b). When comparing the 3D 
reconstructed Z-stack images (made by compiling the 80 images taken at 0.4 μm slices), 
the collagen fibrils (white signal) appear more densely packed, more frequent and shorter in 
AuNR-containing gels than in control gels. Images from other concentrations of AuNRs can 
be seen in Figure 2.18 and the signal increase from the collagen reflectance with increase 
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Figure 2.15 Frequency sweep curves averaged over three samples per AuNR concentration 
with error bars at select points. Data collected in 43 points (step size 20) from 0.1 to 10 Hz 
at 1% strain. Solid lines represent storage modulus and dashed lines represent loss 
modulus. 
 
 
Figure 2.16 Averaged tan(δ) values (tan(δ) = loss modulus/storage modulus) over three 
samples per AuNR concentration at 1 Hz. *p<0.05, **p<0.01 
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Figure 2.17 Microscopy of collagen gels with and without AuNRs. Confocal reflectance 3D 
reconstructed Z-stack image of a) collagen and b) 3x1010 rods/mL collagen gels (scale bars 
= 20 μm); scanning electron micrographs of dehydrated c) collagen and d) 3x1010 rods/mL 
collagen gels on glass slides (scale bars = 1 μm) and of dehydrated, condensed and 
sideways-mounted e) collagen and f) 3x1010 rods/mL collagen gels (scale bars = 1 μm); 
transmission electron micrographs of g) collagen samples and h) 3x1010 rods/mL collagen 
samples (scale bars = 3 μm). i-l) Increased magnification images of AuNRs in 3x1010 
rods/mL collagen samples. AuNRs appear black while collagen appears dark gray. Scale 
bars are i) 500 nm, j) 1 μm, k) 200 nm and l) 1 μm.  
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Figure 2.18  Representative 3D reconstructed Z-stack confocal reflectance microscopy 
image compiled from 80 images taken at 0.4 μm slices for a) control gels, b) 1x109 
rods/mL, c) 5x109 rods/mL, d) 1x1010 rods/mL, e) 2x1010 rods/mL and f) 3x1010 rods/mL. 
 
 
 
in AuNR concentration was quantified using ImageJ (Figure 2.19). Scanning electron 
microscopy (SEM) was used in order to analyze individual fibrils at much higher 
magnifications. Figure 2.17c and 2.17d are representative SEM images of dehydrated gels 
on glass slides. By SEM, AuNR-containing gels appear to be denser with shorter, more rigid 
fibrils. In control samples, often very long, twisted fibrils can be observed and this twisted 
morphology was never seen in 3x1010 rods/mL gels. However, by simply dehydrating 
collagen samples to use for SEM, we were unable to find any AuNRs. Additional samples 
were prepared that were dehydrated, condensed and mounted on their sides to image 
deeper into the polymerized gels. Images of these samples are shown in Figure 2.17e-f. The 
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Figure 2.19 Grayscale pixel value versus pixel count for each AuNR concentration. Plots are 
averaged over data from 2D reconstructed Z-stack images taken at three separate areas per 
AuNR concentration sample.  
 
 
 
same contrasting twisted and rigid fibrils were observed in control and 3x1010 rods/mL gels. 
Additionally, many instances of localized collagen aggregation were found inside the 3x1010 
rods/mL gels and no AuNRs were located. These collagen aggregations disrupted the 
collagen networks and it was hypothesized that the AuNRs were actually inside of these 
aggregations. 
To determine the actual location of the AuNRs relative to the collagen fibrils, we 
performed transmission electron microscopy (TEM) of very thinly sliced collagen gels. In 
these experiments, control gels contained twisted fibrils and the collagen/AuNR gels 
contained many more fibrils that were not twisted and large aggregations of collagen (Figure 
2.17g-h). Higher magnification images of the collagen/AuNR gels are shown in Figure 2.17i-
l. These images show how the large aggregations of collagen do seem to contain AuNRs at 
their center and throughout; no aggregations were found without AuNRs inside. Even where 
 63 
 
spherical aggregations did not form, where there are large numbers of AuNRs, the collagen 
network appears to be denser (Figure 2.17j). There were also many instances of small 
numbers of AuNRs being associated with singular fibrils as well (Figure 2.17k). 
 
2.3.7 Gold Nanorods Restrict Diffusion of Positively-Charged Molecules  
Finally, to examine how the presence of AuNRs in the collagen might alter molecular 
diffusion through the gels, we performed fluorescence recovery after photobleaching (FRAP) 
experiments and visible dye diffusion experiments. The visible dye diffusion experiments 
(Figure 2.20) showed that negatively-charged dyes are able to pass through both control and 
collagen/AuNR gels (3x1010 rods/mL) at comparable rates, while positively-charged dyes 
are trapped near the top of the collagen/AuNR gels. FRAP experiments with fluorescein, 
which is negatively-charged under conditions used, did not shown much change in the 
recovery half-time between control and gels with 3x1010 rods/mL but did show that some 
molecules became part of an immobile fraction in the collagen/AuNR gels (Figure 2.21).  
 
2.4 Discussion 
Many studies examine the effects of nanomaterials on cellular processes; here, we 
add in the key component of the extracellular matrix to the nanomaterial/cell system. Rather 
than focusing on what does of nanomaterials kills cells, we focus on how cellular behavior is 
altered upon nanomaterial exposure at relatively modest levels. 
We have already shown, in previous work, that different polyelectrolytes on gold 
nanorods alter collagen’s mechanical properties, with the high local concentration of charge 
a key parameter.47 As cells respond to mechanical cues as well as chemical cues, it was 
reasonable to expect that cellular behavior would be altered in the presence of 
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Figure 2.20 a) Photographs of collagen samples with 3x1010 rods/mL (right) or without 
AuNRs (left) after 8 h of diffusion of 0.001 M Methylene Blue (structure shown below). b) 
Photographs of collagen samples with 3x1010 rods/mL (right) or without AuNRs (left) after 8 
h of diffusion of 0.001 M Remazol Brilliant Blue R (structure shown below). Dye solutions 
were simply carefully placed on top of pre-formed collagen gels and allowed to diffuse 
through gels overnight.  
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Figure 2.21 Mobile fraction and recovery half-time (s) results for the diffusion of fluorescein 
through control (white) and 3x1010 rods/mL (striped) collagen gels. Top and bottom boxes 
correspond to the 75th and 25th percentile and whiskers mark the minimum and maximum 
value. Center line designates median and + designates mean. Each plot contains data from 
10 separate FRAP experiments. **p<0.01. 
 
 
 
nanomaterial-induced altered extracellular matrix. The question, then, becomes: can we 
disentangle mechanical effects from chemical effects in the nanomaterial-ECM-cell system?  
In the present work, we have shown that negatively charged AuNRs can induce 
spontaneous migration of MDA-MB-231 metastatic cancer cells from one area to another as 
a function of AuNR concentration in 3D ECM mimics. This result is in contrast to earlier 
reports of 2D migration inhibition by gold NPs,22-23 and highlights the importance of the ECM 
and, possibly, cell type, in determining the real in vivo effect NPs could have. We note that in 
our laboratory we have found that different cell types (PC3 and HDF cells) migrate faster or 
slower in 2D upon gold nanoparticle exposure, depending on nanoparticle type and cell 
type.21 In this study, metastatic MDA-MB-231 cancer cells were used in 3D environments; 
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and we find that these cells migrate more to gold nanorod-containing 3D environments. The 
ability of AuNRs in the ECM to promote enhanced spontaneous migration of metastatic 
cancer cells could have important implications in the use of NPs at various stages of cancer 
treatment; NPs in the human body, used as delivery vehicles or as therapeutics,1-3,8-9 could 
have unintended side effects that need to be carefully understood. While type I collagen as a 
model ECM is a good start for studying the effect of nanomaterials in ECM, in reality, the 
ECM of living tissues is a complex, dynamic combination of structural proteins including 
various types of collagen, fibronectin, elastin and laminin along with proteoglycans.56 In our 
experiments, AuNRs were added to the ECM during new collagen polymerization and not to 
pre-existing collagen networks. Cancers (especially breast cancers) are often accompanied 
by the drastic enhancement of new type I collagen production by stromal cells and 
fibrosis.39,57-59 Therefore, our experiments are simple models of how metastatic cancer cells 
respond when they come upon a 3D extracellular matrix that contains nanomaterials. The 
general result that nanomaterial-ECM matrices promote cancer cell migration is, therefore, a 
cause for concern. 
We developed two hypotheses of the mechanism(s) behind the enhanced cell 
migration in these collagen/AuNR matrices: (i) AuNRs could change the mechanical and 
structural properties of the collagen gel networks, leading to predictable cellular changes 
and/or (ii) AuNRs, known for adsorbing proteins ad molecules from media,17-19,25 alter 
biochemical gradients and molecular diffusion that then leads to less-predictable changes in 
cellular behavior. However, these hypotheses are not mutually exclusive; both processes can 
occur during the course of the experiments. Ultimately, we find some evidence for both 
mechanisms. 
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The primary result (Figure 2.3) shows that more metastatic cancer cells move from a 
3D inner gel to an AuNR-containing outer gel as a function of AuNR concentration. 
Rheological measurements comparing gels with and without AuNR incorporation showed 
that gels became stiffer and more elastic with AuNRs, but that this effect was not 
measurably dependent on AuNR concentration. Additionally, fibrillogenesis lag time was 
decreased; collagen polymerizes into fibrils made of cross-linked staggered arrays of 
individual collagen triple-helix molecules.60 This indicates that the AuNRs may promote fibril 
nucleation, most likely via an electrostatic interaction between the slightly positive collagen 
monomers and the negatively charged PSS-coated AuNRs.47,61 This effect was measured 
previously and was shown to occur with other negatively charged AuNRs, but not positively 
charged ones.47 Complementary microscopic studies revealed structural changes such as 
increased individual fibril frequency, rigidity and density, and decreased porosity. AuNRs 
were often found to be accumulated inside of large collagen aggregations that disrupted the 
collagen networks; this is consistent with the negatively charged AuNRs acting as nucleation 
sites for fibril formation. Finally, dye diffusion studies indicated that positively charged 
molecular diffusion is altered in collagen/AuNR gels compared to collagen gels alone. The 
ability of the AuNR-containing collagen to stop the diffusion of some molecules means that 
potentially the soluble milieu that cells experience is altered in these gels, as we have 
observed in previous work.25 Overall, AuNRs influence both the microstructure/mechanical 
properties and biochemical diffusion in self-assembled type I collagen gels in ways that 
could contribute to enhanced spontaneous migration. 
Mechanotransduction pathways allow for cells to “feel” and respond to mechanical 
cues from the outer gel even when inside the inner gel. It is most likely the mechanical 
property and architectural changes that are driving the cells to move toward the outer gel 
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initially.35-37,62-65 The movement of cells towards stiffer, less porous gels is consistent with 
the phenomenon of durotaxis, where cells tend to move along a stiffness gradient toward 
the stiffer region.62-65 It is unclear from these studies whether the cells migrating from the 
inner gel to the outer gel experience a stiffness gradient at the interface. Stiffness of self-
assembled fibrous materials like type I collagen is intrinsically related to the porosity: as 
pore size decreases, stiffness increases. It has been reported that human foreskin 
fibroblasts showed decreased collagen translocation but increased migration in stiffer, less 
porous collagen gels.66 However, the relationship between stiffness and migration may not 
be as simple in 3D; DU-145 human prostate carcinoma cells were found to migrate toward 
softer ECM when ligand density and integrin receptor levels were held constant.67  
While it seems that cells migrating more toward a stiffer substrate than a softer one 
is congruent with durotaxis, durotaxis is thought to be a result of differences in focal 
adhesion strength and lifetime, and increased polarization.62-65, 68-69 This is contrary to 
results of characterization of the migratory phenotype of the cells in collagen/AuNR gels, 
where there is some evidence of an emerging amoeboid-like phenotype. Cells migrating 
through AuNR-containing type I collagen exhibited rounded locomotion compared to the 
cyclic elongated motion of control cells, and migrated in a much more random and 
undirected fashion. Mesenchymal-amoeboid transitions are often distinguished by induction 
of this rounded nature of motion, reduced cellular adhesion and integrin clustering, and lack 
of protease activity.50-55 We found that β1-integrin expression and clustering were 
significantly decreased in cells migrating in collagen/AuNR gels compared to controls, and 
that overall cellular adhesion was greatly decreased to collagen/AuNR gels relative to 
collagen gels. 
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It is well-known that cells respond chemically to both mechanical and biochemical 
cues and that this can result in changes in gene expression of related genes.35-37,70  The 
migratory cells produced increased levels of MMPs, which is the opposite of what is 
expected of amoeboid-like cells.50-55 No evidence of alterations to the Rho-ROCK pathway 
were detected either, opposite to what is expected for a cellular transition to an amoeboid 
type. Furthermore, the amoeboid migration mode is associated with highly porous, soft 
matrices that cells can easily deform,50-55,71 but due to the decreased porosity of the gels 
with AuNRs, MMPs are still required for movement regardless of locomotion strategy. These 
results do not exclude these cells from being categorized as amoeboid-like as there is not a 
simple dichotomy between mesenchymal and amoeboid-like cells but rather a continuum.50-
55,71 Mesenchymal-amoeboid switches are most often induced in MDA-MB-231 cells by 
blocking proteolysis, but is known that the transitions can also be induced by reducing the 
cell-matrix adhesion capability.52,71-73  
 Overall, we propose the following scheme (Figure 2.22): (i) Cells in a cell-rich 3D 
environment migrate out more to a 3D environment containing AuNRs due, initially, to the 
altered mechanical nature of the matrix that is due to the physical presence of the AuNRs 
(ECM stiffer, more dense, more elastic, shorter fibrils, dye diffusion experiments, etc.); (ii) 
Upon crossing to the outer gel, the local chemical environment of the cells is altered due to 
matrix molecule adsorption to AuNRs (cf. dye diffusion experiments); the larger the 
concentration of AuNRs, the more the local concentrations are affected. This might explain 
the concentration dependence of the migration; (iii) Upon encountering ECM containing 
AuNRs, the cell become more rounded, exhibit reduced integrin expression, increased MMP 
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Figure 2.22 Schematic depicting how gold nanorods alter matrix characteristics, which in 
turn alter cell behavior. Thus, gold nanorods indirectly affect cell behavior when incorporated 
into the structural environment. 
 
 
 
expression, and no changes in RhoA/ROCK1/Rac1 expression. These somewhat 
contradictory data may be the result of both mechanical changes and biochemical changes 
in the cellular environment; (iv) If “forced” to uptake AuNRs directly, no changes in cellular 
migration are observed compared to controls, suggesting that direct intracellular effects of 
the nanomaterials on the actin network are not the primary cause of the inner gel/outer gel 
migration data (unlike what we have observed before with smaller gold nanoparticles in 
different cell lines, where the internal actin network can be disrupted).74 
 
2.5 Conclusions 
We have shown that there is a complex effect of AuNRs in the ECM on MDA-MB-231 
cancer cell migration induced by multiple possible factors. AuNRs alter the mechanical 
properties and the structure of collagen matrices, hinder the diffusion of some molecules 
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and reduce cellular adhesion. Inconsistencies between the increased stiffness and 
decreased porosity, and decreased adhesion and amoeboid-like cell movement indicate that 
while changes to the physical properties of the collagen may induce migration to the outer 
gel, reduced adhesion due to the AuNRs themselves at the interface and beyond may be the 
origin of the emergence of the amoeboid-like phenotype. Overall, the AuNRs were shown to 
alter matrix characteristics, which in turn altered cell migration, adhesion and protease 
expression (Figure 2.22). The stark contrast between the results of this study on AuNRs 3D 
cancer cell migration and results based on 2D migration stresses the importance of the ECM 
in the analysis of nanomaterials in vitro.21-23 Control of the ECM and cell-matrix interactions 
is vital for improving our ability to understand and treat  various human diseases, such as 
cancer, heart, liver, renal, central nervous system and lung disease, and just about any type 
of organ fibrosis.73,75-78 In this aspect, improved understanding of the effect AuNRs have on 
the ECM and cell-ECM interactions could be exploited to gain further control over ECM and 
biomaterial properties with a new, multi-dimensional approach.  
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CHAPTER 3: 
Global Transcriptomic Analysis of Model Human Cell Lines 
Exposed to Surface-Modified Gold Nanoparticles: The Effect 
of Surface Chemistry* 
 
3.1 Introduction 
 Interest in gold nanoparticles (Au NPs) for biomedical applications has increased 
exponentially in recent decades due to their unique set of physical properties, as well as the 
ease of surface chemistry manipulation.1-4 Au NPs are relatively chemically inert, show 
plasmonic properties upon proper illumination and have high surface-to-volume ratios, 
making them ideally suited for biomedical applications such as biochemical sensing, drug 
and gene delivery, photothermal therapy, and in vivo and in vitro imaging.4-14 Given the 
widespread impact of Au NPs in nano-biotechnology, it is imperative to carefully characterize 
the influence of Au NPs on living systems at the cellular level.  
While many studies have shown Au NPs to be non-toxic at various concentrations,15-
16 they have still been shown to cause of structural changes in mammalian cells. A549 
(human lung epithelial cancer) cells changed to a rounded morphology with nuclear 
condensation after exposure to 120 nM citrate-functionalized Au NPs, which 
                    
* This chapter is reproduced (and adapted) with permission from The Royal Society of Chemistry from: 
Grzincic, E.M.; Yang, J.A.; Drnevich, J.; Falagan-Lotsch, P.; Murphy, C.J. Nanoscale 2015, 7, 1349-1362.  
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indicates cell stress.17 Others report concentration-dependent disruption of actin fibers and 
tubulin cytoskeleton after Au NP uptake at 10-100 nM doses in a variety of cell lines, and 
after <1 mg/mL doses in human dermal fibroblasts.18-19  The surface charge influences NP 
affinity for cell membranes, with positively charged NPs being endocytosed more than 
negatively charged Au NPs.20 Surface charge-dependent binding of NPs to cell membranes 
has been shown to induce bilayer reconstruction.20-22 A variety of experiments show that Au 
NPs can affect cell morphology in different ways based on size, shape, surface coating, 
concentration and cell type.17-19, 23 
 Other changes to cells may not be as easily observed as morphological changes. An 
effective approach to determining cellular response to an outside stimulus is to analyze 
changes in gene expression. Previous studies in our lab have demonstrated the possibility 
that adsorption of soluble factors in cellular environments to NPs can “shift the equilibria” of 
cellular processes: adsorption of proteins to nanoparticles can make the proteins less 
bioavailable to cells and thereby influence cell response at the transcriptomic level.24 By 
measuring RNA transcript levels in cells upon exposure to differently-coated Au NPs, gene 
expression changes the NPs induce at the molecular level can be quantified. Previous 
studies have shown that Au NPs can activate different cellular pathways based on the size, 
shape and coating.25-27 One study with HeLa cells determined that citrate Au NPs caused 
changes in cell cycle gene expression and induce early apoptosis while nucleic acid-
functionalized Au NPs did not cause any significant changes.28 Another study demonstrated 
that mercaptohexadecanoic acid-functionalized Au NPs induced more changes in the level of 
gene expression than polyethylene glycol (PEG)-coated Au NPs over the 84 genes probed in 
human keratinocyte cells.29  
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 Another study proposed that the affinity of gold itself for thiol groups (this affinity 
would be modulated differently by different surface coatings) induced activation of 
inflammatory pathways in B-lymphocytes.30 These studies (and others) have indicated the 
importance of Au NP surface chemistry on gene expression and pathway signaling, but none 
have measured global gene expression of cells exposed to Au NPs with multiple related 
surface coatings differing in factors such as surface charge and coating structure.26-32 
Moreover, studying the influence on different types of cells is extremely important.17          
 In this paper, we investigate the global gene expression in human dermal fibroblast 
cells (HDF) and prostate cancer cells (PC3) via RNA microarray for 34,127 probes (14,765 
unique genes) after incubation with 20 nm Au NPs with different surface coatings, including 
cationic, anionic and biomimetic lipid-based surface coatings (Figure 3.1). The bimolecular 
lipid coatings are of special interest due to their expected biocompatibility and relationship 
to natural cellular membranes.33-35 We have tested two different cell types that would be 
expected to have different potential routes of exposure at two typical NP concentrations low 
enough not to induce acute toxicity. We combined statistical analysis of RNA microarray data 
with weighted gene co-expression network analysis and gene functional annotation 
clustering to connect Au NP surface coating to changes in specific cellular pathways. In 
order to more closely study the role of NP electrostatics in the gene expression changes, 
theoretical isoelectric points of proteins encoded by some of the differentially expressed 
genes were compared. The role of differences in uptake between the NP types was also 
studied. Taken together, we were able to better learn how surface chemistry of Au NPs 
influences gene expression in human cells expected to be exposed to nanomaterials via 
both environmental (skin) and therapeutic (prostate cancer) means. 
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Figure 3.1 a) Experimental scheme for incubation of cells with Au NPs, followed by 
microarray gene expression analysis and real-time PCR validation. Portions of the artwork 
adapted with permission from Ref. 49. Copyright © 2013 American Chemical Society. b) 
Types of Au NPs used for incubation. PAH is modeled as a blue layer and lipids and 
alkanethiol are shown as individual molecules (not to scale). L-PAH = lipid bilayer 
electrostatically adsorbed onto PAH. HL = hybrid lipid = lipids hydrophobically associated 
with C18 tail of self-assembled monolayer of C18SH on gold. Adapted with permission from 
Ref. 34. 
 
 
 
NOTE TO READER: The NP synthesis, functionalization and characterization, cell incubation 
with NPs, and microarray preparation were completed by former student Dr. Jie An Yang. My 
role (in collaboration with Dr. Priscila Falagan Lotsch and Dr. Jenny Drnevich) was to analyze 
the gene expression data, validate it by qPCR and determine what the data meant. I made 
significant intellectual contributions by deciding how to analyze the data (WGCNA, DAVID 
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analysis) in terms of NP surface chemistries, uptake rates and protein isoelectric points and 
by writing the manuscript. 
 
3.2 Materials and Methods 
3.2.1 Materials 
 Gold(III) chloride trihydrate (HAuCl4•3H2O, ≥99.9%), sodium citrate tribasic dihydrate 
(C6H5Na3O7•2H2O, ≥99%), 1-octadecanethiol (C18SH, 98%), poly(allylamine hydrochloride), 
(PAH, M.W. 15,000 g/mol), and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
were obtained from Sigma Aldrich and were used as received. 1-palmitoyl-2-oleoyl-sn-
glycero-3-phospho-L-serine (sodium salt) (POPS), 1-palmitoyl-2-hydroxy-sn-glycero-3-
phosphocholine (LPC) were obtained from Avanti Polar Lipids and were used as received. 
Trizol (Invitrogen) and RNeasy kit (Qiagen) were used in the extraction of RNA. Ultrapure 
deionized water (17.9 MΩ, Barnstead NANOpure II) was used for all solution preparations. 
Glassware was cleaned with aqua regia and rinsed thoroughly before use. Absorption 
spectra of Au NPs were taken on a Cary 500 scan UV-vis-NIR spectrophotometer. Zeta 
potential and dynamic light scattering measurements were performed on a Brookhaven Zeta 
PALS instrument. 
 
3.2.2 Synthesis of Gold Nanoparticles (Citrate Au NPs) 
 Au NPs of diameter 20 nm were synthesized via the boiling citrate method as 
previously described.33-34 Briefly, 2.5 mL of 0.01 mM HAuCl4 solution and 97.5 mL ultrapure 
deionized water were combined and heated to a gentle boil with stirring. After 5 min, 2 mL of 
5% (w/w) sodium citrate was added. Another 0.5 mL of 5% sodium citrate was added after 
30 additional min (during which the solution turned red). After boiling for another 10 min, 
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the solution was allowed to cool while stirring before centrifugation and purification. The 
citrate Au NPs were negatively charged (ζ-potenial of -19.2 mV ± 1.2 in water, -22.7 mV ± 
0.4 in cell media) with a diameter of 32.3 nm ± 0.2 in water (83.2 nm ± 1.1 in cell media) by 
dynamic light scattering (DLS), as previously reported.34  
 
3.2.3 PAH Coating of Gold Nanoparticles (PAH Au NPs) 
 All surface modification procedures were performed as previously described.33-34 The 
Au pellet after centrifugation of 1 mL of Au NPs was redispersed in 1 mL of deionized water. 
100 μL of 0.1 M NaCl and 200 μL 10 mg mL-1 PAH were added to the Au NP solution and 
vortexed before incubating overnight. Purification was done by centrifugation and the PAH 
Au NPs were characterized (ζ-potential 16.6 mV ± 1.6 in water, -18.8 mV ± 0.6 in cell media; 
diameter by DLS 34.7 nm ± 0.3 in water, 169.1 nm ± 7.2 in cell media).34 
 
3.2.4 Preparation of 1:1 POPS/LPC Lipid Vesicles 
 A 1:1 weight ratio of 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine/1-palmitoyl-2-
hydroxy-sn-glycero-3-phosphocholine (POPS/LPC) was used to make hybrid-lipid-coated Au 
NPs (HL Au NPs) and lipid-coated PAH Au NPs (L-PAH Au NPs), detailed previously.33-34 
Briefly, a total of 1 mg of lipid (0.5 mg of each POPS and LPC) in chloroform was dried under 
nitrogen, followed by vacuum drying for 6 h. 1 mL of 20 mM HEPES buffer was added to give 
a final concentration of 1 mg mL-1. The mixture was sonicated for about 1 h to create a 
clear, colorless lipid vesicle solution. The vesicles averaged ~90 nm by DLS.33-34 
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3.2.5 Synthesis of Lipid-Coated Gold Nanoparticles (L-PAH Au NPs, HL Au NPs) 
 The Au pellet from centrifugation of 1 mL as-made Au NPs was redispersed in 0.5 mL 
of 20 mM HEPES buffer. For lipid-coated PAH Au NPs (L-PAH Au NPs), 0.5 mL of the 1:1 
POPS/LPC lipid solution was added to PAH Au NPs and mixed.33-34 For hybrid lipid Au NPs 
(HL Au NPs), 0.5 mL of the lipid solution was added to purified as-made Au NPs, followed by 
2 µL of C18SH (0.5 mg/mL in ethanol).33-34 The mixture was incubated overnight at room 
temperature. The mixture was then centrifuged (700 rcf, 30 min then 2000 rcf, 30 min for L-
PAH Au NPs and 4000 rcf, 25 min for HL Au NPs) and the Au pellet was resuspended in 
HEPES buffer. The HL Au NPs had a ζ-potential of -51.9 mV ± 1.3 in water (-10.8 mV ± 2.2 in 
cell media) and a diameter by DLS of 38.4 nm ± 0.3 in water (43.1 nm ± 2.0 in cell media), 
and the L-PAH Au NPs had a ζ-potential of -48.7 mV ± 1.3 in water (-27.4 mV ± 0.8 in cell 
media) and a diameter by DLS of 163.2 nm ± 1.6 in water (150.2 nm ± 1.2 in cell media).34 
 
3.2.6 Cell Culture and Nanoparticle Incubation 
 HDF and PC3 cells were plated in 6-well plates and grown to confluency in their 
respective growth media. HDF cells were grown in Dulbecco’s Modified Eagle Medium 
(DMEM, Mediatech) with 1 mM sodium pyruvate, 10% fetal bovine serum (FBS, Gemini Bio-
Products), and penicillin/streptomycin (pen-strep) solution. PC3 cells were grown in 1:1 
DMEM/Ham’s F-12 (Mediatech) with 2 mM sodium pyruvate, 1.5 g L-1 NaHCO3, 10% FBS, 
and pen-strep. Au NPs were first suspended in cell media, and then added to cells (1 nM Au 
NPs for PC3, 0.1 nM for HDF). HDF cells were incubated with Au NPs for 24 hours and PC3 
cells for 48 hours before RNA extraction. 
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3.2.7 RNA Extraction 
 A combined Trizol extraction, followed by RNeasy purification was used, according to 
manufacturer’s protocol. Briefly, cells were first washed thrice with PBS, and 1 mL Trizol 
added. The cells were homogenized by pipetting up and down several times and transferred 
to a centrifuge tube. The samples were allowed to sit for about 5 min at room temperature 
before adding 0.2 mL chloroform. The mixture was vortexed for 20 sec, incubated for 12 
min at room temperature and centrifuged at 20,000 rcf for 20 min at 4 °C. The upper 
aqueous phase was extracted, taking care to avoid the organic layer. To this aqueous layer, 
an equal amount of ethanol was added and mixed. This sample was loaded into an RNeasy 
column and purified according to kit instructions. Collected RNA was checked for amount 
and quality using a NanoDrop 1000 (NanoDrop Technologies) and Bioanalyzer 2100 (Agilent 
Technologies), respectively, and stored at -80 °C until ready for microchip array analysis. 
 
3.2.8 Microarray Labeling and Hybridization 
 For each sample 200 ng of total RNA was labeled using the Agilent 2-color Low Input 
Quickamp Labeling kit (Agilent Technologies) according to the manufacturer's protocols. 
Labeled samples were hybridized to a Human 4 x 44 Agilent microarray kit and scanned on 
an Axon 4000B microarray scanner at 5 um resolution. Each array contains 45,220 spots 
with 34,127 unique 60-mer probes. All microarray data files were submitted to Gene 
Ontology Omnibus (GEO) and are available for download with accession number GSE56432. 
 
3.2.9 Microarray Data Analysis 
 Microarray data pre-processing and statistical analyses were done in R (v 3.0.1)36 
using the limma package (v 3.16.7).37 Median foreground and median background values 
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from the 15 arrays were read into R and any spots that had been manually flagged (-100 
values) were given a weight of zero.38 The background values were ignored because 
investigations showed that trying to use them to adjust for background fluorescence added 
more noise to the data. 
 The individual Cy5 and Cy3 values from each array were all normalized together 
using the quantile method and then log2-transformed.38 Agilent's Human Gene Expression 
4x44K v2 Microarray interrogates 27,958 genes using 33,128 probes spotted one time (1X) 
and 999 probes spotted ten times (10X) each. Correlations between the replicate spots per 
probe were high and so they replicate spot values were simply averaged for each sample. 
The positive and negative control probes were used to assess what minimum expression 
level could be considered "detectable above background noise" (6 on the log2 scale) and 
then discarded. A mixed effects statistical model39 was fit on the 34,127 unique probes to 
estimate the mean expression level for each of the 10 line X nanoparticle groups while 
accounting for dye effects and the correlation due to array.40 After fitting the model, probes 
that did not have expression values > 6 in at least 3/30 samples were discarded. Pairwise 
comparisons between the nanoparticles within each cell line were pulled as contrasts from 
the model, along with the equivalent of a one-way ANOVA test for nanoparticle within each 
cell line and the overall interaction test between cell line and nanoparticle. Raw p-values 
were adjusted separately for each comparison using the False Discovery Rate method.41 
 Initial heatmaps for each cell line using probes that had a within-line one-way ANOVA 
FDR p-value < 0.05 showed a fairly simple expression pattern across the 4 nanoparticles 
plus control for the HDF cell line, but a much more complex expression pattern for PC3 
(Figure 3.4). Therefore, we did a Weighted Gene Correlation Network Analysis (WGCNA)42-43 
on a subset of the probes for the PC3 line to computationally assess the different expression 
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patterns.  WGCNA clusters probe using a complicated distance metric then separates them 
into different "modules" that share a consistent expression pattern. We selected 4,496 
probes that had a reasonable level of statistical evidence for differential expression (PC3 
one-way ANOVA FDR p-value < 0.2) and reasonable amount of changed expression (at least 
1.3 FC between any 2 of the 5 groups) and performed WGCNA (v 1.27-1) using the default 
values of the blockwiseModules() function except for:  soft thresholding power β = 22, an 
unsigned topological overlap matrix, a minimum module size of 20 and merging similar 
modules at 0.15. This resulted in 18 modules ranging from 1452 to 21 probes, plus the 
"module 0" consisting of 8 probe sets that did not fit any of the 18 patterns.  
 Gene functional clusters for expressed genes were generated using DAVID (Database 
for Annotation, Visualization and Integrated Discovery) developed at National Cancer 
Institute at Frederick.44-45 Up- and down-regulated genes were submitted and analyzed using 
functional annotation clustering and functional annotation chart.44-45 The classification 
stringency was set at medium and kappa similarity threshold was set at 0.50. Clusters were 
selected based on their Fisher exact p-value as well as their relevance. Theoretical 
isoelectric points of proteins were calculated using a web tool (http://isoelectric.ovh.org/). 
 
3.2.10 Quantitative Real-Time Polymerase Chain Reaction (qPCR) 
 To validate the microarray results, a real-time quantitative polymerase chain reaction 
(qPCR) analysis was performed on HDF and PC3 cells exposed to the same experimental 
conditions used for the microarray assay. For both cell types, genes investigated by qPCR 
were those that presented the largest gene expression changes after exposure to PAH and 
L-PAH Au NPs by microarray in some selected pathways: cell proliferation and cell 
metabolism considering HDF cells, and inflammation, apoptosis, cell proliferation, cell 
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growth and differentiation and organization of the cytoskeleton considering PC3 cells. The 
reaction was performed using the AgPath-ID™ one-step RT-PCR kit (Applied Biosystems). 
Briefly, 2 μL purified RNA (25 ng μL-1) was reverse transcribed and amplified in a 10 μL 
reaction mixture containing 5 μL of 2X RT-PCR buffer, 0.4 μL of 25X RT-PCR enzyme mix, 
and 1.25 μL yeast RNA (5 mg mL-1, Ambion). Gene-specific primers and TaqMan® probe 
sets for each gene were obtained from Assay-on-Demand Gene Expression Products 
(Applied Biosystems). Three RNA samples were collected for each Au NP type and were run 
in duplicate for each gene along with a no-template control. Three reference genes, GADPH, 
B2M, and HPRT1, were used as internal controls to normalize the target gene expression in 
both HDF and PC3 cells.46-47 The mRNA of individual genes were quantified on the 7900HT 
Fast Real-Time PCR System (Applied Biosystems) with corresponding Sequence Detection 
Systems software (Applied Biosystems). Thermal cycling conditions comprised of a 10 min 
RT step at 45°C and a 10 min initial PCR activation step at 95°C (AmpliTaq Gold activation), 
followed by 40 cycles of 95°C for 15 s and 60°C for 45 s each. Relative expression levels 
were calculated for each sample after normalization against the geometric averaging of the 
three reference genes for HDF cells. For PC3 cells, only GAPDH threshold cycle was used to 
normalize the gene expression data obtained. The ΔΔCt method was performed for 
comparing relative fold expression differences. .Statistical analysis of the qRT-PCR data was 
performed using the web-based RT2 Profiler™ PCR Array Data Analysis software 
(SABiosciences, www.SABiosciences.com/pcrarraydataanalysis.php). 
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3.3 Results and Discussion 
3.3.1 Global Gene Expression Changes after Au NP Incubation 
 The transcriptomic impacts of 20 nm spherical Au NPs with four different surface 
coatings on two types of cells were investigated. The experimental layout and schematics of 
the four Au NP types are shown in Figure 3.1. As-made Au NPs have citrate (anionic) ions on 
the surface. By polyelectrolyte coating with poly(allylamine hydrochloride) (PAH), the surface 
becomes primary amine-terminated, making the Au NPs cationic under physiological 
conditions. We also investigated the influence of pre-coating Au NPs with biomolecules, 
which may improve the biocompatibility of Au NPs. Au NPs were coated with a 1:1 mixture of 
lipids (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (anionic, POPS)/1-palmitoyl-2-
hydroxy-sn-glycero-3-phosphocholine (zwitterionic, LPC)) and were allowed to adsorb 
differently based on the initial surface chemistry (PAH or alkanethiol in this case).33-34 By 
first coating with PAH and then lipids, lipid-coated PAH Au NPs (L-PAH Au NPs) were 
formed.33-34 Alternatively, by first functionalizing citrate Au NPs with octadecanethiol (C18SH), 
hybrid lipid layers were formed on Au NPs (HL Au NPs), as previously described by our 
laboratory.33-34 All of these NP types were well-characterized and checked for stability in cell 
medium as previously reported by UV-Vis spectroscopy (Figure 3.2), dynamic light scattering 
(DLS), zeta potential measurements (Table 3.1), and transmission electron microscopy.33-34 
Two different cell types were studied under different conditions mimicking intentional 
and unintentional exposure to Au NPs. Unintentional exposure to NPs (at low dosage) would 
most often occur via contact with the skin; therefore, human dermal fibroblasts (HDF) were 
investigated as our model system. HDF cells were incubated with Au NPs at a low particle 
concentration of 0.1 nM (~70,000 NP/cell). Alternatively, NPs are often used at higher 
concentrations in biological applications, either for imaging or therapy. Prostate cancer cells 
 89 
 
 
Figure 3.2 UV-Vis spectra of citrate, PAH, HL and L-PAH Au NPs in water. 
 
 
Table 3.1 Dynamic light scattering (DLS) and zeta potential (ζ) characterization results for 
each Au NP typea 
     
aDiameter and zeta potential results as reported previously by Ref. 34 
 
 
 
(PC3) were chosen to represent typical targeted cells and were exposed to Au NPs at 1.0 nM 
concentrations (~470,000 NP/cell). In both cases, cells were exposed to Au NPs for 24-48 h 
(24 for HDF, 48 for PC3), after which >95% were alive in all cases (data not shown). 
Additionally, studying these types of Au NPs and cells allowed for an improved 
understanding of earlier related experiments on cellular response to gold nanoparticles in 
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our group.34 Control samples consisted of cells not exposed to any Au NPs. Au NPs and all 
solutions used for synthesis were tested for endotoxin contamination using a Pierce LAL 
Chromogenic Endotoxin Quantification kit (Thermo Scientific) and were negative for 
endotoxins (at least <0.01 ng/mL per the kit’s detection limits). 
After RNA extraction and microarray analysis, downstream global gene expression 
analysis was performed for both cell types with the four kinds of Au NPs. Firstly, all of the 
normalized gene expression data was evaluated using principal component analysis (PCA), 
which identifies the largest variations in the data as principal components (Figure 3.3).48 
This provided a first look at the separate sample types relative to each other. By PCA, we 
conclude that 1) HDF and PC3 are distinct cell types; 2) incubation of HDF cells with citrate       
    
    
Figure 3.3 Principal component analysis of PC3 and HDF gene expression data. Principal 
components 1 and 2 are shown. PC3 samples are represented by circles and HDF samples 
by diamonds. Different sample types are shown in various colors as follows: control = green, 
citrate Au NPs = yellow, HL Au NPs = red, PAH Au NPs = blue, L-PAH Au NPs = purple. 
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or HL Au NPs induced very small changes in gene expression as compared to control 
samples; 3) incubation of HDF cells with PAH or L-PAH Au NPs induced substantial changes 
in gene expression as compared to controls; 4) the differences in gene expression in HDF 
cells between PAH and L-PAH Au NPs were small; and 5) incubation of PC3 cells with 
different Au NPs elicited different gene responses from HDF cells which suggests that PC3 
cells are more responsive to the coated Au NPs than HDF cells, though it must be noted that 
PC3 cells were exposed to higher concentrations of Au NPs than the HDF cells were.  
To obtain a broad view of the expression patterns in each cell type, we constructed 
heatmaps of the genes that showed significant difference across the four treatment groups 
within each cell type compared to control samples, unexposed cells (oneway ANOVA within 
each cell type, false discovery rate (FDR) p-value < 0.05 (more conservative than p-value; 
FDR p-value < 0.05 means that 5% of significant tests will result in false positives); Figure 
3.4). The heatmaps include 3364 genes for HDF cells and 5169 genes for PC3 cells. For 
HDF cells, there is an overwhelming pattern in which genes with low expression levels in 
control, citrate and HL Au NP samples are highly expressed in PAH and L-PAH Au NP 
samples, and vice versa. With PC3 cells, this distinct pattern is not observed. Instead, 
different types of Au NPs elicited more complex gene responses from PC3 cells. Table 3.2 
lists the number of genes that were differentially expressed with a raw p-value < 0.05 and a 
log2 fold change (FC) of at least ±1.5 versus control after Au NP treatment. Raw p-values 
were used here rather than FDR p-values because the large differences in number of genes 
changed between different sample types affect the FDR correction. As estimated from the 
PCA and heatmaps, only a small number of genes were significantly differentially expressed 
by citrate and HL Au NPs in HDF cells, while PAH and L-PAH Au NPs elicited a similarly larger 
gene response. Exposure of PC3 cells to citrate Au NPs showed more, yet still modest, 
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Figure 3.4 Heatmaps showing changes in global gene expression of a) HDF and b) PC3 cells 
after exposure for four types of Au NPs. Plus and minus symbols refer to the initial surface 
charge of the Au NPs. Each row represents one gene (within-cell type oneway ANOVA FDR p-
value < 0.05). Using a scale of standard deviations from the mean expression level, the 
change in expression level is shown as red (higher expression) or blue (lower expression) 
relative to the mean across all samples. Each column corresponds to one sample; all 
samples were collected in triplicate and samples exposed to the same Au NP type cluster 
together. 
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Table 3.2 Number of genes in HDF and PC3 cells which were differently expressed after 
exposure to Au NPs 
 
    
 
aGenes are filtered with a cut-off criteria of raw p-value of < 0.05 and either a log2 fold 
change (FC) < -1.5 for down-reguated or FC > 1.5 for up-regulated genes. 
 
 
 
changes than with HDF cells. Both PAH and L-PAH Au NPs caused the down-regulation of 
many more genes than were up-regulated, and HL Au NPs also showed more significant 
expression changes with HDF cells. While PAH and L-PAH Au NPs changed the expression of 
about the same number of genes in HDF cells, L-PAH Au NPs caused over three times more 
gene expression changes than did PAH Au NPs in PC3 cells. These results show that PAH 
and L-PAH Au NPs induced greater cellular responses from both HDF and PC3 cells 
compared to citrate and HL Au NP genes responses, with L-PAH Au NPs having the largest 
effect in PC3 cells. 
For HDF cells, not only did PAH and L-PAH Au NPs change the expression of similar 
numbers of genes, but a large portion of the same genes were differentially expressed by 
both types, as seen in Figure 3.5 (840 genes were differentially expressed versus controls 
by both PAH and L-PAH Au NPs). For PC3 cells, most of the genes differentially expressed by 
PAH Au NPs were also changed by L-PAH Au NPs (77%) with L-PAH Au NPs affected many 
additional genes. Interestingly, there were 49 genes affected by both HL and L-PAH Au NPs, 
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Figure 3.5 Venn diagrams comparing the number of genes that showed expression changes 
(raw p-value < 0.05, FC > 1.5, FC < -1.5) for a) HDF and b) PC3 cells. Each Venn diagram is 
divided according to the type of Au NP treatment, and the number of genes differentially 
expressed are shown in the overlapping regions. 
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and there were even some similarities in gene expression changes between HL and PAH Au 
NPs, and citrate and L-PAH Au NPs.  
 
3.3.2 Quantification of NP Uptake 
In our study, while cells were incubated with Au NPs at fixed concentrations (0.1 nM 
or ~70,000 NP/cell for HDF cells, 1.0 nM or ~470,000 NP/cell for PC3 cells), the total 
uptake of Au NP per cell depended on the Au NP surface chemistry (Figure 3.6). Uptake was 
measured by first washing away excess (non-internalized) Au NPs, followed by digestion of 
Au NPs by aqua regia and measurement of gold content by ICP-MS. The relative uptake rates 
are similar but not identical to the trends seen by overall gene expression patterns between 
different Au NPs. For instance, the uptake of HL Au NPs was significantly lower compared to 
PAH and L-PAH Au NPs in HDF cells, but L-PAH Au NPs were taken up much less than PAH Au 
NPs. For PC3 cells, L-PAH Au NPs caused the most gene expression changes and were also 
the most efficiently uptaken into the cells. At the same time,  PAH and HL Au NPs were taken 
into the cells at about the same rate, even though PAH Au NPs caused many more changes 
than did HL Au NPs, and citrate Au NPs were at almost the same NP/cell concentration as L-
PAH Au NPs. Positively-charged NPs have been shown by others to be more readily uptaken 
by cells than negatively-charged NPs, but this was not observed here, and HDF cells took in 
more PAH Au NPs than did PC3 cells even though they were delivered at 1/10 the 
concentration. In both cell types, uptake of citrate Au NPs was the second highest though 
these NPs caused by far the lowest gene expression changes. These observations suggest 
that the gene expression changes imperfectly correlate with dose; initial surface chemistry 
of the nanoparticles matter. For citrate Au NPs, even though relatively many Au NPs are 
taken up by cells, the influence is small as the impact per Au NP is small.  
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Figure 3.6 a) Au NP total uptake per cell quantified by ICP-MS for PC3 (circles) and HDF 
(diamonds) cells versus number of genes differently expressed for each type of Au NP-
exposed samples. PC3 cells were incubated with Au NPs at 1.0 nM and HDF cells with Au 
NPs at 0.1 nM overnight. b) Transmission electron microscopy of HL Au NPs in PC3 cells at 
1.0 nM. Inset shows HL Au NPs in a vesicle at higher magnification. 
 
 
 97 
 
3.3.3 Gene Expression Changes in HDF Cells after Au NP Incubation 
To understand the significance of the altered gene expression with NP exposure, and 
the possible biological pathway/terms that are affected, the changed genes were analyzed 
using the high-throughput bioinformatics tool DAVID (Database for Annotation, Visualization 
and Integrated Discovery).44-45 Using DAVID for gene annotation enrichment analysis and 
functional annotation clustering, all of the genes (raw p-value < 0.05) that were up-regulated 
(FC > 1.5) and down-regulated (FC < -1.5) for each NP type were separately analyzed. 
Incubation of HDF cells with citrate Au NPs did not yield any results, and with HL Au NPs 
showed one significantly relevant cluster having to do with the extracellular matrix. Specific 
highly enriched gene ontology categories were included in Table 3.3 to represent relevant 
clusters. High percentages of up-regulated genes in both the PAH and L-PAH Au NP samples 
were categorized into cell cycle annotations with very high significance. Also noteworthy is 
that categories like extracellular matrix, cell migration, metal ion binding, polysaccharide 
binding, and metabolic enzyme activities were down-regulated significantly by PAH and L- 
PAH Au NPs. For further detail, the most significantly differentially expressed genes that fall 
into the cell cycle gene ontology category are provided in Figure 3.7. 
Because the largest fold changes by far were found after PAH and L-PAH Au NP 
incubation, the most highly changed genes (raw p-value < 0.05) in these samples are shown 
in Table 3.4. The most highly up-regulated genes are associated with increased cell 
proliferation, as predicted by functional annotation analysis, but also with other oncogenic 
pathways. CXCL1 is related to cancer and senescence in fibroblasts, inflammation, 
angiogenesis and proliferation.50-52 CCNE2 is involved in the cell cycle via the G1 to S phase 
transition,53-54 RRM2 expression is correlated to increased cell proliferation and 
angiogenesis55-56 and HAS2 has been implicated in increased invasiveness of breast
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Table 3.3 Analysis of selected gene categories after treatment of HDF cells with 0.1 nM Au 
NPs 
 
aGene ontology classifications are cellular component (CC), biological process (BP) or 
molecular function (MF). bDenotes up for up-regulation, down for down-regulation. cGenes 
that were sufficiently up-regulated (raw p-value < 0.05, FC > 1.5) and down-regulated (raw p-
value < 0.05, FC < -1.5) were separately entered into DAVID using medium stringency 
threshold. The number of genes that fall into the GO category for either the up- or down-
regulated genes is shown. dPercent of up- or down-regulated genes entered into DAVID that 
fall under selected GO category. eOne-tail Fisher Exact p-value for gene-enrichment analysis. 
The smaller the value, the more enriched the gene category; p-value < 0.05 considered 
significant. 
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Figure 3.7 Most significantly changed genes of HDF cells after 0.1 nM Au NP incubation that 
fall under the “cell cycle” gene category (GO accession number GO:0007049) 
 
 
 
cancer.57 However, the negative cell cycle regulator DTL and anti-proliferative GAL and 
WFDC1 genes are also highly up-regulated.58-60 Additionally, the anti-angiogenic RCAN2, 
SERPINF1 and EFEMP1,61-63 and tumor suppressor RUNX1T1 are down-regulated.64 KLF9 is 
also a possible cancer biomarker when down-regulated.65-66 In contrast, the pro-angiogenic 
PDGFRB and PTGIS are down-regulated67-68 and the down-regulated SLC9A9 (pH regulator), 
TNXB and SECTM1 (CD7 ligand) are all typically up-regulated in cancerous environments as 
well.69-72 Decreased gene expression also occurred to genes associated with cell 
metabolism, such as FAXDC2, AKR1C4, AKR1C3, ADH1A, ADH1C and MAN1C1.72-74 
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Table 3.4 Most significantly differently expressed genes of HDF cells after incubation with 
PAH and L-PAH Au NPsa 
  
aGenes included have a raw p-value < 0.05 and FC > 3.0 or < -3.0 in either PAH or L-PAH Au 
NP samples. Entries that are not significant (p > 0.05) are italicized and those that are 
significant are in bold. bAverage theoretical isoelectric points as calculated at 
http://isoelectric.ovh.org. 
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3.3.4 Gene Expression Changes in PC3 Cells after Au NP Incubation 
Consistent with previous analysis, DAVID functional annotation clustering for PC3 
gene expression data showed more variety than with the HDF data (Table 3.5). There were 
some significant ontology clusters for citrate Au NP samples related to the down-regulation 
of protein ubiquitination, and many more diverse categories related to metal binding, 
angiogenesis, cell migration, and immune response were clustered for HL Au NP samples. 
PAH Au NPs down-regulated genes related to cell cycle categories and L-PAH Au NPs may 
have induced immune responses and affected apoptosis regulation and signal transduction 
of proteins involved in many pathways. 
The fold changes of some of the most significantly changed genes (FC > 3.0 or <-3.0 
and p < 0.05 for one type of Au NP sample) are shown in Table 3.6. All of the most highly up-
regulated genes (with exception of C15orf48) have been associated with the NF-κB pathway, 
which induces inflammation and tumorigenesis at abnormal activation levels.75-79 These 
genes associated with inflammation and angiogenesis are typically up-regulated by both HL 
and L-PAH Au NPs.51,75,78,80 The L-PAH Au NPs samples showed expression level changes in 
genes involved in apoptosis regulation in both DAVID functional annotation analysis and by 
the changes induced to BCL2A1 and BAK1 genes. BCL2A1 is an anti-apoptotic protein 
controlled by pro-apoptotic BAK1, and their respective up- and down-regulation could signify 
activation of survival pathways.78 However, the anti-apoptotic RRBP1 is also highly down-
regulated with PAH and L-PAH Au NPs.81 Most of the highly down-regulated genes are only 
down-regulated by PAH and L-PAH Au NPs. TNK2 is known to encourage prostate 
tumorigenesis,82-83 Some of the down-regulated genes, like SEMA3F, BAK1, and BAP1 are 
associated with tumor suppression.80,84-85 Many of the down-regulated genes are also 
associated with decreased invasion and motility, such as DDR1, ZYX, NES, and PLEC.86-90 
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Table 3.5 Analysis of selected gene categories after treatment of PC3 cells with 1 nM Au 
NPs 
      
aGene ontology classifications are cellular component (CC), biological process (BP) or molecular function (MF). bDenotes up 
for up-regulation, down for down-regulation. cGenes that were sufficiently up-regulated (raw p-value < 0.05, FC > 1.5) and 
down-regulated (raw p-value < 0.05, FC < -1.5) were separately entered into DAVID using medium stringency threshold. The 
number of genes that fall into the GO category for either the up- or down-regulated genes is shown. dPercent of up- or down-
regulated genes entered into DAVID that fall under selected GO category. eOne-tail Fisher Exact p-value for gene-enrichment 
analysis. The smaller the value, the more enriched the gene category; p-value < 0.05 considered significant. 
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Table 3.6 Most significantly differentially expressed genes of PC3 cells after incubation with 
Au NPsa 
 
aGenes included have a raw p-value < 0.05 and FC > 3.0 or < -3.0 in either PAH or L-PAH Au 
NP samples. Entries that are not significant (p > 0.05) are italicized and those that are 
significant are in bold. Pseudogenes, non-coding RNA and uncharacterized, unnamed genes 
not included. bAverage theoretical isoelectric points as calculated at 
http://isoelectric.ovh.org. 
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In order to better analyze gene expression patterns between the different Au NP 
treatments, we used weighted gene co-expression network analysis (WGCNA) to divide the 
genes studied into groups of genes that all share the same expression pattern across the 
data for all treatments.42-43 WGNCA allowed the complex global heatmap to be visualized in 
18 separate modules separated by patterns in gene expression (Figure 3.8, Modules 1-12 
shown). This is especially useful because genes that share the same expression patterns 
across many groups are most likely co-regulated.  
 
3.3.5 Quantitative Real-Time Polymerase Chain Reaction (qPCR): Validation of Microarray 
Microarray gene expression results are commonly validated by quantitative real-time 
PCR (qPCR). Properly validating microarray data by qPCR is the best choice with these 
samples because optical signal-based assays are subject to interference by Au NPs.91 
Selected genes from the list of the genes with the highest fold changes observed for HDF 
and PC3 cells (Tables 3.4 and 3.6, respectively) were investigated by qPCR. Because PAH 
and L-PAH Au NPs caused the greatest changes, genes selected were highly up- or down-
regulated in these two types of samples and qPCR was only done on these samples. For HDF 
cells, all the genes evaluated (CXCL1, CCNE2, DTL, GAL, RRM2, WFDC1, SLC9A9, FAXDC2, 
ADH1A, and AKR1C3) were found to be changed the same as they were in the microarray 
assay. For PC3 cells incubated with PAH, most of the qPCR results (60%) were in agreement 
with the microarray assay (BAK1, BAP1, DDR1, LAMB2, NES, and TNK2 genes), 30% 
reported the same direction of change by both methods (BCL2A1 and CXCL1, down-
regulation; IL8, up-regulation; p-values > 0.05), and for the LTB gene, the qPCR results 
showed down-regulation versus up-regulation in the microarray assay. For PC3 cells 
incubated with L-PAH, the qPCR results were in agreement with the microarray in 80% of the 
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Figure 3.8 Heatmaps of first 12 gene modules (those containing more than 100 genes) 
obstained by weighted gene co-expression network analysis (within PC3 oneway ANOVA FDR 
p-value < 0.2, FC > 1.3 or < -1.3 between any two of the 5 groups included in analysis. Each 
row corresponds to one gene and columns to one sample; columns in all modules 
correspond to the column labels shown in Module 1. Green represents down-regulation from 
the mean and red is for up-regulation. Scale shown in standard deviations from the mean. 
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investigated genes (BCL2A1, CXCL1, DDR1, IL8, LAMB2, LTB, NES and TNK2); 20% 
presented the same direction of change by both methods (BAK1 and BAP1) but without 
statistical significance. 
Although the data obtained by both methodologies (microarray and qPCR) often 
result in disagreement, non-agreeing data is rarely presented.92 The lack of concurrence 
between methods observed in our PC3 cell data for genes exhibiting low levels of change 
(<1.4 fold) and for genes exhibiting down-regulation has been commonly reported.92-94 The 
same was not observed for HDF cells, for which selected gene expression data obtained by 
microarray was 100% confirmed by qPCR. The microarray data was properly validated by 
qPCR. 
 
3.3.6 Effect of Au NP Surface Chemistry on Cellular Pathways 
 HDF cells and they changed similar types and numbers of genes: about two-thirds of 
the affected genes were commonly expressed between the two NP types. One possible 
mechanism involves the lability of the surface ligands. The electrostatic interaction of lipid 
with the underlying PAH or L-PAH Au NPs is relatively weak; lipids can dissociate from 20 nm 
Au NPs inside cells, as shown previously.34 This exposes the underlying PAH layer, which 
could result in the similar gene expression changes when compared to PAH Au NPs. In 
contrast, HL Au NPs had little to no effect on gene expression in HDF cells. HL Au NPs are 
coated with lipid by the stronger hydrophobic interaction between lipids and C18SH tails 
(energy of electrostatic interaction between two opposite charges in water separated by 0.5 
nm is ~3.5 kJ/mol; energy of hydrophobic interaction per 2 methylene units is 6 kJ/mol).95 
Only a few genes were commonly changed between both lipid-coated Au NP samples in HDF 
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cells, suggesting that the underlying chemistry on Au NPs impacts lipid layer formation and 
ultimately how the cells interact with these Au NPs. 
 Incubation of HDF cells with PAH and L-PAH Au NPs results in the up-regulation of 
genes related to the cell cycle gene ontology and the down-regulation of genes belonging to 
extracellular matrix, cell migration, apoptosis and metabolism ontology categories. Analysis 
of individual genes that were highly and significantly changed by PAH and L-PAH Au NPs also 
highlights the enhanced activation of cell cycle and angiogenesis-related genes. However, at 
the same time, some anti-proliferative genes are up-regulated and some pro-angiogenic 
genes are down-regulated. Additionally, many changes in genes associated with cell 
metabolism shows that metabolism pathways were altered: this could be also be a sign of 
cancer progression regulation which may indicate that the cells are trying to control 
oncogenic processes.84 We are currently investigating the long-term effect of Au NP 
incubation on cells in vitro. 
 While it was clear from the beginning that PAH and L-PAH Au NPs elicited similar 
gene expression patterns in HDF cells, the heatmap patterns and functional gene categories 
for PC3 cells were much more complex. From Figure 3.5, most of the genes altered by PAH 
Au NPs were also altered by L-PAH Au NPs, but L-PAH Au NPs had a much larger impact, and 
some similarities between L-PAH and HL Au NPs were hinted at. PAH and L-PAH Au NPs both 
down-regulated most of the highly down-regulated genes, while HL and L-PAH Au NPs up-
regulated most of the up-regulated ones (Table 3.4). HL and L-PAH Au NPs up-regulated 
inflammation and pro-angiogenic genes, and PAH and L-PAH Au NPs down-regulated tumor 
suppressor genes and genes associated with decreased invasion of cancer. The oncogenic 
pathways activated by these genes could lead to enhanced cellular inflammation and 
vascularization with HL and L-PAH Au NPs, increased tumorigenicity with PAH and L-PAH Au 
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NPs and resistance to apoptosis with L-PAH Au NPs. The ability of cancer cells to proliferate, 
avoid apoptosis, sustain angiogenesis, invade and induce inflammatory environments are 
some of the hallmarks of cancer,96 and the additional induction of these pathways by any Au 
NPs are concerning. Again, by our analysis with both HDF and PC3 cells, citrate Au NPs 
appear to be relatively safe. 
 By looking at distinct patterns separated by WGCNA, we were able to find co-
expressed sets of genes that are changed between Au NPs types (Figure 3.8). By using more 
liberal significance and fold change cut-offs, we observed more interesting patterns between 
Au NP types than we could with functional annotation clustering. Module 1, the most 
populated module with 1452 genes, showed the same basic pattern as the HDF gene 
expression patterns: while citrate and HL Au NPs did not greatly change gene expression 
from controls, PAH and L-PAH Au NPs did, in a similar fashion. This was also observed in 
Modules 6, 7, 9 and 10, but this is not consistent for all modules. Module 2 interestingly 
showed citrate Au NP-induced up-regulation with L-PAH Au NP-induced down-regulation. 
Modules 4, 5 and 8 showed connections between HL and L-PAH Au NPs and Module 6 
showed HL Au NPs inducing the opposite effect as PAH and L-PAH Au NPs did. HL Au NPs did 
induce up-regulation uniquely in Module 11, showing that the changes HL Au NPs caused 
were not always changed by L-PAH Au NPs as well. 
 All together, with PC3 cells, there is a strong correlation in gene expression changes 
between PAH and L-PAH Au NP samples, but also between HL and L-PAH Au NP samples, 
and there is a set of genes that are only influenced HL Au NP samples alone. These results 
cannot simply be attributed to PAH exposure during to L-PAH lipid lability. While 80% of the 
PC3 genes changed by PAH Au NPs were also changed by L-PAH Au NPs, over three times as 
many genes were changed by L-PAH Au NPs than by PAH Au NPs. One possible reason for 
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this is that electrostatics play a role, which could also explain why L-PAH and HL Au NPs 
would have some similar expression patterns. Both the HL and L-PAH Au NPs are initially 
highly negatively charged, compared to the slightly anionic citrate Au NPs and initially 
positively charged PAH Au NPs. PAH and HL Au NP samples also showed the opposite effect 
on genes in Module 5. 
 The possibility of an electrostatic effect inside the cells acting on gene expression is 
further illustrated by comparing the theoretical isoelectric points of the proteins encoded by 
the most highly changes genes after Au NP exposure. For PC3 cells, the average calculated 
isoelectric point of the up-regulated proteins is 8.36, and for the down-regulated proteins is 
6.60 (Table 3.6). With the pH of the media being 7.32, almost two-thirds of the up-regulated 
proteins would be positively charged, and 70% of the down-regulated proteins would be 
negatively charged. This is consistent with positively charged proteins becoming adsorbed by 
electrostatic interactions with the negatively charged HL and L-PAH Au NPs, making these 
proteins less bioavailable to the cell and therefore causing up-regulation by the cell. This 
same correlation is observed with HDF cells, with average isoelectric points being 8.12 and 
6.81 for up- and down-regulated genes in Table 3.4, respectively. However, this observation 
cannot explain why negatively-charged proteins would be down-regulated by positively-
charged Au NP exposure. 
 Uptake levels are also different among the Au NP types for each cell type. Uptake 
rates, and thus Au NP concentrations inside the cells, are likely to have a large effect on the 
extent of gene expression differences. However, uptake rates alone do not explain gene 
expression patterns due to the inconsistencies between the NP/cell measurements and 
relative gene expression changes between Au NP types. Uptake rates themselves may be 
influenced by the surface chemistries of the NPs in more intricate ways that just differences 
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in charge. One instance that could be imagined is that free lipids from L-PAH Au NPs could 
affect the uptake mechanism of these NPs.97 
 
3.4 Conclusions 
By making use of microarray technology to probe differentially expressed genes via 
RNA expression throughout the entire transcriptome combined with data mining using 
readily available analysis programs, the global impact of Au NPs on cells can be uncovered. 
In all, we have found that the surface coating of Au NPs greatly affects certain cellular 
processes. The up-regulation of HDF cell cycle genes when exposed to PAH and L-PAH Au 
NPs is a source of concern, especially in toxicology. Cell cycle genes have been used as 
profile genes for metastatic cancer, and CCNE2 in particular is often used as a prognostic 
marker for breast and prostate cancer.53,98-100 Up-regulation of CCNE2 and other genes, 
without proper control, can lead to genomic instabilities such as chromosomal aberrations 
and genetic mutations.99 However, it is encouraging that other surface coatings (citrate and 
HL) generated almost no transcriptomic changes at dosage levels meant to mimic 
environmental exposure.  
 With HDF cells, we have shown that while some surface modifications of Au NPs 
disrupt cells by inducing oncogenic pathways, other chemistries seem to be completely 
benign. Our findings that cells are nearly unaffected by citrate Au NPs on the level of gene 
expression with both HDF and PC3 cells are interesting in comparison to other published 
results with the same NPs. Massich et al. found similarly sized (15 nm) citrate Au NPs to be 
responsible for increased cell growth and apoptosis induction in HeLa at 10 nM 
concentrations,28 while Li et al. measured decreased cell cycle progression and increased 
oxidative stress in lung fibroblasts with 20 nm citrate Au NPs at 1 nM.101 We also found 
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many changes induced by polyelectrolytes (PAH) when coating Au NPs, whereas Hauck et al. 
found no significant changes with poly(diallyldimethylammonium chloride)-coated gold 
nanorods (we note, however that PAH contains primary amines but the Hauck et al. polymer 
contains quaternary ammoniums).32 This is further evidence of the importance of cell type 
and dosage in determining the effect of surface-modifed Au NPs on cellular transcriptome. 
 The effect of cell type and dosage was observed within this study. In switching from 
HDF to PC3 cells and 0.1 nM to 1 nM Au NP media concentrations, many more genes were 
changed in more intricate ways between Au NP samples. Various cancer-related pathways 
such as inflammation and proliferation may be activated by HL, PAH and L-PAH Au NPs in 
PC3 cells. Because many of the differentially expressed genes are related by pathway (i.e. 
NF-κB for PC3 cells) it is very difficult to tell which genes could have been changed by direct 
interaction with Au NPs and which are differentially expressed due to down-stream signaling 
from that interaction. It should also be understood that not all of these changes to gene 
expression will cause down-stream physiological effects. Despite this, we have shown that 
the underlying surface chemistry is important, possibly in terms of outer layer structure and 
lability, and that the initial surface charge may affect electrostatic interactions with proteins. 
The initial surface chemistry and Au NP dosages also determine the concentration of Au NPs 
inside the cells, but even the uptake rate is also dependent on cell type (i.e. PAH Au 
NP/cell). Overall, our results and analysis reveal a cell-specific complex relationship between 
surface coating and toxicity mechanism due to a combination of factors, including uptake 
rate, coating lability and electrostatic NP-protein interactions.  
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CHAPTER 4: 
Long-Term Evaluation of Acute and Chronic Exposures of 
Human Cells to Low Doses of Surface-Functionalized Gold 
Nanospheres and Nanorods 
 
4.1 Introduction 
Gold nanoparticles (Au NPs) are promising materials for solving a wide range of 
issues, especially within the field of medicine.1–4 The extraordinary combination of factors 
make them ideal for biological applications ranging from sensing, to targeted drug delivery 
and therapy, to diagnostic imaging.1–4 Many of the applications of Au NPs are based on their 
plasmonic properties; upon irradiation of Au NPs with a certain frequency of light, a surface 
plasmon resonance is generated.1–7 This phenomenon induces strong local electric fields, 
absorption and scattering of light, and “localized” heat generation.1–7 NPs in general have 
high surface areas and can be transported through the body to be taken up by cells, and Au 
NPs (above ~4-5 nm) are relatively chemically inert compared to other plasmonic metal 
NPs.1–4,8,9 The wavelength of (visible to near-infrared) light that induces a plasmon depends 
on many factors, including the size, shape and dielectric constant around the NPs.5–7 Thus, 
both the physical and optical properties are highly tunable through scalable, water-based 
synthetic conditions and facile post-synthetic surface functionalization techniques.1,10–16  
With the increased relevance of inorganic NPs in biological systems, regulatory 
agencies are raising some concerns regarding NP adverse effects in human health and in 
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the environment.9,17–21 The scientific community has responded with exponential increases 
in the number of publications on nanotoxicology since the first published use of the word in 
2004.22-23 There are considerations unique to NP-cell/body interactions (as opposed to 
small molecules) that need to be thoroughly understood for safe and optimized use in 
medical applications and commercial products.9,17–21 The same properties that allow us to 
add targeting surface moieties and to access the inside of cells make cell-NP interactions 
more difficult to predict. In addition to the size, shape and composition of the NP itself, the 
interactions between organic surface coatings and biological environments must be 
analyzed and other variables such as aggregation state must be considered.9,17–21  
Many papers have investigated the acute impact of Au NPs on cultured cells and 
have found that the toxicity indeed depends on Au NP physiochemical properties such as 
size and surface chemistry. A majority of toxicity studies have found Au NPs to be rather non-
toxic, as long as they are above the 4-5 nm threshold below which NPs have sufficient 
surface area and reactivity to induce cytotoxicity.8,9,24–26 Au NPs within this size range that 
are found to cause toxic effects to cells often have inherently toxic surface coatings.19,25–27 
Most other findings of acute toxicity can be attributed to the use of very high concentrations 
(Klebtsoc and Dykman suggest an upper limit of 1012 particles/mL) and different cell type 
sensitivities.17,26,28–32 The physiochemical properties also affect the ability of the cell to 
uptake the NPs, which itself can influence toxicity.33–37 Most of the literature available on 
the toxicological impact of Au NPs focuses on whether or not there is an acute stress 
response (viability, oxidative stress, apoptosis).38–40 However, at low concentrations, signs of 
toxicity may be difficult to distinguish based on typical markers. The absence of a direct 
cytotoxic response does not rule out more subtle non-toxic biological responses on many 
levels. For instance, cells exposed to sub-cytotoxic doses of different Au NPs have shown 
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been shown to undergo morphological changes accompanied by F-actin disruption in human 
dermal fibroblasts.41 Others have found Au NPs to alter cell migration and proliferation, stem 
cell differentiation, and membrane receptor internalization.42–46 
On a molecular level, many chemicals that trigger changes to signaling pathways and 
induce molecular responses illicit no acute response.38,39,47 The acceptance of certain Au 
NPs as non-toxic makes a deeper understanding of their interactions with biological systems 
even more imperative. The surface chemistry of Au NPs most likely plays the largest role in 
determining the interactions of Au NPs with biomolecules.40 High local concentrations of 
charged ligands on NP surface may interact with cell receptors differently than the ligands 
would alone, resulting in unexpected cell signaling changes.2,36,48 It is also well-known that 
NPs bind free molecules in the biological milieu, typically resulting in hard and soft (dynamic) 
protein coronas.49,50 The composition of the protein coronas can depend on the identity, 
density, lability, hydrophobicity and charge of the surface ligands.51–53 As biochemical 
signaling molecules adhere to NPs and/or change structure, they become less bioavailable 
and can thus alter cell signaling.2,36,54–56 There is even cause for concern that biomolecules 
could become inactive by denaturation after contact with NPs.36 Size and shape may affect 
these interactions as well by influencing both uptake rates (as does surface coating) and 
contact area between biomolecules and NP surfaces.8,26,27,33,48,57 A reliable and quantitative 
way to measure effects of NP shape, size and surface coating to cell signaling and 
biomolecule availability is to perform gene expression profiling. Analysis of gene expression 
can determine which cellular pathways are affected by NP exposure in order to elucidate 
subtle cellular changes and provide mechanistic insight into NP-cell interactions on a 
molecular level. 
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Various shapes, sizes and surface modifications of Au NPs have been tested in vitro 
at the level of gene expression after acute exposure. Khan et al. found that 18 nm citrate Au 
NPs at 2.0 nM in HeLa cells (6 hour exposure time) only significantly changed gene 
expression of four out of 19,000 human genes, while another study determined that 17 nm 
citrate Au NPs at 10.0 nM in HeLa cells induced large up-regulation of genes related to cell 
cycle control and early apoptosis (nucleic acid-coated Au NPs did not).58-59  Polyelectrolyte-
coated gold nanorods induced minimal response to HeLa cells at 25 µM gold (~0.05 nM 
NPs).37 Previous work in our lab has shown that differently surface-functionalized 20 nm Au 
nanospheres induce gene expression patterns based on uptake rate, coating lability and 
electrostatics; 0.1 and 1.0 nM citrate Au NPs caused almost no significant changes over 
14,000 genes.56 Manshian et al. revealed that hydrophobicity, as opposed to surface 
charge, was the main cause of the changes in the expression of genes related to 
inflammation and autophagy pathways.60 PEGylated gold nanorods at 25 µg/mL (~0.25 nM)  
exposure were found by one group to up-regulate inflammatory, apoptotic and DNA damage 
repair gene expression in human skin cells, while smaller PEGylated gold nanorods at 50 
µg/mL (~2 nM) down-regulated similar genes in an earlier study on HaCaT cells.61,62 The 
combined results of the studies available of gene expression analysis of cells exposed to Au 
NPs indicate the importance the physicochemical parameters of the NPs on cell response on 
a molecular level. 
Despite the ever-widening range of knowledge into the effects of NPs and their 
physical parameters on cells, there are still many unknowns in the big picture. Firstly, many 
studies use very high concentrations of NPs (that would be unrealistic to encounter in most 
situations of exposure) in order to measure an effect.3,17–21,26 It is important to do more 
rigorous studies at low, realistic dosages. Furthermore, it is most likely that accidental 
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exposure to Au NPs would occur in long-term low-dose exposures.38,39,47 It is rare to find 
data on cellular response to NPs in vitro longer than 24-72 hours, and most long-term 
studies that have been done used Ag, TiO2 or ZnO NPs.63–68 More in vivo studies exist, but 
these typically focus on biodistribution.69–73 In vivo studies have obvious advantages, but 
long-term in vitro studies are also required to thoroughly characterize subtle interactions in a 
highly controlled environment.9,20,21 Finally, most studies of Au NP effects on cells only 
include one shape, size and/or surface coating; a lack of standardization between studies 
(including cell type, NP concentrations/dosages and incubation times) means separate 
research can often not be directly prepared.9,17–21,25 Along these same lines, there is a lack 
of thorough characterization and reporting of the material properties of the Au NPs being 
tested, with the surface chemistry being both the most important and least reported factor. 
Other times, more than one variable (often NP shape and surface chemistry) is tested in the 
same sample and conclusions about the effect of one of those variables cannot be 
determined.61,74–76  
Herein, we report (to our knowledge) the first study comparing in vitro long-term (20 
weeks) effects of cell exposure to Au NPs with varying shapes and surface coatings under 
both “non-chronic” (initial acute cell exposure, followed by 20 weeks in NP-free cell media) 
and chronic (exposure to Au NPs continuously over 20 weeks) conditions. Cell viability, 
proliferation, morphology and gene expression over 84 genes was tested, along with the 
levels of cellular uptake of each NP type. We study the effects at the molecular and cellular 
levels, while also attempting to address some of the above-mentioned issues; long-term, low 
doses of Au NPs applied to a commonly-used skin cell model to mimic unintentional 
environmental exposure. Additionally, the ability of cells to recover properly from acute NP 
exposure over time is tested by “non-chronic” experiments. By coating Au nanospheres and 
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Au nanorods in two different functionalities each (20 nm Au nanospheres, with citrate or 
poly(acrylic acid) (PAA); aspect ratio 3 Au nanorods with PAA or PEG) and also having a 
common surface coating (PAA) between the two NP shapes, comparison of the gene 
expression changes induced by both shape and surface coating of Au NPs was done within 
the same experiment.  
 
4.2 Materials and Methods 
4.2.1 Materials 
 Gold (III) chloride triydrate (HAuCl4•3H2O, ≥99.9%), sodium borohydride (NaBH4), 
poly(allylamine hydrochloride) (PAH, M.W. 17,500 g/mol), and poly(acrylic acid, sodium salt) 
(PAA, M.W. 15,000 g/mol) were purchased from Aldrich and used as received. Sodium 
citrate tribasic dihydrate (C6H5Na3O7•2H2O, ≥99%) and silver nitrate (AgNO3, ≥99.0%) were 
obtained from Sigma-Aldrich, and hexadecyltrimethylammonium bromide (CTAB, for 
molecular biology) and L-ascorbic acid (BioXtra, ≥99.0%, crystalline) from Sigma; all used as 
received. Methoxypolyethylene glycol thiol (mPEG-SH, M.W. 5,000 g/mol) was purchased 
from Nanocs and stored at -20°C. All glassware was clean with aqua regia prior to 
nanoparticle synthesis. All solutions were made with ultrapure deionized water (18.2 MΩ, 
Barnstead NANOpure II). All cell culture and experiments involving cells were completed in a 
sterile environment with autoclaved supplies. Cell media contained Dulbecco’s modified 
eagle medium (DMEM, without phenol red), nonessential amino acids and 1% penicillin-
streptomycin solution from Mediatech, along with 10% fetal bovine serum (FBS) from Gemini 
Bio-Products.  
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4.2.2 Synthesis and Preparation of Gold Nanoparticles 
 20 nm spherical gold NPs were prepared by a scaled-up Turkevich synthesis 
method.77,78 25 mL of 0.01 aqueous mM HAuCl4 was added to 975 mL of ultrapure 
deionized water and the solution was brought quickly to a rolling boil with rapid stirring. 20 
mL of 5% (w/w) sodium citrate was added and the heat was lowered to keep solution at a 
gentle boil. After 30 min, another 5 mL of 5% sodium citrate was added and the solution 
was stirred for 10 more minutes. The heat was then turned off, and the solution was allowed 
to cool to room temperature slowly on the hotplate. The particles were cleaned by 
centrifugation at 8,000 rcf for 20 min and resuspended in minimal water. These as-made 
NPs were used in exposure experiments as “citrate spheres”.  
 To make poly(acrylic acid)-coated nanospheres (“PAA spheres”) the as-made citrate 
NPs were wrapped first with PAH polyelectrolyte followed by a PAA layer following typical 
layer-by-layer procedures.79,80 A portion of citrate Au spheres were diluted back to their as-
made concentration in water. 25 mL of 0.01 M NaCl and 50 mL of 10 mg/mL PAH (with 1 
mM NaCl) were combined, then slowly added to 1 L of NPs while stirring vigorously. The 
solution was allowed to stir for 3 h, then centrifuged at 8,000 rcf for 20 min and 
resuspended in 1 L of water. The procedure was repeated a second time with 10 mg/mL 
PAA solution (with 1 mM NaCl), and after centrifugation the solution was resuspended in 
minimal water to get “PAA spheres”. 
 Gold nanorods were produced via a scaled up seed-mediated silver-assisted 
method.81,82 Gold seeds were first made by combining 0.25 mL of 0.01 M HAuCl4 with 9.75 
mL of 0.1 M CTAB and stirring vigorously. 0.6 mL of freshly made, ice-cold 0.01 M NaBH4 
was injected into the solution, resulting in a brown solution. The seed solution was stirred for 
10 minutes and allowed to sit for 1 hour before use. Gold nanorods were synthesized in 2 L 
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batches by first mixing 16 mL of freshly made 0.01 M AgNO3 with 1900 mL of 0.1 M CTAB 
solution. Then 100 mL of 0.01 M HAuCl4 was added, turning the solution orange. 11 mL of 
freshly made 0.1 M ascorbic acid was then added, and the solution reverted to colorless. 
Finally, 2.4 mL of the gold seed solution was added, and the nanorod solution was stirred 
slowly overnight. The next day, the solution was centrifuged at 13,500 rcf for 20 min two 
times and finally resuspended to 40 mL in water.  
 The as-made gold nanorods contained a CTAB bilayer on the surface. Two techniques 
were used to make these into either “PAA rods” or “PEG rods”. Firstly, nanorods were 
modified by sequential layer-by-layer polyelectrolyte three times (PAA/PAH/PAA). 20 mL of 
the nanorod solution was diluted 2X in a centrifuge tube. 4 mL of 0.01 M NaCl and 8 mL of 
10 mg/mL PAA (with 1 mM NaCl) were added. The solution was put on a shaker for 2 hours, 
then centrifuged at 8,000 rcf for 20 min. This procedure was followed twice more, once with 
PAH and another with PAA, respectively. After the third and final coating of PAA, the “PAA 
rods” were redispersed in minimal water. To make “PEG rods” the CTAB layer was displaced 
by thiolated methoxy-PEG (mPEG-SH). 20 mL of as-made nanorods were diluted to 40 mL in 
water and 20 mL of 0.5 mM mPEG-SH was added. The solution was left on a shaker 
overnight, and centrifuged twice at 8,000 rcf for 20 min before being redispersed in minimal 
water. 
 Nanosphere solutions were characterized by UV-Vis spectroscopy (Cary 500 Scan UV-
vis-NIR spectrophotometer, Varian), dynamic light scattering (DLS), zeta potential 
measurements (ZetaPALS DLS/zeta potential analyzer, Brookhaven Instruments) and 
transmission electron microscopy (TEM, 2100 JEOL Cryo TEM). Nanorod solutions were 
characterized by UV-Vis, DLS, zeta potential measurements and TEM.  
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4.2.3 Cell Culture and NP Exposure Protocol  
 Human dermal fibroblast (HDF) cells were cultured for at least two passages before 
beginning the long-term (20 passages/weeks, 5 months) cultures. A schematic depicting the 
week-long cycle for exposing HDF cells to NPs over the course of 20 weeks is shown in 
Figure 4.1. Cells were plated at 100,000 cells per well in a 6-well plate with 1.2 mL of 
media. Cells were plated in three wells for controls that were never exposed to NPs and 
three wells (replicates) per sample type (CIT spheres, PAA spheres, PAA rods and PEG rods; 
chronic and “non-chronic”). At each passage, all cells were plated with NP-free media for 24 
h to ensure that NP sedimentation did not interfere with cell adhesion to the surface. During 
the first week of exposure, the media in all samples (other than controls, which was just 
changed with normal media) was changed to media containing 0.1 nM NPs 24 h after 
plating cells. After another 24 h, the NP-containing media on the non-chronic samples was 
removed and replaced with NP-free media. The non-chronic samples only received NP doses 
(0.1 nM) for this 24-hour period and never again throughout the study. The media on all 
samples was replaced again four days after plating, with new 0.1 nM NP/media solutions 
being added to chronic samples. After one week, cells in each sample were trypsinized and 
counted before being plated again in new 6-well plates at 100,000 cells/1.2 mL media/well. 
Only chronic samples were given NP-containing media after 24 h (all other samples received 
new media without NPs). This cycle continued for 20 weeks. In order to have enough cells to 
study at the end of the 20 weeks, we began plating extra cells from passage 17-19 to 
increase the total number of cells in each sample type. These extra wells were treated the 
same, based on sample type. 
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Figure 4.1 Schematics showing the exposure procedure for chronic and non-chronic 
samples. a) Chronic samples were plated at 100,000 cells/well and NPs/media (0.1 nM 
NPs) was added after 24 hours. NP/media solution was changed 3 days later, and cells 
were passaged after an additional 3 days to start a new cycle. b) Non-chronic were plated at 
100,000 cells/well and NPs/media (0.1 nM NPs) was added after 24 hours. NP/media was 
changed to just media after another 24 hours. Media was refreshed 2 days later, and 
another 3 days later, the cells were passaged. c) After the first week, the non-chronic 
subsequent passage cycles followed the chronic sample schedule, with no NPs added. 
Controls followed same schedule, with no NPs ever added. 
 
 
 
4.2.4 Viability and Proliferation Assays 
 A standard trypan blue assay, combined with automated cell quantification, was used 
to test the viability and proliferation rates of cells exposed to NPs for up to 14 days.83 
Samples were plated in triplicate (including controls) for each time point (72 hours, 7 days 
and 14 days) into 24-well plates at 40,000 cells/well with 0.5 mL of media. The cells were 
allowed to adhere to the plate overnight before the media was changed and replaced with 
0.5 mL of 0.1 nM NPs in all but controls. After 24 h, the media in non-chronic samples was 
replaced with NP-free media. 72 h after adding NPs, the samples for the 72-hour time-point 
were trypsinized, centrifuged and resuspended in 300 µL of media. 10 µL of cells/media 
was combined with 10 µL of trypan blue solution (0.4%, Invitrogen) and this solution was 
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counted using a Countess Automated Cell Counter (Thermo Fisher). This instrument counts 
cells in a 10 µL sample and differentiates between live and dead (based on trypan blue 
uptake).  
 In order to give the 7-day and 14-day samples enough room to keep growing, the 
cells were passaged and re-plated into larger wells. Four days after plating the cells, the 7-
day samples were trypsinized, centrifuged and re-plated into 6-well plates with 1.2 mL of NP-
free media. The next day, the media was again replaced by 0.1 nM NP/media in the chronic 
samples (and new media was given to all other samples). These cells were counted 7 days 
after adding NPs. The 14-day samples were re-plated into 60 mm dishes with 2.4 mL of 
media (with NPs being added to chronic samples again the next day). Media was changed 
again for the 14-day samples a few days later before counting those cells 14 days after 
originally adding NPs. 
 
4.2.5 Confocal Fluorescence Microscopy 
 To visualize any changes to cell morphology during chronic and non-chronic NP 
exposure, confocal fluorescence microscopy was done on cells exposed to NPs for 24 hours, 
48 hours and long-term (after 20 weeks). For the 24-hour and 48-hour samples, fresh cells 
were plated into 35 mm tissue culture dishes containing 14 mm glass-bottomed wells 
coated in poly-d-lysine (MatTek Corporation). In order to keep cells at low enough density to 
see individual morphologies, cells were plated at 4,000 cells/14 mm well. To keep the 
NP/cell concentration in these samples equal to the main 6-well exposure experiments, NPs 
were added at a concentration of 0.024 nM in 200 µL media. Cells were plated in NP-free 
media for 24 h before adding NP-containing media. Non-chronic 48-hour samples only 
received NP-laden media for 24 h. For the long-term samples, chronic and non-chronic cells 
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at passage/week 19 of exposure were plated the same way into MatTek dishes. Only 
chronic long-term samples were given NP-containing media after 24 h. Long-term samples 
were imaged 24 h after adding NPs (48 h after plating).  
 To prepare the samples for imaging, they were first fixed at the appropriate time 
point by adding 200 µL of pre-warmed 4% paraformaldehyde (in PBS) for 15 min. All steps 
were completed at room temperature. The fixative was washed away by three 2-5 min 
washes with PBS. The samples were then permeabilized with 0.5% Triton X-100 (Sigma, 
BioUltra) in PBS for 15 min, followed by three 2-5 min PBS washes. To prevent non-specific 
binding, 3% bovine serum albumin (BSA, ChemCruz) in DPBS was added for 1 hour. A 
working solution of 5 units/mL (~0.17 µM) fluorescein phalloidin (F-actin stain, Molecular 
Probes) in PBS was added to each dish for 90 min in the dark, followed by three 2-5 min 
PBS washes. Finally, samples were incubated in a 300 nM working solution of 4’,6-
diamidino-2-phenylidole dihydrochloride in PBS (DAPI, nuclei stain, Molecular Probes) for 30 
min. Samples were wash three times with PBS and stored in PBS at 4°C until imaging. 
Samples were imaged with a Zeiss LSM 710 multiphoton confocal microscope with the laser 
power, gain, magnification, and all other parameters held constant. Ten to twenty images 
were collected across two samples for each sample type. A threshold was applied to images 
in ImageJ software (NIH) to select only the cells and the area was measured to get average 
cell areas.84 Threshold values were held constant for all images within each time point, but 
was adjusted between time points. Cell area was calibrated to the number of cells per image 
by counting the nuclei.  
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4.2.6 Nanoparticle Uptake Measurements  
 The uptake of NPs into the cells was measured after 72 hours and long-term chronic 
exposure to NPs by inductively-coupled plasma optical emission spectrometry (ICP-OES; 
PerkinElmer 2000DV ICP-OES). For the 72-hour time-point, fresh cells were plated at 
100,000 cells/well in a 6-well plate with 1.2 mL media. To ensure that the concentration of 
NPs was high enough to be detected by ICP-OES, nine wells were plated per sample type to 
be combined into three ICP-OES samples per sample type. After 24 h, media was replaced 
with media containing 0.1 nM NPs (except for controls, which received NP-free media again). 
After another 48 h (72 in total), wells were washed three times with PBS (to remove excess 
NPs not endocytosed by cells) and trypsinized. Three wells were combined into each 15 mL 
centrifuge tube for ICP-OES samples to total three ICP-OES samples per NP type. Cells in 
each sample were centrifuged, resuspended in PBS and counted with a hemocytometer. 
Samples were then centrifuged again and redispersed in 1 mL of lysis buffer (2% Triton X-
100 in PBS). 1 mL of 30% hydrogen peroxide and 3 mL of 70% nitric acid were added to 
each tube to dissolve cell debris; tubes were left with caps loose inside acid hood overnight 
(CAUTION: be careful not to mix these chemicals at higher concentration of nitric acid, as the 
solution may become unstable. Must allow pressure release and handle inside hood with 
proper personal protective equipment (PPE)). The next day, 4 mL of fresh aqua regia (3:1 
HCl:HNO3) was added very carefully to each sample to dissolve gold (CAUTION: aqua regia is 
extremely corrosive and should be handled with proper PPE inside acid hood. Gas release 
from samples will occur, so allow pressure release by leaving tubes uncapped). These were 
left for three hours with loose caps in the acid hood before being diluted to 10 mL with 
ultrapure deionized water. These samples were analyzed by ICP-OES for gold content. 
Controls with cells and without cells (treated the same after the point of lysis buffer addition) 
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were made in triplicate. To minimize gold contamination from the laboratory, new bottles of 
reagents were opened and sterile serological pipettes were used in place of micropipettes. 
The same procedure was used for the long-term samples, except cells from passage/week 
19 long-term exposure were plated in the first step.  
 Transmission electron microscopy (TEM) was also used to visualize the uptake of NPs 
into the cells after 20 weeks. Three wells of cells from each sample type (chronic and non-
chronic, all four NP types) and controls were washed with PBS three times, trypsinized and 
centrifuged in microcentrifuge tubes. The cell pellets were then re-suspended in a few drops 
of pre-warmed, sterile-filtered Karnovsky’s fixative, followed by microwave fixation and 
washing in Sorenson’s buffer. A secondary 2% osmium tetroxide fixative was then added, 
followed by the addition of 3% potassium ferricyanide for 30 minutes. Samples were then 
washed with water and stained with saturated uranyl acetate and dehydrate with a series of 
increasing concentrations of ethanol. Samples then were transferred into epoxy using 
acetonitrile. These epoxy sample blocks were polymerized at 90°C overnight, trimmed and 
ultrathin sectioned with diamond knives. Sections were then loaded onto TEM grids, stained 
again with uranyl acetate and lead citrate, and imaged using an Hitachi H600 TEM at 75kV. 
 
4.2.7 RNA Extraction and Purification 
 RNA extraction and purification was performed in triplicate for long-term (20 weeks) 
samples and controls (unexposed cells cultured for 20 weeks) using the AllPrep® 
DNA/RNA/miRNA universal kit from Qiagen, according to the manufacturer’s instructions. 
Both genomic DNA and total RNA were collected, but only total RNA was used in this study. 
Briefly, after 20 weeks of culture under both chronic and non-chronic exposure conditions, 
cells from the samples in 6-well plates were trypsinized, centrifuged, then lysed and 
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homogenized with the lysis buffer provided with the kit. Lysate was transferred to a DNA 
Mini spin column in a collection tube and centrifuged. The RNAs were contained in the flow-
through, to which Proteinase K and ethanol were added for digestion. These samples were 
transferred to an RNeasy Mini spin column and centrifuged, leaving total RNA bound to the 
column. This was followed by a washing step, a DNase I digestion step, and various other 
washing steps to remove contaminants, according to the manufacturer’s instructions. Total 
RNA was eluted into RNase-free water and stored at -80°C. Samples were analyzed for 
concentration and purity by Nanodrop 1000 (Thermo Scientific) quantification. RNA integrity 
was verified by Agilent 2100 Bioanalyzer, and all samples have two distinct 28S and 18S 
peaks (28S:18S ~ 2.0) and RNA quality numbers greater than 8. 
 
4.2.8 Two-Step Real-Time Polymerase Chain Reaction (qPCR) 
 For mRNA expression analysis, the cDNA was first synthesized from 0.5 µg of total 
RNA using the RT2 First Strand Kit (Qiagen). The quantitative gene expression analysis was 
performed on cDNA using 2x RT2 SYBR® Green/ROX qPCR Mastermix (Qiagen) in PCR array 
plates (RT2 Profiler™ PCR Array Human Stress & Toxicity PathwayFinder, Qiagen) containing 
specific primers for 84 genes related to oxidative stress, inflammatory response, osmotic 
stress, hypoxia, cell death (apoptosis, necrosis and autophagy) heat shock proteins and DNA 
damage. The plates also contained ACTB, B2M, GAPDH, HPRT1, RPLP0 and HGDC primers 
as housekeeping genes, three reverse transcription controls and three positive PCR controls. 
Experiments were performed on LightCycler® 480 (Roche) instrument with cycle conditions 
comprised of one 10 min cycle at 95°C, followed by 40 cycles of 15 s at 95°C and 1 min at 
60°C. Melting curve analysis was performed for all samples. 
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4.2.9 Gene Expression Analysis 
Three housekeeping genes (ACTB, B2M and RPLP0) with stable expression levels 
across all samples were used to normalize the gene expression levels of all samples via 
geometric averaging. Relative fold expression differences and accompanying statistics were 
calculated by the ΔΔCt method and web-based RT2 Profiler™ PCR Array Data Analysis 
software (SABiosciences, http://www.SABiosciences/pcrarraydataanalysis.php). Relative 
fold changes (compared to measured levels in control samples) are expressed in log2 format 
so that down-regulation will be represented by a negative number and up-regulation by a 
positive number (with zero change relative to control being equal to a fold change (FC) of 
1.00). The STRING database version 10 was used to map functional interactions among 
genes differently expressed based on different sources, including experimental repositories, 
computational prediction methods, and public text collections.85 Individual networks were 
generated for each specific type of Au NP according to the exposure (chronic or non-chronic). 
 
4.3 Results 
4.3.1 Nanoparticle Characterization Results 
 In order to determine the effect of both surface coating and shape of Au NPs on long-
term gene expression changes, two shapes of Au NPs (nanospheres and nanorods), each 
with two different surface coating types, were synthesized and characterized. A schematic 
depicting the different types of Au NPs used in this study is shown in Figure 4.2. 
Nanospheres (20 nm) were made with either citrate or poly(acrylic acid) (PAA) coatings 
(denoted as “citrate spheres” and “PAA spheres”) and nanorods (average 48 nm x 16 nm) 
were made with either PAA or poly(ethylene glycol) (PEG) coatings (“PAA rods” and “PEG 
rods”). “Citrate spheres” were chosen because the boiling citrate method using sodium 
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Figure 4.2 Schematic of the gold nanoparticles used. Colors surrounding the nanoparticles 
correspond to surface coating layers of the color-coded molecules at the bottom of the 
figure. Surface charge of each layer is indicated by minus and plus signs within the layers. 
 
 
 
citrate as both the reducing agent and stabilizing agent is the most ubiquitous choice for 
synthesis of nanospheres and this leaves the as-made NPs with citrate on their surfaces. 
Two very popular choices for polyelectrolyte coating of Au NPs in this size range are cationic 
poly(allylamine hydrochloride) (PAH) and anionic PAA. In order to keep the charge the same 
between the two nanosphere types, PAA was chosen. PAH was also found to be more toxic 
to HDF cells (data not shown) and we were interested in long-term effects of non-cytotoxic 
Au NPs. Citrate on the surface leaves the Au NPs with a net negative surface charge, 
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allowing for coating with positively-charged PAH and subsequently negatively-charged PAA. 
Nanorods have cetyltrimethylammonium bromide (CTAB) bilayers on their surfaces after 
synthesis and cannot be used in biological environments as-is because CTAB is highly toxic. 
Nanorods are made biocompatible by either overcoating it with polyelectrolytes or by 
displacing the CTAB bilayer. We wanted to test nanorods made by both of these routes. In 
order to compare two NPs with nearly identical surfaces but different shapes, nanorods with 
a final layer of PAA were created in the same way as PAA spheres, except the first layer is 
positively-charged CTAB. Three layers of polyelectrolytes were used rather than one PAA 
layer in order to ensure the biocompatibility of the nanorods (one layer is not sufficient to 
prevent CTAB from leaching out). A well-studied surface functionalization on nanorods is 
PEG, which when conjugated to a thiol, covalently binds to the gold surface and can displace 
CTAB; this neutral, anti-fouling coating was the choice for the final NP type tested. 
After synthesis of the Au NP cores, the NPs were fully characterized by transmission 
electron microscopy (TEM), UV-Vis spectroscopy and dynamic light scattering (DLS)/zeta 
potential measurements. To verify that the subsequent surface modifications were 
successful, a combination of UV-Vis, DLS and zeta potentials were used after each step. The 
characterization results are tabulated in Tables 4.1-4.2 for the separate NP types at each 
coating step. UV-Vis spectra of the NP types at each coating step are in Figure 4.3 and TEM 
images of spheres and nanorods are shown in Figure 4.4.  
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Table 4.1 Characterization Results for CIT Spheres and PAA Spheres 
 
Table 4.2 Characterization Results for PAA Rods and PEG Rods 
 
       
Figure 4.3 UV-visible spectra of all four nanoparticle type used in water. Spectra for each 
step of the coating procedure shown. a) CIT spheres, b) PAA spheres (layer one = CIT, layer 
two = PAH, layer three = PAA), c) PAA rods (layer one = CTAB, layer two = PAA, layer three = 
PAH, layer four = PAA) and PEG rods (original CTAB coating replaced by PEG). All spectra 
within the same plot are normalized to the transverse peaks. 
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Figure 4.4 Representative transmission electron microscopy images of gold nanoparticles as 
a) spheres (18.4 nm ± 2.0 nm) and b) rods (46.0 nm ± 4.1 nm; 15.9 nm ± 2.6 nm). 
 
 
 
 
4.3.2 Nanoparticles Do Not Have Large Effect on Viability Nor Proliferation 
Viability and proliferation studies were conducted on cells that were exposed to 0.1 
nM NPs for 3, 7 and 14 days, with media changes and passages into larger plates as 
necessary. Non-chronic samples were tested as well, after receiving NPs for the first 24 
hours only. Upon trypan blue viability testing and cell growth rate measurements, very little 
difference was observed between NP-treated and control samples (Figure 4.5). Chronic PAA 
rods and chronic PAA spheres were statistically different from controls after 7 (rods only) 
and 14 days (both), but viability was above 92% in all instances. Additionally, cells were 
counted at each passage throughout the long-term study (data not shown) and cell numbers 
stayed steady for each sample type. Cell numbers at 3, 7 and 14 days did not significantly 
vary from control for any NP sample type, indicating no effect of NPs on proliferation. No 
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Figure 4.5 a) Viability and b) proliferation results for HDF cells exposed to 0.1 nM CIT 
spheres, PAA spheres, PAA rods and PEG rods both chronically and non-chronically at 3, 7 
and 14 days. *p < 0.05, **p < 0.01 versus control. 
 
 
 
statistical difference were observed between chronic and non-chronic samples of the same 
NP type. 
 
4.3.3 Nanoparticles Exert Little Change on Morphology of HDF Cells 
Morphology imaging was done to compare the short- and long-term effects. 
Morphology imaging was done by plating cells in small, poly-lysine coated dishes, then 
exposing these cells to NPs for 24 hours or 48 hours. Cells were fixed and prepared for 
confocal fluorescence microscopy at the specified time points. 72 hour samples were 
 140 
 
attempted, but this cell type is difficult to grow for 72 hours at a low enough cell density to 
avoid near-complete monolayer formation, which rendered morphological examination 
impossible. Non-chronic 48-hour samples were exposed to NPs for 24 hours then the 
NP/media was replaced with fresh media until fixation at 48 hours. Long-term samples were 
moved to poly-lysine dishes, allowed to adhere for 24 hours and given NPs (for chronic 
samples only) for another 24 hours before fixation. Typical images for each time point are 
shown in Figures 4.6-4.8. Average cell area was calculated for each sample type (Figure 
4.9). At 24 hours, the cells in the PEG samples were smaller, and at 48 hours all non-chronic 
samples has significantly decreased cell areas. The cell areas measured the same as 
controls in the long-term samples, except for non-chronic PAA rods and non-chronic and 
chronic PEG rods, which had increased cell area relative to controls. 
 
 
Figure 4.6 Confocal fluorescence micrographs of HDF cells exposed to a) no NPs (control), b) 
citrate spheres, c) PAA spheres, d) PAA rods and e) PEG rods for 24 hours. Green signal = 
phalloidin stain for actin, blue signal = DAPI stain for nuclei. All scale bars are 50 µm. 
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Figure 4.7 Confocal fluorescence micrographs of HDF cells exposed to a) no NPs (control), b) 
non-chronic citrate spheres, c) non-chronic PAA spheres, d) non-chronic PAA rods, e) non-
chronic PEG rods, f) chronic citrate spheres, g) chronic PAA spheres, h) chronic PAA rods and 
i) chronic PEG rods for 48 hours. Non-chronic samples exposed to NPs for 24 hours only, 
then media for 24 hours. Green signal = phalloidin stain for actin, blue signal = DAPI stain 
for nuclei. All scale bars are 50 µm. 
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Figure 4.8 Confocal fluorescence micrographs of HDF cells exposed to a) no NPs (control), b) 
non-chronic citrate spheres, c) non-chronic PAA spheres, d) non-chronic PAA rods, e) non-
chronic PEG rods, f) chronic citrate spheres, g) chronic PAA spheres, h) chronic PAA rods, 
and i) chronic PEG rods over 20 weeks. Cells plated into glass-bottomed lysine-coated 
dishes for imaging; NPs added to chronic samples after 24 hours; cells allowed to adjust for 
48 hours total before fixation. Green signal = phalloidin stain for actin, blue signal = DAPI 
stain for nuclei. All scale bars are 50 µm. 
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Figure 4.9 Average area (µm2) per cell at a) 24 and b) 48 hours, and c) 20 weeks. *p < 
0.05, **p < 0.01 relative to control. Error bars represent standard deviation. 
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4.3.4 Relative Uptake Rates For Different Nanoparticles are Consistent Over Time 
 The number of NPs uptaken by cells was measured for chronic incubations of each 
NP type (Figure 4.10). Non-chronic samples were not run because the low levels of NPs were 
undetectable by inductively-coupled plasma optical emission spectroscopy (ICP-OES). 
Uptake measurements were compared between short- and long-term exposures by 
measuring the gold content inside cells exposed to NPs for 72 hours and cells that had been 
chronically exposed to NPs for 20 weeks. At both time points, PAA spheres were 
endocytosed at higher levels than CIT spheres and PAA rods were ingested more than PEG 
rods. At 72 hours, CIT spheres were the least preferred for uptake and at 20 weeks, PEG 
rods were the least preferred. In both cases, PAA rods were uptaken much more than all 
other NP types. The general trend (PAA rods > PAA spheres > CIT spheres/PEG rods) is 
consistent between the time points. The number of NPs found in cells was comparable in 
the same order of magnitude between 72 hours and 20 weeks. 
 
4.3.5 PEG Rods Do Not Accumulate in Vesicles, But Escape to Cytosol 
 Examination of TEM samples of cells (Figure 4.11) after 20 weeks found no NPs still 
present in the cells 20 weeks after acute exposure (non-chronic). Dark lamellar bodies were 
present in all sample types (both chronic and non-chronic), but were also very prevalent in 
the control cells. Lamellar bodies (often termed myelin figures) appear as dark spots after 
staining in TEM and are common structures often associated with cell stress when found in 
fibroblasts when lipid metabolism is disturbed.86  However, as these were present in control 
cells as well, their presence cannot be linked to NP exposure. NPs were found in all of the 
chronic samples, and the shapes of the NPs are conserved. It was observed that while many 
NPs can be found together in large lysosomes in citrate spheres, PAA spheres and PAA rods 
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Figure 4.10 Average number of NPs per cell measured by ICP-OES analysis for gold content 
at a) 72 hours and b) 20 weeks. Stars above data points indicate significant difference 
versus CIT spheres, other differences denoted with brackets. c) Comparison of average 
number of NP per cell between short- and long-term experiments. Stars indicate significant 
different between short- and long-term samples of the same NP type. *p < 0.05, **p < 
0.01. Error bars represent standard deviation. 
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Figure 4.11 Transmission electron micrographs of samples under chronic exposure to a) 
citrate spheres, b) PAA spheres, c) PAA rods and d) PEG rods, after 20 weeks. All scale bars 
are 100 nm. 
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samples, most of the PEG rods were located directly inside of the cytoplasm or in relatively 
empty endosomes.87  
 
4.3.6 More Changes to Gene Expression are Measured in Non-Chronic Samples than in 
Chronic Samples 
 84 genes related to stress and toxicity pathways (oxidative stress, inflammatory 
response, osmotic stress, hypoxia, apoptosis, necrosis, autophagy, heat shock and DNA 
damage) were probed for gene expression levels in chronic and non-chronic samples (and 
controls) after 20 weeks. No sample amplification or non-specific amplification (melting 
curve analysis) was observed in 12 sets of primers and the corresponding genes were not 
considered (AQP2, AQP4, CD40LG, FTR, CRP, EPO, IFNG, IL1A, IL1B, IL8, MMP9 and TNF). A 
table of the genes tested and their associated pathways is shown in Table 4.3. 
Even after 20 weeks of continual exposure to Au NPs, the majority of the 72 genes 
was unaffected; only 25 genes (~35%) were significantly differentially expressed (log2 fold 
change [FC] > 1.5 or < -1.5 with a p-value < 0.05) in at least one sample type (chronic or 
non-chronic, any NP type). The number of genes significantly affected by these parameters 
for each NP type is shown in Table 4.4 and the specific genes with accompanying fold 
changes/p-values are tabulated in Tables 4.5-4.6. In order to see comparisons between 
sample conditions for the same gene, all genes with at FC > 1.5 or < -1.5 and p-value < 0.05 
for at least one sample type (chronic or non-chronic, any NP type) are grouped by pathway 
and color-coded based on up- or down-regulation for a quick visual in Table 4.7.  
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Table 4.3 Genes Probed by PCR Array 
Gene 
Entrez 
ID 
Gene Name Pathway 
ADM 133 Adrenomedullin Hypoxia 
AKR1B1 231 Aldo-keto reductase family 1, member b1  Osmotic Stress 
AQP1 358 Aquaporin 1 (Colton blood group) Osmotic Stress 
AQP2 359 Aquaporin 2 (collecting duct) Osmotic Stress 
AQP4 361 Aquaporin 4 Osmotic Stress 
ARNT 405 Aryl hydrocarbon receptor nuclear translocator Hypoxia 
ATF4 468 Activating transcription factor 4 Heat Shock/Unfolded Protein 
ATF6 22926 Activating transcription factor 6 Heat Shock/Unfolded Protein 
ATF6B 1388 Activating transcription factor 6 beta Heat Shock/Unfolded Protein 
ATG12 9140 Autophagy related 12 Autophagy 
ATG5 9474 Autophagy related 5 Autophagy 
ATG7 10533 Autophagy related 7 Autophagy 
ATM 472 ATM serine/threonine kinase DNA Damage Signaling 
ATR 545 ATR serine/threonine kinase DNA Damage Signaling 
BBC3 27113 BCL2 binding component 3 Heat Shock/Unfolded Protein 
BECN1 8678 Beclin 1, autophagy related Autophagy 
BID 637 BH3 interacting domain death agonist Heat Shock/Unfolded Protein 
BNIP3L 665 BCL2/adenovirus E1B 19kDa interacting protein 
3-like 
Hypoxia 
CA9 768 Carbonic anhydrase IX Hypoxia 
CALR 811 Calreticulin Heat Shock/Unfolded Protein 
CASP1 834 Caspase 1, apoptosis-related cysteine peptidase Apoptosis 
CCL2 6347 Chemokine (C-C motif) ligand 2 Inflammatory Response 
CD40LG 959 CD40 ligand Inflammatory Response 
CDKN1A 1026 Cyclin-dependent kinase inhibitor 1A (p21, Cip 1) Cell Cycle Checkpoint/Arrest 
CFTR 1080 Cystic fibrosis transmembrane conductance 
regulator (ATP-binding cassette sub-family C, 
member 7) 
Osmotic Stress 
CHEK1 1111 Checkpoint kinase 1 Cell Cycle Checkpoint/Arrest 
CHEK2 11200 Checkpoint kinase 2 Cell Cycle Checkpoint/Arrest 
CRP 1401 C-reactive protein, pentraxin-related Inflammatory Response 
DDB2 1643 Damage-specific DNA binding protein 2, 48kDa DNA Damage Signaling 
DDIT3 1649 DNA-damage-inducible transcript 3 Cell Cycle Checkpoint/Arrest, 
Heat Shock/Unfolded Protein 
DNAJC3 5611 DnaJ (Hsp40) homolog, subfamily C, member 3 Heat Shock/Unfolded Protein 
EDN1 1906 Endothelin 1 Osmotic Stress 
EPO 2056 Erythropoietin Hypoxia 
FAS 355 Fas cell surface death receptor Apoptosis, Autophagy, 
Necrosis 
FTH1 2495 Ferritin, heavy polypeptide 1 Oxidative Stress 
GADD45A 1647 Growth arrest and DNA-damage-inducible, alpha DNA Damage Signaling 
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Table 4.3 (Cont.) 
   
Gene 
Entrez 
ID 
Gene Name Pathway 
GADD45G 10912 Growth arrest and DNA-damage-inducible, gamma DNA Damage Signaling 
GCLC 2729 Glutamate-cysteine ligase, catalytic subunit Oxidative Stress 
GCLM 2730 Glutamate-cysteine ligase, modifier subunit Oxidative Stress 
GRB2 2885 Growth factor receptor-bound protein 2 Necrosis 
GSR 2936 Glutathione reductase Oxidative Stress 
GSTP1 2950 Glutathione S-transferase pi 1 Oxidative Stress 
HMOX1 3162 Heme oxygenase 1 Oxidative Stress, Hypoxia 
HSP90AA1 3320 Heat shock protein 90kDa alpha family class A 
member 1 
Heat Shock/Unfolded Protein 
HSP90B1 7184 Heat shock protein 90kDa beta family member 1 Heat Shock/Unfolded Protein 
HSPA4 3308 Heat shock 70kDa protein 4 Heat Shock/Unfolded Protein 
HSPA4L 22824 Heat shock 70kDa protein 4-like Osmotic Stress 
HSPA5 3309 Heat shock 70kDa protein 5 (glucose-regulated 
protein, 78kDa) 
Heat Shock/Unfolded Protein 
HUS1 3364 Checkpoint protein HUS1 Cell Cycle Checkpoint/Arrest 
IFNG 3458 Interferon, gamma Inflammatory Response 
IL1A 3552 Interleukin 1, alpha Inflammatory Response 
IL1B 3353 Interleukin 1, beta Inflammatory Response 
IL6 3569 Interleukin 6 Inflammatory Response 
IL8 3576 Interleukin 8 Inflammatory Response 
LDHA 3939 Lactate dehydrogenase A Hypoxia 
MCL1 4170 Myeloid cell leukemia 1 Apoptosis 
MMP9 4318 Matrix metalloproteinase 9 Hypoxia 
MRE11A 4361 MRE11 homolog A, double strand break repair 
nuclease 
Cell Cycle Checkpoint/Arrest 
NBN 4683 Nibrin Cell Cycle Checkpoint/Arrest 
NFAT5 10725 Nuclear factor of activated T-cells 5, tonicity-
responsive 
Osmotic Stress 
NQO1 1728 NAD(P)H dehydrogenase, quinone 1 Oxidative Stress 
PARP1 142 Poly (ADP-ribose) polymerase 1 Necrosis 
PRDX1 5052 Peroxiredoxin 1 Oxidative Stress 
PVR 5817 Poliovirus receptor Necrosis 
RAD17 5884 RAD17 checkpoint clamp loader component Cell Cycle Checkpoint/Arrest 
RAD51 5888 RAD51 recombinase DNA Damage Signaling 
RAD9A 5883 RAD9 checkpoint clamp component A Cell Cycle Checkpoint/Arrest 
RIPK1 8737 Receptor (TNFRSF)-interacting serine-threonine 
kinase 1 
Necrosis 
SERPINE1 5054 Serpin peptidase inhibitor, clade E (nexin, 
plasminogen activator inhibitor type 1), member 1 
Hypoxia 
SLC2A1 6513 Solute carrier family 2 (facilitated glucose 
transporter), member 1 
Hypoxia 
SLC5A3 6526 Solute carrer family 5 (sodium/myo-inositol 
cotransporter), member 3 
Osmotic Stress 
SQSTM1 8878 Sequestosome 1 Oxidative Stress 
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Table 4.3 (Cont.)   
   
Gene 
Entrez 
ID 
Gene Name Pathway 
TLR4 7099 Toll-like receptor 4 Inflammatory Response 
TNF 7124 Tumor necrosis factor Inflammatory Response 
TNFRSF10A 8797 Tumor necrosis factor receptor superfamily, 
member 10a 
Apoptosis, Necrosis 
TNFRSF10B 8795 Tumor necrosis factor receptor superfamily, 
member 10b 
Apoptosis 
TNFRSF1A 7132 Tumor necrosis factor receptor superfamily, 
member 1a 
Apoptosis, Necrosis 
TP53 7157 Tumor protein 53 DNA Damage Signaling 
TXN 7295 Thioredoxin Oxidative Stress 
TXNL4B 54957 Thioredoxin-like 4b Necrosis 
TXNRD1 7296 Thioredoxin reductase 1 Oxidative Stress 
ULK1 8408 Unc-51 like autophagy activating kinase 1 Autophagy 
VEGFA 7422 Vascular endothelial growth factor A Hypoxia 
XPC 7508 Xeroderma pigmentosum, complementation 
group C 
DNA Damage Signaling 
 
 
Table 4.4 Number of genes significantly differentially expressed by each sample type (0.1 
nM Au NP doses)a 
 
Chronic Non-Chronic 
 
Up-Regulated Down-Regulated Up-Regulated Down-Regulated 
Citrate Spheres 0 0 4 0 
PAA Spheres 1 2 4 1 
PAA Rods 1 5 2 3 
PEG Rods 3 3 10 8 
 
aGenes included have an average FC > 1.5 or < -1.5 and a p-value < 0.05 in at least one 
sample type. Entries that are significant in both aspects are highlighted in red (up-regulated) 
or blue (down-regulated).  
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4.4 Discussion 
 The goal of this study was to understand how Au NPs of different shapes and surface 
coatings affected cells over a long period of time at low, non-cytotoxic doses. Viability and 
proliferation tests over two weeks confirmed that 0.1 nM concentration and the individual 
types of Au NPs were indeed generally non-cytotoxic; viability never dropped below 92% for 
any sample type. The concentration is a major factor in ensuring that the NPs do not induce 
acute toxicity, as others have found citrate Au NPs of slightly smaller diameters to induce 
changes to cell area and morphology in the same HDF cells at very high concentrations 
(from 0.1 mg/mL up to 0.8 mg/mL or about 7 nM to 57 nM; 0.1 nM of 20 nm citrate Au NPs 
is approximately 0.005 mg/mL) over 6 days, though direct toxicity was never measured.29 
Another group found these 13 nm citrate Au NPs to induce apoptosis at about 0.1 mg/mL (7 
nM) as well.30 However, earlier work in our lab with the same HDF cells has found 20 nm 
citrate Au NPs to induce negligible changes to viability from 0.1 nM to 2.0 nM.56,41   
We also observed minimal changes to cell morphology between controls and NP 
samples at each time point tested. Actin structures did not appear to change in any 
discernible way. However, at 24 hours, cell area decreased significantly for PEG rod samples 
and all non-chronic NP samples decreased in cell area from control at 48 hours. After long-
term exposure, the decrease in cell area recovers in the non-chronic samples and cell area 
actually increases for non-chronic PAA rods and both chronic and non-chronic PEG rods. 
Pernodet et al. and Mironava et al. report a decrease in cell area with increasing 
concentrations of 13 nm citrate Au NPs and an increase in cell aspect ratio with 13 and 45 
nm citrate Au NPs; again these are at much higher concentrations and morphology analysis 
was done with cells in near-monolayers in some samples but not others by Mironava et 
al.29,30 Yang and coworkers also found that 20 nm citrate Au NPs disrupted F-actin fibers in  
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HDF cells, but at 1.0 nM.41 Increases in the cell size over time are observed, but are 
consistent between all the samples, including the control. As the HDF cells age, they tend to 
get larger, and at the end of the study the cells were nearing senescence.88 However, the 
cells were still dividing and growing as the number of cells each passage stayed steady. 
Additionally, the CDKN1A gene (an indicator of senescence when up-regulated) was not 
differentially regulated by any samples compared to control.89 
Uptake of the NPs by HDF cells was highly dependent on both surface coating and 
shape. The level of NP uptake is a big factor for determining the impact that the NPs will 
have on the cells. PAA spheres were taken up by cells about 3 times more than citrate 
spheres at both 72 hours and long-term, and PAA rods were taken up almost 6 and over 30 
times more than PEG rods at 72 hours and 20 weeks, respectively. PAA-coated spheres 
were also found to be more readily endocytosed by SK-BR-3 cells than citrate spheres by 
Cho et al. and PEG has been shown to decrease the uptake of NPs.90–92 Interestingly, 
nanorods were highly preferred for uptake by HDF cells over spheres with PAA coatings. At 
72 hours, 4.0 times more PAA rods were uptaken than PAA spheres, with the difference 
moving closer to 4.5 times after 20 weeks. This is directly opposed to the general consensus 
that nanorods are more difficult for cells to endocytose than spheres of similar sizes, but 
there are few studies in which shape effects are measured with surface chemistry being 
properly controlled. For instance, Schaeublin et al. compared uptake rates between 3-
mercaptopropanesulfonate spheres and PEG-coated nanorods, Zhang et al. and Wang  et al. 
between citrate spheres and polyelectrolyte-coated nanorods, and Favi et al. between citrate 
spheres and HEPES-reduced nanostars.61,74–76 Some studies use spheres and nanorods 
both with CTAB surfaces, but CTAB breaks down the cell membrane; Chithrani et al. tried to 
replace CTAB on nanorods with citrate to compare uptake to citrate spheres, but it is unlikely 
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that citrate could effectively displace CTAB bilayers.93–95 However, other reports that did 
compare like-functionalized NPs found PEGylated spheres and nanorods to have 
comparable uptake rates, longer tannic acid-coated nanorods to have increased 
internalization than shorter nanorods, and transferrin- or (1-mercaptoundec-11-
yl)hexaethylene glycol-coated spheres to be more readily uptaken than nanorods in different 
cell types.92,96–98  
Chronic uptake levels were slightly increased after 20 weeks compared to 72 hours, 
but not by much. This can be due to a few factors, including passaging the cells, cells 
splitting into daughter cells, and exocytosis processing.99,100 The balance between these 
factors kept the NPs inside cells more or less steady between time points. No NPs were 
observed in non-chronic samples after 20 weeks by TEM, and many NPs were found in cells 
in chronic samples by TEM. It is well-known that NPs in this size range are uptaken by cells 
via receptor-mediated endocytosis and usually stay inside of endosomes and lysosomes.100 
However, PEG rods were almost exclusively found outside of distinct vesicles, unlike the 
other NP types tested. Occasional lysosomal escape have been reported with positively and 
negatively charged gold nanorods before, and it was found that PEGylated gold nanospheres 
escaped into the cytoplasm of macrophages while cationic, cysteamine-coated NPs did 
not.101,102  
 Our gene expression results show that a very low concentration of NPs (0.1 nM) was 
able to impact the gene expression of HDF cells. Though the fold changes are relatively low, 
the fact that there are perturbations to gene expression, even 20 weeks after any NP 
exposure for some samples, is concerning. For chronic exposure conditions, different 
profiles of gene expression were observed according to NP type. Cells treated with citrate 
spheres did not show significant changes in the expression of any of the genes evaluated. 
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PAA rods down-regulated genes related to inflammation (CCL2), metabolism (SCL2A1 and 
VEGFA) and cell cycle regulation and apoptosis (GADD45A, TNFRSF10A and TP53). PEG rods 
also down-regulated genes related to apoptosis (TNFRSF10A and BBC3). On the other hand, 
genes related to antioxidant pathways such as NQO1 and PRDX1 were up-regulated by PEG 
rods and the heat shock protein-coding gene HSPA5 was up-regulated by PAA rods. For the 
non-chronic exposure conditions, the results show more of a pattern of gene expression 
among the different types of NPs. Overall, genes related to antioxidant (FTH1 and PRDX1) 
and proteotoxic stress (HSPA5) pathways were up-regulated. The MCL1 (anti-apoptotic gene) 
was significantly induced by all types of NPs while AQP1, important for the maintenance of 
cell homeostasis, was down-regulated by PAA spheres, PAA rods and PEG rods with non-
chronic exposure. PAA rods were the only NP type in the non-chronic samples to not 
significantly up-regulate the tested anti-oxidative stress genes.  
Shape did not seem to have as large of an effect on gene expression as did surface 
coating. Even though the PAA rods were uptaken by cells at levels many times higher than 
their spherical counterparts, they had similar amounts of changes to gene expression (11 
genes changed for PAA rods versus 8 genes for PAA spheres, over both exposure 
conditions). However, in non-chronic samples, there are similar patterns of gene expression 
changes between citrate spheres and PAA spheres. Half of the genes with altered 
expression in the citrate spheres samples were also altered by PAA spheres and PAA rods, 
but two of the genes (PRDX1 and FTH1, related to oxidative stress) are not significantly 
changed by PAA rods.  
Surprisingly, though PEG rods were the least endocytosed NPs after long-term 
culture, they induced the most gene expression changes among the genes probed (18 in 
total). IL6 was about 12 times more expressed than in control cells. Although some different 
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genes were down-regulated compared to other NP types, gene categories that were affected 
were similar (oxidative stress, inflammation, cell cycle checkpoint/arrest and cell death). 
PEG is often used to increase circulation time in vivo by way of reducing cell uptake and is 
considered to be highly biocompatible.103,104 However, we have found that PEG rods are 
able to interact more freely with the contents of the cytoplasm without a barrier (endosomes 
or lysosomes). This is most likely the reasoning behind their enhanced gene expression 
changes relative to the other NP types, despite the fact that PEG-coated NPs have been 
shown to adsorb fewer proteins than other, charged surface coatings.103 Functional network 
analysis using the STRING database of the 18 genes significantly differentially expressed by 
non-chronic PEG rods samples (Figure 4.12) shows connections between these genes. 
Groups of genes related to oxidative stress, cell cycle arrest and inflammatory response are 
mostly up- or down- regulated similarly in this network.  
In addition to surface coating, time of exposure had a large impact on determining 
the level of gene expression changes after 20 weeks: most of the gene expression changes 
didn’t occur within the chronic PEG rod samples, but within the non-chronic PEG rod 
samples. Chronic PEG rods only induced 6 significant changes and non-chronic PEG rod 
samples had 18. All of the genes that were up-regulated in chronic PEG rod samples were 
also up-regulated in non-chronic PEG rod samples (EDN1, PRDX1 and NQO1), which are all 
related to oxidative or osmotic stress. VEGFA was up-regulated in non-chronic PEG rod 
samples, but down-regulated in chronic PEG rod samples. Schaeublin et al. used the same 
PCR arrays to test the effect of similarly sized PEG nanorods.61 While the doses used did 
decrease viability in HaCaT cells over 24 hours, comparison could be helpful: we found very 
different genes to be up-regulated by PEG rods to a much lesser extent (their up-regulated 
genes include GADD45A, PCNA, RAD23A, TNFRSF10, HSPA2, IL18, IL1A, IL1B, ANXA5, 
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Figure 4.12 Network of known functional interactions between significantly differentially 
expressed (FC > 1.5 or < -1.5 and p-value < 0.05) in the most highly affected sample type, 
non-chronic PEG rods. Network was built using STRING database version 10 at medium 
confidence levels (scores between 0.4 and 0.7). The relative thickness of lines connecting 
proteins indicates the confidence score of their interaction. Red arrows pointed up indicate 
genes that are up-regulated and blue arrows pointed down indicate genes that are down-
regulated. The solid line encircles a set of genes that are all related to oxidative stress, the 
dotted line encircles a set of genes all related to cell cycle checkpoint/arrest, and the 
dashed line encircles a set of genes all related to inflammatory response. 
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CASP1, CASP8 and EGR1) and some genes that were up-regulated at 24 hours were actually 
down-regulated by PEG rods in our study (GADD45G, TNFRSF10A).61 An earlier study by the 
same group used the same PCR array to look at exposure to PEG rods at about half the 
concentration we used (50 µg/mL versus ~100 µg/mL) and found CASP1, CHEK2 and 
GADD45A to be down-regulated immediately after acute exposure.62 All of the other non-
chronic NP sample types showed more significant changes (to different genes) than their 
chronic counterparts as well. The only gene similarly differentially expressed between 
chronic and non-chronic samples (besides in PEG rods) was HSPA5, a heat shock-related 
gene up-regulated by PAA rods. One gene, MCL1, was up-regulated in all NP types under 
non-chronic conditions. All non-chronic samples but citrate spheres had significantly down-
regulated AQP1 levels, and all non-chronic samples but PAA rods had significantly increased 
PRDX1 and FTH1 levels. None of these gene changes that are common among non-chronic 
samples were significantly changed in chronic samples by our parameters.  
These unexpected findings show that something is happening in the ability of these 
cells to reach molecular homeostasis after it is apparently disrupted by NP exposure. The 
cell response to insults or stressors (in this case the NPs) is an attempt by the cell to ensure 
survival. Chronic, low doses may lead to a prolonged change in cell physiology as part of an 
adaptive response to the long-term effects of a specific stimulus.105 The results obtained 
from the chronic exposure in the present study show that cell changes on the molecular 
level have possibly reached an adapted state. But between the chronic and the non-chronic 
samples, the gene expression profile is quite different; only four genes had similar 
expression patterns between chronic and non-chronic samples with the same NP type. The 
cells in the chronic samples seem to develop a tolerance to the Au NPs, while in the non-
chronic samples, the addition of Au NPs followed by their sudden removal has disrupted cell 
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processes to a level at which the cells cannot regain homeostasis. Biomarkers for heat 
shock/unfolded protein responses and cell cycle arrest are often down-regulated, while 
inflammation-, hypoxia- and oxidative stress-related genes are up-regulated in non-chronic 
samples. Chronic cell samples often have down-regulated biomarkers for cell stress. The 
non-chronic cells seem to be trying to regulate themselves in ways that the chronic cells no 
longer need to do.  
 
4.5 Conclusions 
In all, this study has shown that exposure of HDF cells to a very low concentration of 
Au NPs influenced their gene expression. The long-term effects of acute and chronic 
exposure to Au NPs of varying shapes and surface coatings have been shown to be largely 
different. Initial cellular responses to some NP types could be observed as reductions in cell 
area and slight decreases in viability. The recovery of cell area in non-chronic samples over 
time compared to control indicates that some processes that are affected by the exposure 
to NPs for short periods of time can recover in the long run. On the other hand, the gene 
expression data tells a different story; long-term effects of acute Au NP exposure can be 
more pronounced than with continuous, chronic exposure. Up-regulation of cytokines like IL-
6 and CCL2, anti-apoptotic MCL1, and hypoxia and oxidative stress markers 20 weeks post-
exposure indicates chronic inflammation and stress as a long-term response to acute Au NP 
exposure. We also found the down-regulation of genes related to cell cycle arrest and cell 
death in both chronic and non-chronic exposure conditions. Similar gene expression 
changes are often observed during the onset and progression of cancer.106,107 Long-term 
changes to components of apoptotic pathways can also make the cells more susceptible to 
cell death.108 Hypoxia, oxidative stress and inflammation in fibroblasts is especially of 
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concern as these cells are known have a large role in immune response and homeostasis of 
surrounding cells in tissues.109  
Surface chemistry of the NPs determined the extent to which gene expression 
changes would be induced. Citrate spheres are relatively benign to HDF fibroblasts, 
especially chronically. PAA spheres and PAA rods induced more changes. PAA rods were the 
only NP type not to activate anti-oxidant pathways (by the genes probed), but overexpression 
of the endoplasmic reticulum resident chaperone HSPA5 by PAA rods independent of the 
exposure conditions indicates that these NPs may be involved in inhibition of protein 
synthesis. This gene was overexpressed by all of the negatively charged NPs under non-
chronic conditions. PEG-coated rods by far induced the largest gene expression response. 
These NPs are able to travel into the cytoplasm of the cell as observed by TEM, which is 
possibly the root cause of increased stress-induced gene expression changes that were 
found with these Au NPs relative to the others. This study, relative to others, has also shown 
that the effect of shape on uptake levels may be highly cell-type and surface moiety-
dependent. Depending on surface chemistry, Au NPs at low doses that appear benign by 
various measures may still de-stabilize the regulatory responses of cells to induce cellular 
stress long after NP removal. 
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